data_2luv_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2luv _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . 0.481 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.817 0.341 . . . . 74.32 110.865 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 54.7 t -155.01 -40.05 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 72.12 111.107 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.18 -11.82 81.77 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.744 -0.741 . . . . 70.22 112.45 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.481 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.4 m-85 -85.43 -43.02 13.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.878 0.371 . . . . 74.44 110.905 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.427 ' O ' ' N ' ' A' ' 9' ' ' TYR . 22.3 m-85 -67.26 -32.8 74.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 75.21 110.889 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.4 mmtt -54.07 -33.67 58.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 73.05 110.887 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -108.76 -19.53 13.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 74.34 110.892 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 40.8 mm-40 -89.39 -46.33 8.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 72.03 110.925 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.427 ' N ' ' O ' ' A' ' 5' ' ' PHE . 10.0 t80 -64.1 -42.99 96.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 72.55 110.932 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.1 ptmt -66.55 -32.28 73.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.099 -0.5 . . . . 75.05 110.89 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -76.15 -36.5 58.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 71.2 110.913 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.5 mmt -76.97 -21.5 54.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 73.24 110.848 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 6.2 tpt -85.27 -36.3 20.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 64.33 110.897 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -76.64 -25.81 54.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.198 -0.456 . . . . 73.22 110.876 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.48 -30.97 42.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 72.44 110.919 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -94.75 -10.53 31.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 73.21 111.108 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.69 -10.3 55.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.205 -0.452 . . . . 74.5 110.919 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 120.24 42.85 0.49 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.778 -0.725 . . . . 72.45 112.501 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -47.46 -25.61 1.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.793 0.33 . . . . 74.14 110.921 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.96 -11.25 9.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 74.15 111.157 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -106.74 164.81 14.08 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.572 0.701 . . . . 64.55 111.136 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -4.46 14.05 Favored 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.719 2.279 . . . . 73.12 112.382 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -64.66 -30.64 71.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.456 . . . . 70.12 110.897 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.115 -0.493 . . . . 73.52 110.87 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . 0.473 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.834 0.349 . . . . 73.33 110.9 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 53.1 t -155.12 -39.71 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.281 -0.418 . . . . 75.44 111.092 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.44 -11.82 82.4 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.717 -0.754 . . . . 72.1 112.514 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.473 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.5 m-85 -85.35 -43.93 13.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.891 0.377 . . . . 75.34 110.865 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.417 ' O ' ' N ' ' A' ' 9' ' ' TYR . 18.7 m-85 -67.2 -31.67 72.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 75.52 110.853 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.45 -34.43 61.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 74.1 110.923 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -108.71 -19.11 13.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 73.01 110.827 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -89.49 -46.35 8.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.444 . . . . 72.2 110.942 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.417 ' N ' ' O ' ' A' ' 5' ' ' PHE . 9.9 t80 -64.28 -43.08 95.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 74.34 110.955 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.51 -32.01 73.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 74.15 110.886 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -76.66 -34.42 58.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.227 -0.442 . . . . 73.42 110.9 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.3 mmm -77.46 -23.68 50.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 74.5 110.897 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.23 -36.79 24.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 73.44 110.901 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -75.92 -26.33 56.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 64.04 110.923 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -79.03 -30.74 44.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 74.11 110.848 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.13 -10.4 30.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 70.24 111.074 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -86.15 -9.49 56.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.251 -0.431 . . . . 73.35 110.921 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 119.62 42.46 0.53 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.687 -0.768 . . . . 73.42 112.463 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -47.62 -25.59 1.21 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.783 0.325 . . . . 74.23 110.926 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.19 -10.88 9.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 75.43 111.055 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -106.14 165.26 13.33 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.557 0.694 . . . . 63.41 111.083 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 -4.57 14.27 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.639 2.226 . . . . 71.14 112.296 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.07 -34.77 78.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 73.34 110.921 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 75.35 110.879 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . 0.475 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.849 0.357 . . . . 75.51 110.877 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 54.5 t -155.04 -39.55 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 71.02 111.148 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.93 -11.05 83.95 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.735 -0.745 . . . . 72.12 112.488 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.475 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.4 m-85 -86.37 -41.11 14.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.897 0.379 . . . . 75.04 110.898 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.411 ' O ' ' N ' ' A' ' 9' ' ' TYR . 20.5 m-85 -69.65 -32.41 71.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.483 . . . . 74.23 110.842 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.9 -32.33 60.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 75.32 110.861 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.55 -18.62 13.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 74.41 110.853 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -90.46 -46.23 8.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 73.51 110.894 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.411 ' N ' ' O ' ' A' ' 5' ' ' PHE . 10.0 t80 -64.29 -42.92 96.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.247 -0.433 . . . . 74.24 110.967 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.4 mmmt -69.27 -33.81 73.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.082 -0.508 . . . . 64.23 110.903 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -76.32 -35.44 58.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.26 -0.427 . . . . 72.04 110.837 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.3 ptm -77.78 -20.6 53.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 70.14 110.916 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.63 -36.68 20.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 74.23 110.861 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.79 -27.1 57.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 64.44 110.907 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -78.27 -31.48 49.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 74.22 110.902 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -94.91 -9.0 35.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 72.31 111.054 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.62 -11.08 54.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 73.04 110.869 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 120.97 43.26 0.45 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.765 -0.731 . . . . 72.33 112.502 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -47.44 -25.72 1.14 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.751 0.31 . . . . 74.42 110.892 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.49 -11.0 9.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 71.32 111.13 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -106.54 164.31 15.17 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.59 0.71 . . . . 70.11 111.081 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.68 -5.51 16.32 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.698 2.265 . . . . 71.44 112.336 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -62.05 -33.74 74.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 65.12 110.892 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 72.43 110.925 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . 0.493 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 1.1 mttt . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.792 0.33 . . . . 63.23 110.908 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 54.4 t -154.73 -39.87 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.271 -0.422 . . . . 71.12 111.11 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.32 -12.39 76.52 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.725 -0.75 . . . . 72.14 112.507 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.493 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.5 m-85 -84.91 -41.98 15.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.883 0.373 . . . . 75.24 110.854 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.446 ' O ' ' N ' ' A' ' 9' ' ' TYR . 25.4 m-85 -67.18 -33.59 75.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 75.44 110.87 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.9 mmtt -53.99 -33.32 56.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 71.14 110.902 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 13.7 mmt85 -108.52 -19.8 13.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 75.24 110.908 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.1 mm100 -89.19 -46.39 8.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 74.2 110.917 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 5' ' ' PHE . 9.9 t80 -63.81 -43.04 97.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.223 -0.444 . . . . 75.13 110.938 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.5 ptmt -66.7 -32.42 73.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.136 -0.484 . . . . 75.33 110.888 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -76.47 -35.35 58.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 73.32 110.911 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 29.4 mtt -77.78 -21.73 51.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.099 -0.5 . . . . 75.43 110.888 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -85.27 -36.4 20.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.255 -0.43 . . . . 74.42 110.921 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.14 -26.02 55.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.247 -0.433 . . . . 73.42 110.881 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -78.96 -32.37 45.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.473 . . . . 74.44 110.895 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -93.38 -10.33 35.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.123 -0.49 . . . . 72.31 111.09 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.62 -10.47 55.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 74.33 110.896 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 120.18 42.42 0.51 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.698 -0.763 . . . . 75.24 112.485 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -47.67 -25.56 1.24 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.804 0.335 . . . . 75.3 110.951 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.28 -11.16 9.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 73.55 111.117 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -106.74 164.6 14.52 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.571 0.7 . . . . 74.04 111.093 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -4.64 14.44 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.666 2.244 . . . . 74.51 112.366 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -62.71 -34.75 77.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.459 . . . . 72.23 110.895 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 75.13 110.914 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . 0.477 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.851 0.358 . . . . 73.0 110.895 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 53.7 t -155.03 -39.62 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 74.53 111.107 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.9 -11.03 83.9 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.737 -0.744 . . . . 71.43 112.478 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.477 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.4 m-85 -86.41 -41.13 14.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.881 0.372 . . . . 63.41 110.858 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.412 ' O ' ' N ' ' A' ' 9' ' ' TYR . 20.6 m-85 -69.55 -32.47 71.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 64.14 110.902 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.93 -32.18 60.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 74.02 110.912 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.57 -18.66 13.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.234 -0.439 . . . . 72.32 110.857 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 14.9 tp60 -90.49 -46.08 8.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 74.53 110.905 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.412 ' N ' ' O ' ' A' ' 5' ' ' PHE . 9.9 t80 -64.11 -43.14 96.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.185 -0.461 . . . . 74.5 110.942 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.1 mmtt -69.17 -34.08 74.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.078 -0.51 . . . . 73.32 110.889 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -80.02 -21.43 43.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 74.43 110.909 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.6 mmt -86.26 -27.19 24.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.476 . . . . 63.24 110.872 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.19 -30.36 22.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 70.32 110.909 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -82.09 -23.87 35.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 73.35 110.854 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.75 -31.27 32.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.445 . . . . 73.34 110.867 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -94.52 -9.3 35.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 55.13 111.072 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.43 -11.3 54.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 72.45 110.895 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 121.21 43.44 0.43 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.794 -0.717 . . . . 44.23 112.536 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.29 -25.7 1.04 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.773 0.32 . . . . 74.13 110.913 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.38 -10.97 9.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 74.21 111.172 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -106.42 164.16 15.49 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.539 0.685 . . . . 75.22 111.122 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -5.62 16.64 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.646 2.23 . . . . 74.52 112.346 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -62.05 -34.11 75.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.455 . . . . 75.33 110.912 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.468 . . . . 70.54 110.809 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . 0.478 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.775 0.322 . . . . 75.13 110.922 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 54.7 t -154.99 -39.73 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 63.42 111.095 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.78 -11.01 83.58 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.776 -0.726 . . . . 72.44 112.502 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.478 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.4 m-85 -86.48 -41.11 14.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.915 0.388 . . . . 74.01 110.882 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.427 ' O ' ' N ' ' A' ' 9' ' ' TYR . 21.4 m-85 -69.49 -32.56 71.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 74.44 110.893 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.68 -33.01 60.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 72.33 110.893 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.77 -18.5 13.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 75.21 110.858 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.7 tm0? -90.81 -45.41 8.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 72.34 110.935 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.427 ' N ' ' O ' ' A' ' 5' ' ' PHE . 9.1 t80 -66.31 -39.43 89.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.456 . . . . 74.42 110.987 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.0 ptmm? -68.23 -33.36 74.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.11 -0.496 . . . . 73.23 110.897 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.15 -25.91 36.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 62.51 110.868 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.41 -20.29 32.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 64.03 110.866 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.4 tpt -86.87 -35.89 18.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.254 -0.43 . . . . 74.03 110.852 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -77.11 -25.47 52.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.216 -0.447 . . . . 74.44 110.91 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.37 -31.87 43.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 74.21 110.922 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -93.96 -10.56 33.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.112 -0.495 . . . . 73.22 111.13 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.53 -10.33 56.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 72.32 110.911 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 120.19 42.78 0.5 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.726 -0.749 . . . . 75.24 112.495 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -47.51 -25.55 1.13 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.785 0.326 . . . . 63.12 110.942 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.01 -11.24 9.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 75.31 111.145 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -106.83 164.84 14.01 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.594 0.711 . . . . 74.42 111.114 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -4.53 14.21 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.663 2.242 . . . . 72.24 112.347 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -64.45 -30.84 71.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.192 -0.458 . . . . 65.43 110.879 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 74.45 110.898 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . 0.479 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.783 0.325 . . . . 70.53 110.91 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 55.1 t -155.05 -39.76 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 72.43 111.104 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.72 -11.45 83.21 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.803 -0.713 . . . . 71.02 112.469 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.479 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.4 m-85 -85.77 -42.09 14.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.913 0.387 . . . . 74.4 110.896 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.455 ' O ' ' N ' ' A' ' 9' ' ' TYR . 20.2 m-85 -68.81 -32.93 73.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 74.53 110.837 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.76 -33.94 57.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 74.13 110.864 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -109.37 -18.68 13.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 74.5 110.887 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -90.2 -45.96 8.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 72.33 110.925 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.455 ' N ' ' O ' ' A' ' 5' ' ' PHE . 8.6 t80 -66.19 -37.86 86.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.46 . . . . 73.44 110.917 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.02 -33.42 73.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 64.43 110.911 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.04 -26.28 36.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 73.02 110.906 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.14 -20.29 32.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 65.34 110.843 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.8 tpt -86.64 -36.06 19.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.439 . . . . 64.01 110.904 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -76.93 -25.77 53.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.203 -0.453 . . . . 74.43 110.902 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.11 -31.81 44.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 73.22 110.887 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -94.11 -10.43 33.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.103 -0.498 . . . . 70.05 111.134 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.74 -10.2 55.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 61.11 110.884 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 120.02 42.42 0.52 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.732 -0.747 . . . . 64.14 112.477 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -47.66 -25.65 1.26 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.812 0.339 . . . . 74.35 110.954 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.35 -11.1 9.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 74.32 111.15 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -106.71 164.72 14.27 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.59 0.709 . . . . 71.41 111.074 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -4.71 14.58 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.708 2.272 . . . . 74.34 112.322 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.5 -34.44 76.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.232 -0.44 . . . . 73.41 110.918 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.139 -0.482 . . . . 75.13 110.905 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . 0.492 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.804 0.335 . . . . 72.05 110.888 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 54.4 t -154.69 -39.84 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 70.14 111.087 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.49 -12.03 76.97 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.746 -0.74 . . . . 33.32 112.492 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.492 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.6 m-85 -85.31 -40.78 16.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.904 0.383 . . . . 74.31 110.87 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -68.95 -33.18 73.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.09 -0.505 . . . . 64.21 110.898 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.0 mmtp -54.68 -32.04 58.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 72.52 110.888 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.93 -17.91 13.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 73.05 110.882 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.95 -45.13 8.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 73.14 110.944 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -66.72 -41.39 88.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 75.43 110.906 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.7 mmtt -69.12 -39.26 79.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 73.11 110.919 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -77.14 -23.96 51.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 62.14 110.901 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 6.9 mmt -84.26 -22.68 30.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.468 . . . . 71.3 110.898 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 7.4 tpt -85.59 -35.76 20.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 72.44 110.868 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -77.56 -24.92 49.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.25 -0.432 . . . . 73.11 110.889 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -80.2 -30.74 38.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 74.04 110.909 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.09 -10.57 30.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.109 -0.496 . . . . 72.23 111.056 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.93 -9.68 56.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 72.54 110.914 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 119.73 42.57 0.52 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.747 -0.74 . . . . 70.13 112.493 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -47.59 -25.61 1.21 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.745 0.307 . . . . 72.33 110.876 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.05 -10.92 9.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.434 . . . . 71.52 111.118 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -106.11 165.27 13.31 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.589 0.709 . . . . 63.43 111.1 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -4.61 14.39 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.684 2.256 . . . . 72.22 112.327 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.06 -34.83 78.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.454 . . . . 74.21 110.898 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 70.25 110.93 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . 0.497 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 4.2 mtmt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.875 0.369 . . . . 75.42 110.915 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 55.8 t -154.61 -39.44 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 73.52 111.113 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.0 -12.51 75.4 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.746 -0.74 . . . . 74.25 112.487 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.497 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.5 m-85 -84.82 -41.94 15.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.892 0.377 . . . . 61.03 110.904 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.411 ' O ' ' N ' ' A' ' 9' ' ' TYR . 24.2 m-85 -67.22 -33.32 75.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 73.43 110.881 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.11 -33.44 57.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 74.42 110.913 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -108.54 -19.62 13.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 73.02 110.897 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -89.23 -46.42 8.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 74.12 110.884 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.411 ' N ' ' O ' ' A' ' 5' ' ' PHE . 9.7 t80 -64.27 -42.38 96.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 75.32 110.89 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.27 -30.34 69.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 74.52 110.905 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -77.92 -36.88 48.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.201 -0.454 . . . . 73.35 110.901 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -77.26 -20.85 54.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 74.41 110.877 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.401 ' O ' ' HB2' ' A' ' 17' ' ' ASN . 10.1 tmm? -84.93 -37.03 21.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 72.3 110.91 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -74.54 -28.8 61.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.189 -0.459 . . . . 72.01 110.899 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.426 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 23.6 pt-20 -76.24 -32.68 59.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.117 -0.492 . . . . 70.4 110.836 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -93.75 -9.36 37.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 52.33 111.114 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.401 ' HB2' ' O ' ' A' ' 13' ' ' MET . 0.7 OUTLIER -85.02 -11.48 55.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 75.43 110.902 -179.936 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 119.68 42.56 0.53 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.736 -0.745 . . . . 73.54 112.505 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.426 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 4.8 tm0? -47.62 -25.4 1.15 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.806 0.336 . . . . 71.2 110.915 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.02 -11.73 10.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 73.14 111.133 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -107.12 164.76 14.13 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.557 0.694 . . . . 75.01 111.103 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -4.18 13.52 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.615 2.21 . . . . 75.1 112.35 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -64.18 -32.2 73.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 65.35 110.936 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.094 -0.503 . . . . 75.43 110.894 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . 0.48 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.792 0.329 . . . . 75.21 110.91 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 53.4 t -155.16 -39.73 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 75.53 111.145 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.68 -11.7 83.02 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.732 -0.747 . . . . 62.41 112.487 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.48 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.5 m-85 -85.39 -43.46 13.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.914 0.388 . . . . 74.44 110.855 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.409 ' O ' ' N ' ' A' ' 9' ' ' TYR . 20.9 m-85 -67.18 -32.69 73.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 74.23 110.837 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -54.03 -33.8 58.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.13 -0.486 . . . . 70.14 110.904 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.84 -19.42 13.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 75.53 110.866 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -89.47 -46.4 8.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 73.42 110.895 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.409 ' N ' ' O ' ' A' ' 5' ' ' PHE . 9.9 t80 -63.99 -43.17 96.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 72.23 110.938 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.5 ptmt -66.25 -32.41 73.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.116 -0.493 . . . . 75.23 110.927 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -75.38 -36.61 60.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 65.45 110.854 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 22.4 mtm -74.87 -25.33 58.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 74.34 110.885 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.23 -37.57 32.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 73.51 110.898 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -72.58 -31.98 65.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 75.43 110.914 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -74.21 -31.23 62.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 75.15 110.859 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -94.38 -10.18 33.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 75.04 111.089 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.8 -10.18 55.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 74.32 110.885 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 119.98 42.28 0.52 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.757 -0.735 . . . . 63.22 112.496 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 25.0 tp60 -47.75 -25.7 1.33 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.793 0.33 . . . . 74.24 110.881 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.21 -10.89 9.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 74.21 111.127 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -106.5 165.15 13.46 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.618 0.723 . . . . 73.04 111.055 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 -4.33 13.84 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.685 2.257 . . . . 74.45 112.383 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -64.27 -34.16 77.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 74.21 110.874 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 75.22 110.896 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . 0.495 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 1.4 mtmm . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.814 0.34 . . . . 64.11 110.935 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 55.5 t -154.46 -39.4 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 72.32 111.121 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.58 -11.6 77.12 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.739 -0.743 . . . . 72.44 112.493 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.495 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.6 m-85 -85.85 -39.48 16.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.901 0.382 . . . . 73.23 110.879 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.436 ' O ' ' N ' ' A' ' 9' ' ' TYR . 24.1 m-85 -69.62 -34.28 73.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 74.31 110.846 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.43 -31.22 54.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 74.53 110.888 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 10.7 mtp180 -110.38 -19.27 13.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 74.2 110.873 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -90.34 -46.26 8.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 65.55 110.9 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.436 ' N ' ' O ' ' A' ' 5' ' ' PHE . 9.7 t80 -63.52 -42.68 98.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.22 -0.446 . . . . 73.55 110.928 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.5 mmmt -70.73 -29.16 65.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 73.2 110.902 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -81.2 -30.02 34.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 75.13 110.913 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 5.0 ptt? -80.92 -24.8 37.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 74.01 110.871 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 8.8 ptt? -85.87 -33.9 21.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 73.33 110.856 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -79.14 -24.47 43.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 74.23 110.903 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.423 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 0.0 OUTLIER -80.8 -31.06 35.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 72.35 110.895 -179.911 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.02 -9.79 32.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 63.52 111.088 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.24 -11.39 54.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.431 . . . . 74.24 110.861 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 119.71 42.44 0.53 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.782 -0.723 . . . . 62.11 112.499 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.423 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 0.7 OUTLIER -47.67 -25.32 1.15 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.738 0.304 . . . . 73.04 110.923 -179.899 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -119.93 -11.63 10.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 64.02 111.157 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -106.96 164.74 14.18 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.556 0.693 . . . . 74.14 111.111 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 -4.46 14.12 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.709 2.272 . . . . 75.15 112.307 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -63.01 -35.73 81.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.235 -0.439 . . . . 73.23 110.919 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 72.25 110.918 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . 0.493 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.851 0.358 . . . . 75.54 110.922 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 54.3 t -154.66 -39.94 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 62.54 111.126 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.3 -12.16 76.28 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.754 -0.736 . . . . 72.22 112.497 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.493 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.5 m-85 -85.24 -40.99 16.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.892 0.377 . . . . 75.51 110.893 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -68.48 -33.11 73.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 74.42 110.888 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.3 mmtt -53.9 -34.34 59.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 75.41 110.907 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -108.7 -18.79 13.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 75.1 110.84 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -89.37 -46.12 8.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 73.4 110.899 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -65.38 -40.69 93.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 75.31 110.881 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.64 -30.73 70.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.466 . . . . 74.4 110.875 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -74.85 -39.88 61.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 63.31 110.859 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 17.9 ptp -76.98 -20.66 55.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 73.32 110.859 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -84.69 -36.94 21.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 74.14 110.896 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.57 -30.37 61.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.226 -0.443 . . . . 72.34 110.918 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.42 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 12.7 pt-20 -75.37 -30.83 60.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.098 -0.501 . . . . 73.23 110.877 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -94.95 -9.73 33.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 71.31 111.104 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -87.94 -6.44 58.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 74.32 110.9 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 120.32 47.59 0.33 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.768 -0.73 . . . . 74.33 112.469 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.42 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -46.51 -25.0 0.6 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.788 0.328 . . . . 72.33 110.89 -179.866 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -118.78 -12.49 10.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 75.11 111.096 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -107.43 161.48 22.95 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.609 0.719 . . . . 74.44 111.09 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -5.92 17.35 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.667 2.245 . . . . 75.32 112.374 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -56.48 -32.34 64.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 74.55 110.89 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 74.02 110.855 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . 0.479 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.84 0.352 . . . . 74.44 110.885 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 54.5 t -155.09 -39.66 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 65.11 111.096 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.63 -11.49 82.97 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.738 -0.744 . . . . 70.15 112.488 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.479 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.4 m-85 -85.78 -42.46 14.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.884 0.373 . . . . 75.13 110.921 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.435 ' O ' ' N ' ' A' ' 9' ' ' TYR . 18.1 m-85 -68.81 -31.62 70.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 72.23 110.902 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.6 mttt -54.41 -35.1 62.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 73.41 110.922 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -108.7 -18.13 13.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 75.21 110.904 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -90.15 -45.8 8.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 74.32 110.948 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.435 ' N ' ' O ' ' A' ' 5' ' ' PHE . 9.7 t80 -64.9 -41.85 95.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.455 . . . . 72.11 110.891 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 11.6 pttm -65.42 -35.25 80.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 74.34 110.893 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.18 -25.54 42.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 63.35 110.897 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -83.17 -22.8 33.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 75.52 110.906 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 34.4 ttp -84.8 -36.28 21.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 73.12 110.866 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -77.36 -25.58 51.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.227 -0.442 . . . . 73.5 110.9 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -79.48 -29.82 41.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 73.44 110.89 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.6 -11.98 26.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 74.03 111.12 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -87.27 -6.55 58.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 74.4 110.899 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 117.47 45.4 0.52 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.735 -0.745 . . . . 70.4 112.485 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -46.97 -24.66 0.65 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.759 0.314 . . . . 72.34 110.91 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -117.44 -13.26 10.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.247 -0.433 . . . . 73.21 111.121 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -108.51 162.68 19.1 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.576 0.703 . . . . 74.1 111.104 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 -4.27 13.69 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.658 2.239 . . . . 73.43 112.341 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -56.47 -34.02 66.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 74.43 110.901 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.3 m120 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 52.41 110.888 -179.961 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . 0.483 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.8 0.333 . . . . 74.14 110.873 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 54.3 t -155.11 -39.7 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 65.01 111.119 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.73 -11.43 83.26 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.691 -0.766 . . . . 71.03 112.494 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.483 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.5 m-85 -85.71 -42.68 14.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.896 0.379 . . . . 75.22 110.892 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.403 ' O ' ' N ' ' A' ' 9' ' ' TYR . 16.2 m-85 -69.17 -31.15 69.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 72.32 110.867 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.29 -32.94 62.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.159 -0.473 . . . . 74.45 110.903 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.22 -17.4 13.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 74.35 110.865 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -91.16 -44.94 8.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 73.41 110.897 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.403 ' N ' ' O ' ' A' ' 5' ' ' PHE . 9.3 t80 -67.49 -41.38 84.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 73.31 110.88 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.2 mmtt -69.29 -39.13 78.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 75.14 110.864 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -76.71 -25.35 53.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.216 -0.447 . . . . 75.2 110.87 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.2 mmm -83.09 -23.19 33.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 72.4 110.819 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.419 ' O ' ' HB2' ' A' ' 17' ' ' ASN . 0.0 OUTLIER -83.78 -36.83 23.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.247 -0.433 . . . . 65.41 110.874 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -72.46 -31.85 65.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.199 -0.455 . . . . 74.45 110.905 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -73.02 -35.37 66.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 74.43 110.883 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -91.11 -8.67 48.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 74.43 111.147 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.419 ' HB2' ' O ' ' A' ' 13' ' ' MET . 0.6 OUTLIER -85.6 -11.3 54.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.241 -0.436 . . . . 74.55 110.868 -179.946 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 121.52 42.78 0.45 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.744 -0.741 . . . . 61.35 112.499 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -46.22 -25.91 0.69 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.78 0.324 . . . . 74.04 110.924 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -124.99 -10.01 6.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 74.41 111.205 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -107.11 165.49 12.75 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.619 0.723 . . . . 71.23 111.06 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -19.96 35.63 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.684 2.256 . . . . 72.23 112.36 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -51.02 -24.23 3.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 63.32 110.919 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.091 -0.504 . . . . 75.02 110.838 -179.916 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . 0.453 ' N ' ' HE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.843 0.354 . . . . 74.24 110.93 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.3 t -143.4 -36.86 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 73.41 111.14 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.96 -11.67 81.28 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.757 -0.735 . . . . 73.03 112.45 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.453 ' HE1' ' N ' ' A' ' 1' ' ' LYS . 1.7 m-85 -86.16 -42.42 13.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.918 0.39 . . . . 73.22 110.87 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -69.51 -30.97 68.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 73.35 110.853 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.3 mmtm -55.53 -34.59 64.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.14 -0.482 . . . . 74.05 110.943 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 10.8 ptt180 -108.59 -18.19 13.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 73.42 110.859 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -89.62 -46.16 8.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 72.43 110.899 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -65.15 -42.49 93.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 71.24 110.907 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.97 -29.61 68.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 75.22 110.893 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -78.22 -37.08 46.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.215 -0.448 . . . . 75.4 110.839 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.9 ppp? -77.28 -21.01 54.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.474 . . . . 51.44 110.901 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.2 tpt -85.16 -36.74 20.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 72.44 110.877 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -75.09 -28.02 60.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.226 -0.443 . . . . 74.31 110.91 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -76.95 -32.73 57.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.48 . . . . 74.41 110.915 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -93.06 -10.31 36.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 72.04 111.143 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.5 -10.47 55.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 62.54 110.905 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 120.11 42.3 0.52 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.688 -0.768 . . . . 75.5 112.512 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -47.76 -25.57 1.29 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.777 0.322 . . . . 75.11 110.94 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.33 -11.12 9.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.161 -0.472 . . . . 74.32 111.13 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -106.72 164.66 14.39 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.555 0.693 . . . . 73.43 111.098 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -4.72 14.6 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.698 2.265 . . . . 73.33 112.321 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -62.61 -34.74 77.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 73.41 110.899 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 65.34 110.859 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . 0.444 ' N ' ' HE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.787 0.327 . . . . 74.24 110.878 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 1' ' ' LYS . 40.9 t -142.99 -36.7 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 75.15 111.119 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.29 -12.57 83.47 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.807 -0.711 . . . . 64.21 112.466 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.444 ' HE1' ' N ' ' A' ' 1' ' ' LYS . 1.6 m-85 -85.72 -45.41 11.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.848 0.356 . . . . 74.12 110.865 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.416 ' O ' ' HB3' ' A' ' 9' ' ' TYR . 21.5 m-85 -67.43 -29.36 68.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 73.21 110.884 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -55.98 -35.12 66.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 63.12 110.898 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.4 ptt85 -108.68 -18.31 13.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 73.51 110.891 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -89.25 -46.29 8.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.459 . . . . 71.4 110.914 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.416 ' HB3' ' O ' ' A' ' 5' ' ' PHE . 9.9 t80 -64.84 -42.2 95.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 73.42 110.925 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.08 -33.31 75.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.144 -0.48 . . . . 73.34 110.876 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -74.23 -37.6 63.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.438 . . . . 74.12 110.935 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.34 -24.7 59.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 73.12 110.93 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.23 -37.37 28.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 74.1 110.842 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -74.08 -29.14 61.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 74.2 110.864 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -76.81 -30.81 56.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 74.31 110.862 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -94.93 -10.28 31.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 73.51 111.104 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -86.02 -10.05 55.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 75.3 110.892 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 120.04 42.55 0.51 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.728 -0.749 . . . . 52.25 112.448 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -47.61 -25.6 1.21 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.782 0.325 . . . . 75.24 110.911 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.95 -11.16 9.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 70.22 111.134 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -106.68 165.02 13.66 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.623 0.725 . . . . 73.14 111.041 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -4.22 13.59 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.705 2.27 . . . . 75.44 112.345 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -65.17 -31.81 73.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.464 . . . . 72.24 110.863 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 62.31 110.873 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . 0.487 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 1.4 mtmm . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.789 0.328 . . . . 75.12 110.924 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 55.6 t -154.49 -39.44 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 70.22 111.135 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.04 -12.55 75.57 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.704 -0.76 . . . . 73.55 112.438 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.487 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.6 m-85 -84.8 -41.71 15.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.87 0.367 . . . . 74.03 110.884 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.438 ' O ' ' N ' ' A' ' 9' ' ' TYR . 24.3 m-85 -67.39 -33.73 75.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.467 . . . . 75.54 110.846 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.95 -32.71 54.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 75.31 110.905 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.0 ptt180 -109.21 -19.47 13.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.445 . . . . 73.22 110.92 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.419 ' HA ' ' HG2' ' A' ' 11' ' ' GLU . 0.8 OUTLIER -90.0 -45.34 9.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 75.05 110.919 -179.948 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.438 ' N ' ' O ' ' A' ' 5' ' ' PHE . 9.3 t80 -65.83 -40.16 91.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 74.45 110.961 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.2 ptmt -63.87 -40.32 96.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.094 -0.503 . . . . 73.52 110.889 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.419 ' HG2' ' HA ' ' A' ' 8' ' ' GLN . 9.6 pt-20 -77.11 -25.92 52.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 74.03 110.872 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.06 -22.11 33.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 71.13 110.895 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.7 tpt -85.03 -36.66 21.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 70.51 110.905 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -76.33 -26.66 55.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.271 -0.422 . . . . 71.3 110.891 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.411 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 22.9 pt-20 -78.43 -30.59 47.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 74.2 110.89 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -94.88 -11.58 28.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 72.11 111.115 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -87.24 -6.93 58.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.438 . . . . 72.24 110.913 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 117.98 45.58 0.49 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.709 -0.758 . . . . 64.05 112.511 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.411 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 6.1 tt0 -46.91 -24.66 0.63 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.755 0.312 . . . . 74.14 110.874 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -117.17 -13.29 10.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 74.01 111.128 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -108.72 162.48 19.85 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.568 0.699 . . . . 75.41 111.102 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 -4.39 13.96 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.657 2.238 . . . . 75.43 112.342 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -56.73 -33.07 66.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.229 -0.441 . . . . 71.24 110.917 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.2 m120 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 70.43 110.871 -179.936 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . 0.431 ' N ' ' HE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.829 0.347 . . . . 74.24 110.902 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.414 HG21 ' O ' ' A' ' 1' ' ' LYS . 41.1 t -142.99 -36.78 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 72.02 111.117 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.31 -12.03 83.81 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.711 -0.757 . . . . 75.43 112.512 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.431 ' HE1' ' N ' ' A' ' 1' ' ' LYS . 1.6 m-85 -86.24 -43.92 12.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.885 0.374 . . . . 71.02 110.888 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.427 ' O ' ' HB3' ' A' ' 9' ' ' TYR . 20.6 m-85 -69.17 -29.17 67.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.1 -0.5 . . . . 65.11 110.862 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.23 -35.77 67.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 71.42 110.862 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -108.4 -17.47 13.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 74.03 110.914 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -90.01 -45.96 8.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 65.03 110.91 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.427 ' HB3' ' O ' ' A' ' 5' ' ' PHE . 9.6 t80 -65.64 -41.73 92.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 74.24 110.915 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.4 ptmt -64.82 -33.8 76.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.127 -0.488 . . . . 72.42 110.85 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.49 -34.15 58.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 75.53 110.904 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.4 ptt? -77.91 -21.49 51.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 74.14 110.895 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.52 -36.94 21.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.431 . . . . 75.41 110.874 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -74.43 -29.05 61.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 73.31 110.901 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -76.17 -32.74 59.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 73.31 110.88 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -93.0 -10.3 36.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 71.22 111.115 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.47 -10.46 56.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 73.31 110.917 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 120.07 42.33 0.52 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.759 -0.734 . . . . 72.32 112.488 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -47.74 -25.61 1.3 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.807 0.337 . . . . 73.32 110.931 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.36 -11.08 9.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.479 . . . . 74.52 111.166 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -106.74 164.61 14.5 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.581 0.705 . . . . 61.41 111.092 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.68 -4.72 14.53 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.735 2.29 . . . . 74.42 112.343 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -62.55 -34.83 77.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.429 . . . . 73.53 110.903 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.467 . . . . 71.13 110.898 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . 0.457 ' N ' ' HE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.78 0.324 . . . . 75.24 110.912 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.8 t -143.62 -36.84 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.431 . . . . 74.15 111.105 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.65 -11.45 83.03 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.734 -0.746 . . . . 73.13 112.5 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.457 ' HE1' ' N ' ' A' ' 1' ' ' LYS . 1.8 m-85 -86.16 -41.12 14.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.929 0.395 . . . . 75.14 110.902 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.429 ' O ' ' N ' ' A' ' 9' ' ' TYR . 23.4 m-85 -70.8 -33.0 70.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 73.34 110.86 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 42.6 mmtt -56.02 -29.3 60.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.169 -0.469 . . . . 74.24 110.914 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.93 -18.79 12.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.446 . . . . 71.13 110.854 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -92.0 -45.49 8.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 74.54 110.91 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.429 ' N ' ' O ' ' A' ' 5' ' ' PHE . 9.2 t80 -64.73 -38.6 91.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 72.21 110.913 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.7 mmtt -70.89 -37.37 72.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 75.42 110.905 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.15 -27.98 54.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 64.4 110.868 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -82.99 -19.95 36.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 74.41 110.902 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.73 -36.14 18.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 73.44 110.902 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -76.78 -25.99 53.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.239 -0.437 . . . . 74.15 110.902 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.88 -31.87 45.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.105 -0.498 . . . . 74.02 110.901 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -93.97 -10.49 33.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 75.41 111.119 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.59 -10.33 56.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 71.3 110.868 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 120.16 42.37 0.51 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.739 -0.744 . . . . 64.25 112.509 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -47.57 -25.63 1.2 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.766 0.317 . . . . 75.21 110.925 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.23 -11.1 9.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 72.51 111.162 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -106.7 164.72 14.28 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.549 0.69 . . . . 74.23 111.129 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -4.72 14.59 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.733 2.289 . . . . 73.02 112.337 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -62.89 -34.33 77.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.238 -0.437 . . . . 75.24 110.859 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 72.5 110.887 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . 0.446 ' N ' ' HE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.805 0.336 . . . . 73.55 110.869 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.3 t -143.3 -36.53 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 75.21 111.102 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.01 -12.07 83.58 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.771 -0.728 . . . . 54.0 112.487 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.446 ' HE1' ' N ' ' A' ' 1' ' ' LYS . 1.7 m-85 -85.78 -43.83 13.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.836 0.351 . . . . 74.24 110.868 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -68.4 -31.64 71.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.188 -0.46 . . . . 74.54 110.854 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.93 -31.04 62.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 74.44 110.884 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -110.86 -18.88 13.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.269 -0.423 . . . . 75.54 110.905 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -90.63 -45.68 8.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 74.12 110.91 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -63.66 -42.97 98.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.25 -0.432 . . . . 71.41 110.922 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.9 mmmm -65.51 -40.43 92.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 73.55 110.87 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -75.12 -26.04 58.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 74.52 110.918 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 21.2 mmm -82.96 -21.85 33.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 74.34 110.852 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -85.74 -35.99 20.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 74.25 110.875 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -77.16 -24.99 51.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 73.11 110.866 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.431 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 0.0 OUTLIER -80.17 -31.07 38.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 74.0 110.915 -179.935 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.23 -9.7 32.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.134 -0.485 . . . . 44.12 111.112 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.19 -11.38 55.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 75.53 110.956 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 119.85 42.68 0.51 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.728 -0.749 . . . . 72.53 112.481 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.431 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 5.3 tm0? -47.4 -25.36 1.01 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.802 0.334 . . . . 74.14 110.931 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -119.46 -11.76 10.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.436 . . . . 75.55 111.106 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -106.98 165.04 13.56 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.588 0.709 . . . . 71.5 111.101 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 -3.89 12.97 Favored 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.723 2.282 . . . . 72.55 112.335 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.36 -31.19 71.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 72.33 110.87 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 64.53 110.88 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.481 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.817 0.341 . . . . 74.32 110.865 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 54.7 t -155.01 -40.05 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 72.12 111.107 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.18 -11.82 81.77 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.744 -0.741 . . . . 70.22 112.45 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.481 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.4 m-85 -85.43 -43.02 13.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.878 0.371 . . . . 74.44 110.905 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.427 ' O ' ' N ' ' A' ' 9' ' ' TYR . 22.3 m-85 -67.26 -32.8 74.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 75.21 110.889 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.4 mmtt -54.07 -33.67 58.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 73.05 110.887 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -108.76 -19.53 13.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 74.34 110.892 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 40.8 mm-40 -89.39 -46.33 8.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 72.03 110.925 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.427 ' N ' ' O ' ' A' ' 5' ' ' PHE . 10.0 t80 -64.1 -42.99 96.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 72.55 110.932 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.1 ptmt -66.55 -32.28 73.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.099 -0.5 . . . . 75.05 110.89 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -76.15 -36.5 58.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 71.2 110.913 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.5 mmt -76.97 -21.5 54.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 73.24 110.848 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 6.2 tpt -85.27 -36.3 20.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 64.33 110.897 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -76.64 -25.81 54.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.198 -0.456 . . . . 73.22 110.876 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.48 -30.97 42.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 72.44 110.919 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -94.75 -10.53 31.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 73.21 111.108 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.69 -10.3 55.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.205 -0.452 . . . . 74.5 110.919 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 120.24 42.85 0.49 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.778 -0.725 . . . . 72.45 112.501 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -47.46 -25.61 1.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.793 0.33 . . . . 74.14 110.921 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.96 -11.25 9.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 74.15 111.157 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -106.74 164.81 14.08 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.572 0.701 . . . . 64.55 111.136 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -4.46 14.05 Favored 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.719 2.279 . . . . 73.12 112.382 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -64.66 -30.64 71.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.456 . . . . 70.12 110.897 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.1 104.25 0.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.115 -0.493 . . . . 73.52 110.87 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.02 -12.83 12.92 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.714 -0.755 . . . . 75.14 112.537 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.1 m -91.25 -36.38 13.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.753 0.311 . . . . 74.42 111.173 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -111.17 -2.78 15.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 64.22 110.917 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.7 t -45.78 146.81 1.79 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.534 0.683 . . . . 74.13 111.16 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 64.96 1.84 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.694 2.263 . . . . 63.24 112.358 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.8 p -55.17 155.36 9.11 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.689 0.757 . . . . 73.41 110.853 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 167.72 23.59 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.744 2.296 . . . . 72.21 112.328 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -24.4 29.77 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.698 2.265 . . . . 65.01 112.338 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.13 -27.36 64.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.448 . . . . 72.13 110.818 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -102.94 -26.64 13.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 64.24 110.868 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.8 tttt . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.216 -0.447 . . . . 72.14 110.91 179.953 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.473 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.834 0.349 . . . . 73.33 110.9 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 53.1 t -155.12 -39.71 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.281 -0.418 . . . . 75.44 111.092 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.44 -11.82 82.4 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.717 -0.754 . . . . 72.1 112.514 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.473 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.5 m-85 -85.35 -43.93 13.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.891 0.377 . . . . 75.34 110.865 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.417 ' O ' ' N ' ' A' ' 9' ' ' TYR . 18.7 m-85 -67.2 -31.67 72.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 75.52 110.853 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.45 -34.43 61.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 74.1 110.923 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -108.71 -19.11 13.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 73.01 110.827 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -89.49 -46.35 8.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.444 . . . . 72.2 110.942 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.417 ' N ' ' O ' ' A' ' 5' ' ' PHE . 9.9 t80 -64.28 -43.08 95.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 74.34 110.955 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.51 -32.01 73.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 74.15 110.886 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -76.66 -34.42 58.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.227 -0.442 . . . . 73.42 110.9 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.3 mmm -77.46 -23.68 50.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 74.5 110.897 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.23 -36.79 24.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 73.44 110.901 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -75.92 -26.33 56.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 64.04 110.923 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -79.03 -30.74 44.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 74.11 110.848 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.13 -10.4 30.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 70.24 111.074 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -86.15 -9.49 56.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.251 -0.431 . . . . 73.35 110.921 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 119.62 42.46 0.53 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.687 -0.768 . . . . 73.42 112.463 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -47.62 -25.59 1.21 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.783 0.325 . . . . 74.23 110.926 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.19 -10.88 9.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 75.43 111.055 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -106.14 165.26 13.33 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.557 0.694 . . . . 63.41 111.083 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 -4.57 14.27 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.639 2.226 . . . . 71.14 112.296 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.07 -34.77 78.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 73.34 110.921 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -51.87 104.79 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 75.35 110.879 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.38 10.34 8.02 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.774 -0.727 . . . . 71.45 112.474 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 24.3 m -92.12 -54.77 3.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.747 0.308 . . . . 73.43 111.158 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -111.77 -8.42 14.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 72.41 110.93 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.4 ' CG2' ' HD2' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -54.68 159.37 3.55 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.585 0.707 . . . . 65.53 111.15 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.4 ' HD2' ' CG2' ' A' ' 28' ' ' THR . 53.7 Cg_endo -69.75 66.57 1.76 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.671 2.247 . . . . 62.33 112.342 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.2 p -55.12 155.32 8.97 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.631 0.729 . . . . 51.11 110.894 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 167.74 23.61 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.703 2.269 . . . . 74.31 112.317 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 129.48 17.66 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.657 2.238 . . . . 72.44 112.379 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 p -79.94 -26.63 40.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 74.13 110.877 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -74.56 -27.01 60.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 74.42 110.919 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.5 tttt . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 75.4 110.908 179.969 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.475 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.849 0.357 . . . . 75.51 110.877 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 54.5 t -155.04 -39.55 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 71.02 111.148 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.93 -11.05 83.95 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.735 -0.745 . . . . 72.12 112.488 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.475 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.4 m-85 -86.37 -41.11 14.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.897 0.379 . . . . 75.04 110.898 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.411 ' O ' ' N ' ' A' ' 9' ' ' TYR . 20.5 m-85 -69.65 -32.41 71.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.483 . . . . 74.23 110.842 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.9 -32.33 60.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 75.32 110.861 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.55 -18.62 13.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 74.41 110.853 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -90.46 -46.23 8.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 73.51 110.894 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.411 ' N ' ' O ' ' A' ' 5' ' ' PHE . 10.0 t80 -64.29 -42.92 96.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.247 -0.433 . . . . 74.24 110.967 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.4 mmmt -69.27 -33.81 73.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.082 -0.508 . . . . 64.23 110.903 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -76.32 -35.44 58.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.26 -0.427 . . . . 72.04 110.837 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.3 ptm -77.78 -20.6 53.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 70.14 110.916 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.63 -36.68 20.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 74.23 110.861 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.79 -27.1 57.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 64.44 110.907 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -78.27 -31.48 49.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 74.22 110.902 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -94.91 -9.0 35.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 72.31 111.054 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.62 -11.08 54.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 73.04 110.869 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 120.97 43.26 0.45 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.765 -0.731 . . . . 72.33 112.502 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -47.44 -25.72 1.14 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.751 0.31 . . . . 74.42 110.892 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.49 -11.0 9.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 71.32 111.13 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -106.54 164.31 15.17 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.59 0.71 . . . . 70.11 111.081 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.68 -5.51 16.32 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.698 2.265 . . . . 71.44 112.336 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -62.05 -33.74 74.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 65.12 110.892 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.95 104.1 0.12 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 72.43 110.925 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.58 -6.47 16.28 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.764 -0.731 . . . . 53.01 112.482 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.4 m -90.38 -48.41 7.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.728 0.299 . . . . 72.35 111.1 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -111.09 -6.58 14.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 74.33 110.93 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -47.73 155.49 0.79 Allowed Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.539 0.685 . . . . 74.23 111.151 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 68.91 1.66 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.67 2.247 . . . . 71.14 112.379 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.59 155.3 73.73 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.67 0.748 . . . . 61.13 110.857 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 167.7 23.62 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.708 2.272 . . . . 63.33 112.368 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 169.9 17.77 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.728 2.286 . . . . 75.53 112.321 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.2 m -73.34 -28.78 62.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 73.33 110.874 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -78.65 -26.39 45.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 72.44 110.904 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.9 tttt . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.477 . . . . 63.33 110.922 179.994 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.493 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 1.1 mttt . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.792 0.33 . . . . 63.23 110.908 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 54.4 t -154.73 -39.87 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.271 -0.422 . . . . 71.12 111.11 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.32 -12.39 76.52 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.725 -0.75 . . . . 72.14 112.507 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.493 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.5 m-85 -84.91 -41.98 15.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.883 0.373 . . . . 75.24 110.854 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.446 ' O ' ' N ' ' A' ' 9' ' ' TYR . 25.4 m-85 -67.18 -33.59 75.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 75.44 110.87 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.9 mmtt -53.99 -33.32 56.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 71.14 110.902 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 13.7 mmt85 -108.52 -19.8 13.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 75.24 110.908 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.1 mm100 -89.19 -46.39 8.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 74.2 110.917 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 5' ' ' PHE . 9.9 t80 -63.81 -43.04 97.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.223 -0.444 . . . . 75.13 110.938 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.5 ptmt -66.7 -32.42 73.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.136 -0.484 . . . . 75.33 110.888 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -76.47 -35.35 58.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 73.32 110.911 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 29.4 mtt -77.78 -21.73 51.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.099 -0.5 . . . . 75.43 110.888 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -85.27 -36.4 20.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.255 -0.43 . . . . 74.42 110.921 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.14 -26.02 55.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.247 -0.433 . . . . 73.42 110.881 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -78.96 -32.37 45.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.473 . . . . 74.44 110.895 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -93.38 -10.33 35.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.123 -0.49 . . . . 72.31 111.09 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.62 -10.47 55.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 74.33 110.896 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 120.18 42.42 0.51 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.698 -0.763 . . . . 75.24 112.485 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -47.67 -25.56 1.24 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.804 0.335 . . . . 75.3 110.951 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.28 -11.16 9.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 73.55 111.117 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -106.74 164.6 14.52 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.571 0.7 . . . . 74.04 111.093 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -4.64 14.44 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.666 2.244 . . . . 74.51 112.366 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -62.71 -34.75 77.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.459 . . . . 72.23 110.895 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -54.41 104.01 0.1 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 75.13 110.914 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.69 -6.26 16.17 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.715 -0.755 . . . . 63.31 112.457 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 61.4 p -90.41 -48.45 7.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.775 0.321 . . . . 73.45 111.148 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -111.08 -6.71 14.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 72.24 110.928 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -47.76 155.51 0.8 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.597 0.713 . . . . 70.42 111.146 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 68.95 1.67 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.743 2.295 . . . . 65.42 112.332 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.3 m -58.02 155.34 24.79 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.671 0.748 . . . . 73.44 110.85 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 167.74 23.53 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.715 2.277 . . . . 71.54 112.338 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.81 -31.85 19.52 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.684 2.256 . . . . 73.44 112.373 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 50.0 m -63.31 -26.21 68.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 72.04 110.89 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -102.35 -26.3 13.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.107 -0.497 . . . . 73.52 110.895 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.5 tttm . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.155 -0.475 . . . . 75.22 110.884 179.987 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.477 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.851 0.358 . . . . 73.0 110.895 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 53.7 t -155.03 -39.62 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 74.53 111.107 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.9 -11.03 83.9 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.737 -0.744 . . . . 71.43 112.478 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.477 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.4 m-85 -86.41 -41.13 14.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.881 0.372 . . . . 63.41 110.858 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.412 ' O ' ' N ' ' A' ' 9' ' ' TYR . 20.6 m-85 -69.55 -32.47 71.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 64.14 110.902 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.93 -32.18 60.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 74.02 110.912 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.57 -18.66 13.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.234 -0.439 . . . . 72.32 110.857 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 14.9 tp60 -90.49 -46.08 8.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 74.53 110.905 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.412 ' N ' ' O ' ' A' ' 5' ' ' PHE . 9.9 t80 -64.11 -43.14 96.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.185 -0.461 . . . . 74.5 110.942 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.1 mmtt -69.17 -34.08 74.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.078 -0.51 . . . . 73.32 110.889 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -80.02 -21.43 43.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 74.43 110.909 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.6 mmt -86.26 -27.19 24.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.476 . . . . 63.24 110.872 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.19 -30.36 22.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 70.32 110.909 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -82.09 -23.87 35.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 73.35 110.854 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.75 -31.27 32.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.445 . . . . 73.34 110.867 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -94.52 -9.3 35.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 55.13 111.072 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.43 -11.3 54.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 72.45 110.895 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 121.21 43.44 0.43 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.794 -0.717 . . . . 44.23 112.536 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.29 -25.7 1.04 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.773 0.32 . . . . 74.13 110.913 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.38 -10.97 9.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 74.21 111.172 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -106.42 164.16 15.49 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.539 0.685 . . . . 75.22 111.122 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -5.62 16.64 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.646 2.23 . . . . 74.52 112.346 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -62.05 -34.11 75.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.455 . . . . 75.33 110.912 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.47 104.13 0.12 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.468 . . . . 70.54 110.809 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.48 -6.25 16.62 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.709 -0.758 . . . . 74.31 112.502 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 91.2 m -90.34 -48.47 7.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.794 0.33 . . . . 64.31 111.176 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -111.14 -6.34 14.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 74.2 110.931 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -47.76 155.45 0.8 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.581 0.705 . . . . 73.12 111.117 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 69.02 1.66 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.683 2.255 . . . . 64.22 112.319 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.7 155.35 21.97 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.652 0.739 . . . . 74.54 110.863 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 167.73 23.67 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.696 2.264 . . . . 73.01 112.318 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 87.65 0.55 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.685 2.257 . . . . 64.35 112.374 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 64.0 m -78.53 -26.72 45.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 73.45 110.854 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -108.85 -26.72 10.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 70.01 110.856 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 75.25 110.912 179.978 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.478 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.775 0.322 . . . . 75.13 110.922 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 54.7 t -154.99 -39.73 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 63.42 111.095 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.78 -11.01 83.58 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.776 -0.726 . . . . 72.44 112.502 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.478 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.4 m-85 -86.48 -41.11 14.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.915 0.388 . . . . 74.01 110.882 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.427 ' O ' ' N ' ' A' ' 9' ' ' TYR . 21.4 m-85 -69.49 -32.56 71.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 74.44 110.893 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.68 -33.01 60.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 72.33 110.893 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.77 -18.5 13.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 75.21 110.858 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.7 tm0? -90.81 -45.41 8.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 72.34 110.935 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.427 ' N ' ' O ' ' A' ' 5' ' ' PHE . 9.1 t80 -66.31 -39.43 89.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.456 . . . . 74.42 110.987 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.0 ptmm? -68.23 -33.36 74.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.11 -0.496 . . . . 73.23 110.897 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.15 -25.91 36.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 62.51 110.868 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.41 -20.29 32.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 64.03 110.866 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.4 tpt -86.87 -35.89 18.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.254 -0.43 . . . . 74.03 110.852 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -77.11 -25.47 52.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.216 -0.447 . . . . 74.44 110.91 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.37 -31.87 43.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 74.21 110.922 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -93.96 -10.56 33.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.112 -0.495 . . . . 73.22 111.13 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.53 -10.33 56.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 72.32 110.911 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 120.19 42.78 0.5 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.726 -0.749 . . . . 75.24 112.495 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -47.51 -25.55 1.13 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.785 0.326 . . . . 63.12 110.942 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.01 -11.24 9.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 75.31 111.145 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -106.83 164.84 14.01 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.594 0.711 . . . . 74.42 111.114 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -4.53 14.21 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.663 2.242 . . . . 72.24 112.347 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -64.45 -30.84 71.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.192 -0.458 . . . . 65.43 110.879 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.04 104.21 0.11 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 74.45 110.898 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.99 -12.83 12.96 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.704 -0.76 . . . . 62.04 112.508 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 10.6 m -91.31 -36.49 13.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.726 0.298 . . . . 65.45 111.102 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -111.18 -2.74 15.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 73.43 110.905 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.7 t -45.79 146.79 1.8 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.571 0.7 . . . . 71.24 111.137 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 64.97 1.79 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.661 2.241 . . . . 75.04 112.324 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.2 p -88.1 155.33 52.28 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.611 0.719 . . . . 74.03 110.894 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 167.75 23.49 Favored 'Trans proline' 0 N--CA 1.465 -0.189 0 C-N-CA 122.695 2.263 . . . . 74.12 112.377 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 171.57 14.26 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.697 2.265 . . . . 74.32 112.326 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.68 -26.87 45.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 73.01 110.88 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -86.26 -26.41 25.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.153 -0.476 . . . . 54.44 110.866 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.9 ttmm . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 72.23 110.915 179.999 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.479 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.783 0.325 . . . . 70.53 110.91 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 55.1 t -155.05 -39.76 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 72.43 111.104 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.72 -11.45 83.21 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.803 -0.713 . . . . 71.02 112.469 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.479 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.4 m-85 -85.77 -42.09 14.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.913 0.387 . . . . 74.4 110.896 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.455 ' O ' ' N ' ' A' ' 9' ' ' TYR . 20.2 m-85 -68.81 -32.93 73.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 74.53 110.837 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.76 -33.94 57.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 74.13 110.864 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -109.37 -18.68 13.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 74.5 110.887 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -90.2 -45.96 8.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 72.33 110.925 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.455 ' N ' ' O ' ' A' ' 5' ' ' PHE . 8.6 t80 -66.19 -37.86 86.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.46 . . . . 73.44 110.917 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.02 -33.42 73.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 64.43 110.911 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.04 -26.28 36.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 73.02 110.906 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.14 -20.29 32.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 65.34 110.843 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.8 tpt -86.64 -36.06 19.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.439 . . . . 64.01 110.904 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -76.93 -25.77 53.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.203 -0.453 . . . . 74.43 110.902 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.11 -31.81 44.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 73.22 110.887 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -94.11 -10.43 33.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.103 -0.498 . . . . 70.05 111.134 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.74 -10.2 55.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 61.11 110.884 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 120.02 42.42 0.52 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.732 -0.747 . . . . 64.14 112.477 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -47.66 -25.65 1.26 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.812 0.339 . . . . 74.35 110.954 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.35 -11.1 9.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 74.32 111.15 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -106.71 164.72 14.27 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.59 0.709 . . . . 71.41 111.074 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -4.71 14.58 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.708 2.272 . . . . 74.34 112.322 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.5 -34.44 76.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.232 -0.44 . . . . 73.41 110.918 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.95 104.1 0.12 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.139 -0.482 . . . . 75.13 110.905 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.62 -14.61 13.01 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.753 -0.737 . . . . 72.41 112.494 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 27.6 p -94.17 -46.3 7.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.728 0.299 . . . . 74.4 111.136 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -85.96 -27.8 24.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 75.35 110.932 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -50.94 161.42 0.69 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.554 0.692 . . . . 74.11 111.168 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 64.43 1.79 Allowed 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.713 2.275 . . . . 73.12 112.387 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.01 155.32 8.58 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.71 0.766 . . . . 54.11 110.821 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 167.78 23.47 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.677 2.251 . . . . 74.23 112.309 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -171.48 0.48 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.698 2.265 . . . . 65.2 112.344 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 61.7 p -73.49 -26.29 60.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.427 . . . . 73.2 110.877 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -106.22 23.06 14.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.126 -0.488 . . . . 74.01 110.911 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.115 -0.493 . . . . 72.45 110.882 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.492 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.804 0.335 . . . . 72.05 110.888 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 54.4 t -154.69 -39.84 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 70.14 111.087 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.49 -12.03 76.97 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.746 -0.74 . . . . 33.32 112.492 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.492 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.6 m-85 -85.31 -40.78 16.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.904 0.383 . . . . 74.31 110.87 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -68.95 -33.18 73.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.09 -0.505 . . . . 64.21 110.898 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.0 mmtp -54.68 -32.04 58.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 72.52 110.888 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.93 -17.91 13.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 73.05 110.882 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.95 -45.13 8.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 73.14 110.944 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -66.72 -41.39 88.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 75.43 110.906 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.7 mmtt -69.12 -39.26 79.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 73.11 110.919 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -77.14 -23.96 51.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 62.14 110.901 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 6.9 mmt -84.26 -22.68 30.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.468 . . . . 71.3 110.898 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 7.4 tpt -85.59 -35.76 20.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 72.44 110.868 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -77.56 -24.92 49.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.25 -0.432 . . . . 73.11 110.889 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -80.2 -30.74 38.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 74.04 110.909 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.09 -10.57 30.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.109 -0.496 . . . . 72.23 111.056 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.93 -9.68 56.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 72.54 110.914 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 119.73 42.57 0.52 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.747 -0.74 . . . . 70.13 112.493 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -47.59 -25.61 1.21 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.745 0.307 . . . . 72.33 110.876 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.05 -10.92 9.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.434 . . . . 71.52 111.118 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -106.11 165.27 13.31 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.589 0.709 . . . . 63.43 111.1 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -4.61 14.39 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.684 2.256 . . . . 72.22 112.327 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.06 -34.83 78.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.454 . . . . 74.21 110.898 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -51.78 104.71 0.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 70.25 110.93 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.39 10.71 7.77 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.73 -0.748 . . . . 72.44 112.492 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 24.5 p -92.08 -54.89 3.65 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.762 0.315 . . . . 74.45 111.151 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -111.78 -8.36 14.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 72.52 110.907 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -54.78 159.35 3.66 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.56 0.695 . . . . 74.44 111.14 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 66.61 1.75 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.64 2.226 . . . . 73.1 112.37 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -55.02 155.33 8.58 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.64 0.733 . . . . 73.32 110.86 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 167.74 23.67 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.67 2.246 . . . . 74.31 112.309 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 -19.14 36.71 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.728 2.285 . . . . 74.21 112.353 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.6 p -80.98 -26.81 36.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.452 . . . . 73.01 110.849 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -99.26 -26.19 14.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 75.22 110.885 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 72.04 110.888 -179.985 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.497 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 4.2 mtmt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.875 0.369 . . . . 75.42 110.915 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 55.8 t -154.61 -39.44 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 73.52 111.113 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.0 -12.51 75.4 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.746 -0.74 . . . . 74.25 112.487 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.497 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.5 m-85 -84.82 -41.94 15.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.892 0.377 . . . . 61.03 110.904 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.411 ' O ' ' N ' ' A' ' 9' ' ' TYR . 24.2 m-85 -67.22 -33.32 75.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 73.43 110.881 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.11 -33.44 57.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 74.42 110.913 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -108.54 -19.62 13.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 73.02 110.897 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -89.23 -46.42 8.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 74.12 110.884 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.411 ' N ' ' O ' ' A' ' 5' ' ' PHE . 9.7 t80 -64.27 -42.38 96.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 75.32 110.89 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.27 -30.34 69.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 74.52 110.905 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -77.92 -36.88 48.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.201 -0.454 . . . . 73.35 110.901 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -77.26 -20.85 54.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 74.41 110.877 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.401 ' O ' ' HB2' ' A' ' 17' ' ' ASN . 10.1 tmm? -84.93 -37.03 21.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 72.3 110.91 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -74.54 -28.8 61.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.189 -0.459 . . . . 72.01 110.899 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.426 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 23.6 pt-20 -76.24 -32.68 59.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.117 -0.492 . . . . 70.4 110.836 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -93.75 -9.36 37.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 52.33 111.114 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.401 ' HB2' ' O ' ' A' ' 13' ' ' MET . 0.7 OUTLIER -85.02 -11.48 55.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 75.43 110.902 -179.936 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 119.68 42.56 0.53 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.736 -0.745 . . . . 73.54 112.505 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.426 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 4.8 tm0? -47.62 -25.4 1.15 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.806 0.336 . . . . 71.2 110.915 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.02 -11.73 10.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 73.14 111.133 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -107.12 164.76 14.13 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.557 0.694 . . . . 75.01 111.103 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -4.18 13.52 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.615 2.21 . . . . 75.1 112.35 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -64.18 -32.2 73.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 65.35 110.936 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.19 104.17 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.094 -0.503 . . . . 75.43 110.894 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.82 -13.25 13.1 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.731 -0.747 . . . . 74.21 112.489 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 59.0 p -91.5 -37.16 13.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.687 0.279 . . . . 74.43 111.115 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -111.11 -2.6 15.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 74.14 110.912 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.7 t -45.73 146.87 1.74 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.6 0.714 . . . . 74.13 111.099 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 64.98 1.83 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.68 2.253 . . . . 71.01 112.339 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.15 155.29 9.17 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.7 0.762 . . . . 71.22 110.832 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 167.7 23.69 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.682 2.255 . . . . 72.41 112.368 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 167.54 24.05 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.668 2.245 . . . . 63.43 112.36 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.08 -28.85 65.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.444 . . . . 63.31 110.886 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -79.33 -26.4 42.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.095 -0.502 . . . . 75.23 110.888 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 74.33 110.877 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.48 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.792 0.329 . . . . 75.21 110.91 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 53.4 t -155.16 -39.73 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 75.53 111.145 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.68 -11.7 83.02 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.732 -0.747 . . . . 62.41 112.487 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.48 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.5 m-85 -85.39 -43.46 13.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.914 0.388 . . . . 74.44 110.855 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.409 ' O ' ' N ' ' A' ' 9' ' ' TYR . 20.9 m-85 -67.18 -32.69 73.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 74.23 110.837 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -54.03 -33.8 58.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.13 -0.486 . . . . 70.14 110.904 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.84 -19.42 13.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 75.53 110.866 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -89.47 -46.4 8.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 73.42 110.895 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.409 ' N ' ' O ' ' A' ' 5' ' ' PHE . 9.9 t80 -63.99 -43.17 96.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 72.23 110.938 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.5 ptmt -66.25 -32.41 73.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.116 -0.493 . . . . 75.23 110.927 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -75.38 -36.61 60.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 65.45 110.854 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 22.4 mtm -74.87 -25.33 58.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 74.34 110.885 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.23 -37.57 32.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 73.51 110.898 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -72.58 -31.98 65.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 75.43 110.914 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -74.21 -31.23 62.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 75.15 110.859 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -94.38 -10.18 33.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 75.04 111.089 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.8 -10.18 55.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 74.32 110.885 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 119.98 42.28 0.52 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.757 -0.735 . . . . 63.22 112.496 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 25.0 tp60 -47.75 -25.7 1.33 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.793 0.33 . . . . 74.24 110.881 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.21 -10.89 9.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 74.21 111.127 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -106.5 165.15 13.46 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.618 0.723 . . . . 73.04 111.055 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 -4.33 13.84 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.685 2.257 . . . . 74.45 112.383 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -64.27 -34.16 77.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 74.21 110.874 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -51.91 103.87 0.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 75.22 110.896 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.468 ' HA2' ' CG2' ' A' ' 28' ' ' THR . . . 118.1 23.99 3.41 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.752 -0.737 . . . . 72.22 112.492 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 90.9 m -93.1 -66.74 0.9 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.775 0.321 . . . . 74.32 111.148 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -117.11 -3.18 11.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 74.54 110.93 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.468 ' CG2' ' HA2' ' A' ' 25' ' ' GLY . 0.7 OUTLIER -46.27 148.19 1.65 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.608 0.718 . . . . 74.5 111.13 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 65.32 1.78 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.644 2.23 . . . . 74.45 112.368 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.1 p -73.85 155.34 88.83 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.649 0.738 . . . . 64.42 110.87 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 167.8 23.36 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.655 2.237 . . . . 74.23 112.36 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 170.45 16.54 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.697 2.264 . . . . 72.13 112.364 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 57.8 m -68.76 -19.9 64.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 65.21 110.867 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -95.33 23.14 6.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 73.41 110.912 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.48 . . . . 64.11 110.901 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.495 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 1.4 mtmm . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.814 0.34 . . . . 64.11 110.935 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 55.5 t -154.46 -39.4 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 72.32 111.121 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.58 -11.6 77.12 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.739 -0.743 . . . . 72.44 112.493 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.495 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.6 m-85 -85.85 -39.48 16.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.901 0.382 . . . . 73.23 110.879 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.436 ' O ' ' N ' ' A' ' 9' ' ' TYR . 24.1 m-85 -69.62 -34.28 73.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 74.31 110.846 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.43 -31.22 54.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 74.53 110.888 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 10.7 mtp180 -110.38 -19.27 13.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 74.2 110.873 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -90.34 -46.26 8.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 65.55 110.9 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.436 ' N ' ' O ' ' A' ' 5' ' ' PHE . 9.7 t80 -63.52 -42.68 98.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.22 -0.446 . . . . 73.55 110.928 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.5 mmmt -70.73 -29.16 65.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 73.2 110.902 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -81.2 -30.02 34.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 75.13 110.913 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 5.0 ptt? -80.92 -24.8 37.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 74.01 110.871 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 8.8 ptt? -85.87 -33.9 21.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 73.33 110.856 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -79.14 -24.47 43.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 74.23 110.903 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.423 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 0.0 OUTLIER -80.8 -31.06 35.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 72.35 110.895 -179.911 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.02 -9.79 32.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 63.52 111.088 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.24 -11.39 54.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.431 . . . . 74.24 110.861 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 119.71 42.44 0.53 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.782 -0.723 . . . . 62.11 112.499 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.423 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 0.7 OUTLIER -47.67 -25.32 1.15 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.738 0.304 . . . . 73.04 110.923 -179.899 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -119.93 -11.63 10.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 64.02 111.157 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -106.96 164.74 14.18 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.556 0.693 . . . . 74.14 111.111 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 -4.46 14.12 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.709 2.272 . . . . 75.15 112.307 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -63.01 -35.73 81.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.235 -0.439 . . . . 73.23 110.919 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -53.96 104.12 0.1 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 72.25 110.918 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.77 -6.48 15.88 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.743 -0.742 . . . . 31.41 112.5 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 86.7 m -90.46 -48.38 7.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.734 0.302 . . . . 72.15 111.171 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -111.08 -6.81 14.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 74.44 110.884 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -47.75 155.49 0.8 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.541 0.686 . . . . 74.42 111.131 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 68.92 1.67 Allowed 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.666 2.244 . . . . 72.45 112.39 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.4 m -60.92 155.35 54.18 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.626 0.727 . . . . 70.44 110.878 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 167.71 23.69 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.664 2.243 . . . . 74.22 112.33 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 -18.42 37.33 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.707 2.271 . . . . 65.11 112.336 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 60.1 m -57.64 -27.72 63.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 72.35 110.854 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.6 -26.47 29.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.117 -0.492 . . . . 72.3 110.885 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.6 tttm . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 73.22 110.91 179.983 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.493 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.851 0.358 . . . . 75.54 110.922 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 54.3 t -154.66 -39.94 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 62.54 111.126 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.3 -12.16 76.28 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.754 -0.736 . . . . 72.22 112.497 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.493 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.5 m-85 -85.24 -40.99 16.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.892 0.377 . . . . 75.51 110.893 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -68.48 -33.11 73.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 74.42 110.888 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.3 mmtt -53.9 -34.34 59.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 75.41 110.907 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -108.7 -18.79 13.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 75.1 110.84 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -89.37 -46.12 8.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 73.4 110.899 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -65.38 -40.69 93.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 75.31 110.881 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.64 -30.73 70.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.466 . . . . 74.4 110.875 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -74.85 -39.88 61.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 63.31 110.859 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 17.9 ptp -76.98 -20.66 55.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 73.32 110.859 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -84.69 -36.94 21.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 74.14 110.896 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.57 -30.37 61.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.226 -0.443 . . . . 72.34 110.918 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.42 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 12.7 pt-20 -75.37 -30.83 60.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.098 -0.501 . . . . 73.23 110.877 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -94.95 -9.73 33.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 71.31 111.104 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -87.94 -6.44 58.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 74.32 110.9 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 120.32 47.59 0.33 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.768 -0.73 . . . . 74.33 112.469 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.42 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -46.51 -25.0 0.6 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.788 0.328 . . . . 72.33 110.89 -179.866 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -118.78 -12.49 10.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 75.11 111.096 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -107.43 161.48 22.95 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.609 0.719 . . . . 74.44 111.09 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -5.92 17.35 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.667 2.245 . . . . 75.32 112.374 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -56.48 -32.34 64.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 74.55 110.89 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -50.45 103.6 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 74.02 110.855 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.13 4.75 15.84 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.74 -0.743 . . . . 74.24 112.495 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 62.9 m -90.19 -44.32 9.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.756 0.312 . . . . 74.24 111.153 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.16 -3.57 15.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 71.41 110.941 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -47.77 155.36 0.81 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.591 0.71 . . . . 74.51 111.098 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 69.64 1.63 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.673 2.248 . . . . 75.05 112.362 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.75 155.36 31.07 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.634 0.73 . . . . 75.32 110.881 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.83 167.71 23.75 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.693 2.262 . . . . 70.21 112.298 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 137.01 34.63 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.689 2.259 . . . . 72.52 112.35 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.3 t -68.59 -30.15 68.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 72.24 110.845 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -74.23 -26.78 60.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 75.31 110.866 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.7 mttt . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 74.33 110.891 179.933 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.479 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.84 0.352 . . . . 74.44 110.885 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 54.5 t -155.09 -39.66 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 65.11 111.096 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.63 -11.49 82.97 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.738 -0.744 . . . . 70.15 112.488 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.479 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.4 m-85 -85.78 -42.46 14.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.884 0.373 . . . . 75.13 110.921 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.435 ' O ' ' N ' ' A' ' 9' ' ' TYR . 18.1 m-85 -68.81 -31.62 70.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 72.23 110.902 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.6 mttt -54.41 -35.1 62.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 73.41 110.922 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -108.7 -18.13 13.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 75.21 110.904 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -90.15 -45.8 8.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 74.32 110.948 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.435 ' N ' ' O ' ' A' ' 5' ' ' PHE . 9.7 t80 -64.9 -41.85 95.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.455 . . . . 72.11 110.891 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 11.6 pttm -65.42 -35.25 80.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 74.34 110.893 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.18 -25.54 42.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 63.35 110.897 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -83.17 -22.8 33.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 75.52 110.906 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 34.4 ttp -84.8 -36.28 21.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 73.12 110.866 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -77.36 -25.58 51.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.227 -0.442 . . . . 73.5 110.9 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -79.48 -29.82 41.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 73.44 110.89 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.6 -11.98 26.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 74.03 111.12 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -87.27 -6.55 58.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 74.4 110.899 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 117.47 45.4 0.52 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.735 -0.745 . . . . 70.4 112.485 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -46.97 -24.66 0.65 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.759 0.314 . . . . 72.34 110.91 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -117.44 -13.26 10.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.247 -0.433 . . . . 73.21 111.121 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -108.51 162.68 19.1 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.576 0.703 . . . . 74.1 111.104 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 -4.27 13.69 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.658 2.239 . . . . 73.43 112.341 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -56.47 -34.02 66.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 74.43 110.901 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -49.96 103.68 0.06 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 52.41 110.888 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.29 4.26 16.11 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.765 -0.731 . . . . 75.41 112.52 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.0 m -90.18 -50.55 5.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.772 0.32 . . . . 63.32 111.142 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -111.06 -3.65 15.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 75.11 110.935 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -47.87 155.33 0.84 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.585 0.707 . . . . 73.22 111.153 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 69.48 1.63 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.692 2.261 . . . . 70.24 112.375 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.27 155.34 57.42 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.645 0.736 . . . . 72.43 110.856 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 167.75 23.55 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.708 2.272 . . . . 73.32 112.336 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 89.09 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.74 2.294 . . . . 72.02 112.324 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.07 -31.94 34.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 74.43 110.884 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.0 -26.98 61.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.475 . . . . 72.41 110.861 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 74.4 110.942 179.956 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.483 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.8 0.333 . . . . 74.14 110.873 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 54.3 t -155.11 -39.7 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 65.01 111.119 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.73 -11.43 83.26 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.691 -0.766 . . . . 71.03 112.494 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.483 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.5 m-85 -85.71 -42.68 14.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.896 0.379 . . . . 75.22 110.892 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.403 ' O ' ' N ' ' A' ' 9' ' ' TYR . 16.2 m-85 -69.17 -31.15 69.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 72.32 110.867 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.29 -32.94 62.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.159 -0.473 . . . . 74.45 110.903 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.22 -17.4 13.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 74.35 110.865 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -91.16 -44.94 8.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 73.41 110.897 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.403 ' N ' ' O ' ' A' ' 5' ' ' PHE . 9.3 t80 -67.49 -41.38 84.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 73.31 110.88 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.2 mmtt -69.29 -39.13 78.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 75.14 110.864 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -76.71 -25.35 53.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.216 -0.447 . . . . 75.2 110.87 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.2 mmm -83.09 -23.19 33.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 72.4 110.819 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.419 ' O ' ' HB2' ' A' ' 17' ' ' ASN . 0.0 OUTLIER -83.78 -36.83 23.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.247 -0.433 . . . . 65.41 110.874 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -72.46 -31.85 65.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.199 -0.455 . . . . 74.45 110.905 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -73.02 -35.37 66.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 74.43 110.883 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -91.11 -8.67 48.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 74.43 111.147 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.419 ' HB2' ' O ' ' A' ' 13' ' ' MET . 0.6 OUTLIER -85.6 -11.3 54.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.241 -0.436 . . . . 74.55 110.868 -179.946 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 121.52 42.78 0.45 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.744 -0.741 . . . . 61.35 112.499 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -46.22 -25.91 0.69 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.78 0.324 . . . . 74.04 110.924 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -124.99 -10.01 6.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 74.41 111.205 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -107.11 165.49 12.75 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.619 0.723 . . . . 71.23 111.06 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -19.96 35.63 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.684 2.256 . . . . 72.23 112.36 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -51.02 -24.23 3.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 63.32 110.919 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -69.3 104.85 2.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.091 -0.504 . . . . 75.02 110.838 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.79 -12.81 13.27 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.782 -0.723 . . . . 73.23 112.545 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.0 m -90.36 -43.31 10.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.745 0.307 . . . . 75.23 111.193 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -111.15 -8.69 14.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 74.23 110.931 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -47.54 155.64 0.73 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.614 0.721 . . . . 64.42 111.146 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 68.64 1.69 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.68 2.253 . . . . 74.0 112.335 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.41 155.3 75.58 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.625 0.726 . . . . 74.41 110.874 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.71 167.74 23.49 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.674 2.249 . . . . 75.43 112.403 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 130.69 19.71 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.698 2.266 . . . . 74.32 112.332 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 46.6 m -91.4 -31.56 15.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 63.24 110.864 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -94.09 -26.79 16.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 73.32 110.892 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 73.44 110.924 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.453 ' N ' ' HE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.843 0.354 . . . . 74.24 110.93 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.3 t -143.4 -36.86 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 73.41 111.14 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.96 -11.67 81.28 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.757 -0.735 . . . . 73.03 112.45 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.453 ' HE1' ' N ' ' A' ' 1' ' ' LYS . 1.7 m-85 -86.16 -42.42 13.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.918 0.39 . . . . 73.22 110.87 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -69.51 -30.97 68.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 73.35 110.853 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.3 mmtm -55.53 -34.59 64.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.14 -0.482 . . . . 74.05 110.943 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 10.8 ptt180 -108.59 -18.19 13.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 73.42 110.859 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -89.62 -46.16 8.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 72.43 110.899 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -65.15 -42.49 93.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 71.24 110.907 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.97 -29.61 68.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 75.22 110.893 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -78.22 -37.08 46.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.215 -0.448 . . . . 75.4 110.839 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.9 ppp? -77.28 -21.01 54.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.474 . . . . 51.44 110.901 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.2 tpt -85.16 -36.74 20.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 72.44 110.877 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -75.09 -28.02 60.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.226 -0.443 . . . . 74.31 110.91 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -76.95 -32.73 57.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.48 . . . . 74.41 110.915 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -93.06 -10.31 36.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 72.04 111.143 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.5 -10.47 55.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 62.54 110.905 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 120.11 42.3 0.52 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.688 -0.768 . . . . 75.5 112.512 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -47.76 -25.57 1.29 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.777 0.322 . . . . 75.11 110.94 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.33 -11.12 9.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.161 -0.472 . . . . 74.32 111.13 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -106.72 164.66 14.39 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.555 0.693 . . . . 73.43 111.098 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -4.72 14.6 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.698 2.265 . . . . 73.33 112.321 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -62.61 -34.74 77.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 73.41 110.899 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -54.57 104.13 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 65.34 110.859 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.7 -6.51 16.0 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.725 -0.75 . . . . 54.11 112.456 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.2 p -90.43 -48.4 7.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.703 0.287 . . . . 72.13 111.105 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -111.05 -6.81 14.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 74.32 110.951 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -47.79 155.54 0.8 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.631 0.729 . . . . 71.32 111.118 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 68.94 1.68 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.67 2.247 . . . . 74.42 112.345 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -92.95 155.32 41.51 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.662 0.744 . . . . 72.02 110.85 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 167.74 23.49 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.69 2.26 . . . . 64.33 112.374 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 -21.52 33.42 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.705 2.27 . . . . 65.11 112.365 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.63 -29.27 68.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 75.51 110.827 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.41 -26.23 51.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.125 -0.489 . . . . 73.32 110.917 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.118 -0.492 . . . . 74.13 110.926 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.444 ' N ' ' HE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.787 0.327 . . . . 74.24 110.878 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 1' ' ' LYS . 40.9 t -142.99 -36.7 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 75.15 111.119 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.29 -12.57 83.47 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.807 -0.711 . . . . 64.21 112.466 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.444 ' HE1' ' N ' ' A' ' 1' ' ' LYS . 1.6 m-85 -85.72 -45.41 11.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.848 0.356 . . . . 74.12 110.865 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.416 ' O ' ' HB3' ' A' ' 9' ' ' TYR . 21.5 m-85 -67.43 -29.36 68.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 73.21 110.884 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -55.98 -35.12 66.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 63.12 110.898 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.4 ptt85 -108.68 -18.31 13.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 73.51 110.891 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -89.25 -46.29 8.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.459 . . . . 71.4 110.914 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.416 ' HB3' ' O ' ' A' ' 5' ' ' PHE . 9.9 t80 -64.84 -42.2 95.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 73.42 110.925 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.08 -33.31 75.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.144 -0.48 . . . . 73.34 110.876 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -74.23 -37.6 63.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.438 . . . . 74.12 110.935 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.34 -24.7 59.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 73.12 110.93 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.23 -37.37 28.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 74.1 110.842 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -74.08 -29.14 61.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 74.2 110.864 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -76.81 -30.81 56.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 74.31 110.862 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -94.93 -10.28 31.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 73.51 111.104 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -86.02 -10.05 55.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 75.3 110.892 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 120.04 42.55 0.51 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.728 -0.749 . . . . 52.25 112.448 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -47.61 -25.6 1.21 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.782 0.325 . . . . 75.24 110.911 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.95 -11.16 9.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 70.22 111.134 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -106.68 165.02 13.66 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.623 0.725 . . . . 73.14 111.041 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -4.22 13.59 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.705 2.27 . . . . 75.44 112.345 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -65.17 -31.81 73.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.464 . . . . 72.24 110.863 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -52.58 104.19 0.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 62.31 110.873 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.87 -7.03 13.32 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.747 -0.74 . . . . 74.33 112.551 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.0 t -90.77 -31.88 16.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.749 0.309 . . . . 73.31 111.121 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -111.9 -12.52 13.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 64.42 110.923 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -47.35 155.84 0.67 Allowed Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.61 0.719 . . . . 71.22 111.177 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 67.74 1.73 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.716 2.277 . . . . 73.51 112.343 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.9 155.29 54.31 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.692 0.758 . . . . 74.44 110.885 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 167.75 23.48 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.693 2.262 . . . . 73.34 112.353 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -19.06 36.48 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.716 2.277 . . . . 72.12 112.363 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.3 t -68.35 -31.74 71.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 74.45 110.81 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -90.2 -26.86 19.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 74.22 110.884 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.3 mttt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.49 . . . . 73.44 110.928 -179.993 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.487 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 1.4 mtmm . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.789 0.328 . . . . 75.12 110.924 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 55.6 t -154.49 -39.44 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 70.22 111.135 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.04 -12.55 75.57 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.704 -0.76 . . . . 73.55 112.438 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.487 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.6 m-85 -84.8 -41.71 15.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.87 0.367 . . . . 74.03 110.884 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.438 ' O ' ' N ' ' A' ' 9' ' ' TYR . 24.3 m-85 -67.39 -33.73 75.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.467 . . . . 75.54 110.846 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.95 -32.71 54.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 75.31 110.905 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.0 ptt180 -109.21 -19.47 13.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.445 . . . . 73.22 110.92 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.419 ' HA ' ' HG2' ' A' ' 11' ' ' GLU . 0.8 OUTLIER -90.0 -45.34 9.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 75.05 110.919 -179.948 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.438 ' N ' ' O ' ' A' ' 5' ' ' PHE . 9.3 t80 -65.83 -40.16 91.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 74.45 110.961 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.2 ptmt -63.87 -40.32 96.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.094 -0.503 . . . . 73.52 110.889 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.419 ' HG2' ' HA ' ' A' ' 8' ' ' GLN . 9.6 pt-20 -77.11 -25.92 52.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 74.03 110.872 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.06 -22.11 33.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 71.13 110.895 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.7 tpt -85.03 -36.66 21.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 70.51 110.905 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -76.33 -26.66 55.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.271 -0.422 . . . . 71.3 110.891 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.411 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 22.9 pt-20 -78.43 -30.59 47.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 74.2 110.89 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -94.88 -11.58 28.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 72.11 111.115 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -87.24 -6.93 58.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.438 . . . . 72.24 110.913 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 117.98 45.58 0.49 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.709 -0.758 . . . . 64.05 112.511 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.411 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 6.1 tt0 -46.91 -24.66 0.63 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.755 0.312 . . . . 74.14 110.874 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -117.17 -13.29 10.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 74.01 111.128 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -108.72 162.48 19.85 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.568 0.699 . . . . 75.41 111.102 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 -4.39 13.96 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.657 2.238 . . . . 75.43 112.342 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -56.73 -33.07 66.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.229 -0.441 . . . . 71.24 110.917 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -49.58 103.55 0.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 70.43 110.871 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.442 ' HA2' ' CG2' ' A' ' 28' ' ' THR . . . 116.71 32.95 1.49 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.701 -0.761 . . . . 54.4 112.484 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 93.1 m -92.76 -69.69 0.73 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.759 0.314 . . . . 72.41 111.108 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.43 -2.72 11.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 74.52 110.949 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.442 ' CG2' ' HA2' ' A' ' 25' ' ' GLY . 0.7 OUTLIER -46.98 148.22 1.99 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.573 0.701 . . . . 74.3 111.095 -179.905 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 65.34 1.81 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.662 2.241 . . . . 63.22 112.36 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.3 p -68.63 155.32 93.21 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.679 0.752 . . . . 73.33 110.857 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 167.7 23.77 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.689 2.259 . . . . 74.11 112.304 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 171.08 15.05 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.706 2.271 . . . . 75.33 112.367 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 31.3 p -59.46 -35.28 73.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.237 -0.438 . . . . 74.32 110.843 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -63.5 -26.04 68.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.103 -0.498 . . . . 71.1 110.875 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.7 mtmt . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 74.45 110.934 179.989 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.431 ' N ' ' HE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.829 0.347 . . . . 74.24 110.902 . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.414 HG21 ' O ' ' A' ' 1' ' ' LYS . 41.1 t -142.99 -36.78 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 72.02 111.117 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.31 -12.03 83.81 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.711 -0.757 . . . . 75.43 112.512 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.431 ' HE1' ' N ' ' A' ' 1' ' ' LYS . 1.6 m-85 -86.24 -43.92 12.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.885 0.374 . . . . 71.02 110.888 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.427 ' O ' ' HB3' ' A' ' 9' ' ' TYR . 20.6 m-85 -69.17 -29.17 67.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.1 -0.5 . . . . 65.11 110.862 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.23 -35.77 67.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 71.42 110.862 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -108.4 -17.47 13.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 74.03 110.914 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -90.01 -45.96 8.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 65.03 110.91 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.427 ' HB3' ' O ' ' A' ' 5' ' ' PHE . 9.6 t80 -65.64 -41.73 92.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 74.24 110.915 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.4 ptmt -64.82 -33.8 76.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.127 -0.488 . . . . 72.42 110.85 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.49 -34.15 58.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 75.53 110.904 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.4 ptt? -77.91 -21.49 51.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 74.14 110.895 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.52 -36.94 21.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.431 . . . . 75.41 110.874 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -74.43 -29.05 61.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 73.31 110.901 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -76.17 -32.74 59.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 73.31 110.88 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -93.0 -10.3 36.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 71.22 111.115 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.47 -10.46 56.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 73.31 110.917 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 120.07 42.33 0.52 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.759 -0.734 . . . . 72.32 112.488 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -47.74 -25.61 1.3 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.807 0.337 . . . . 73.32 110.931 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.36 -11.08 9.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.479 . . . . 74.52 111.166 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -106.74 164.61 14.5 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.581 0.705 . . . . 61.41 111.092 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.68 -4.72 14.53 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.735 2.29 . . . . 74.42 112.343 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -62.55 -34.83 77.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.429 . . . . 73.53 110.903 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -54.49 104.01 0.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.467 . . . . 71.13 110.898 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.68 -6.48 16.07 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.745 -0.741 . . . . 74.21 112.48 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 24.6 m -90.36 -48.45 7.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.747 0.308 . . . . 75.24 111.138 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -111.03 -6.81 14.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 72.33 110.932 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -47.83 155.52 0.81 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.612 0.72 . . . . 75.11 111.11 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 68.91 1.7 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.655 2.236 . . . . 64.1 112.361 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.2 m -55.71 155.35 11.14 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.67 0.748 . . . . 72.31 110.873 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 167.71 23.64 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.725 2.283 . . . . 64.43 112.338 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 177.69 5.32 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.728 2.285 . . . . 72.41 112.337 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.23 -27.36 24.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 74.2 110.851 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -70.85 -26.17 63.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 74.11 110.854 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.3 ttmt . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.195 -0.457 . . . . 74.41 110.893 179.971 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.457 ' N ' ' HE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.78 0.324 . . . . 75.24 110.912 . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.8 t -143.62 -36.84 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.431 . . . . 74.15 111.105 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.65 -11.45 83.03 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.734 -0.746 . . . . 73.13 112.5 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.457 ' HE1' ' N ' ' A' ' 1' ' ' LYS . 1.8 m-85 -86.16 -41.12 14.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.929 0.395 . . . . 75.14 110.902 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.429 ' O ' ' N ' ' A' ' 9' ' ' TYR . 23.4 m-85 -70.8 -33.0 70.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 73.34 110.86 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 42.6 mmtt -56.02 -29.3 60.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.169 -0.469 . . . . 74.24 110.914 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.93 -18.79 12.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.446 . . . . 71.13 110.854 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -92.0 -45.49 8.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 74.54 110.91 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.429 ' N ' ' O ' ' A' ' 5' ' ' PHE . 9.2 t80 -64.73 -38.6 91.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 72.21 110.913 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.7 mmtt -70.89 -37.37 72.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 75.42 110.905 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.15 -27.98 54.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 64.4 110.868 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -82.99 -19.95 36.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 74.41 110.902 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.73 -36.14 18.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 73.44 110.902 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -76.78 -25.99 53.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.239 -0.437 . . . . 74.15 110.902 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.88 -31.87 45.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.105 -0.498 . . . . 74.02 110.901 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -93.97 -10.49 33.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 75.41 111.119 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.59 -10.33 56.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 71.3 110.868 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 120.16 42.37 0.51 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.739 -0.744 . . . . 64.25 112.509 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -47.57 -25.63 1.2 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.766 0.317 . . . . 75.21 110.925 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.23 -11.1 9.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 72.51 111.162 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -106.7 164.72 14.28 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.549 0.69 . . . . 74.23 111.129 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -4.72 14.59 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.733 2.289 . . . . 73.02 112.337 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -62.89 -34.33 77.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.238 -0.437 . . . . 75.24 110.859 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -54.49 104.11 0.1 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 72.5 110.887 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.62 -5.78 16.59 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.71 -0.757 . . . . 45.11 112.514 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 66.5 p -90.39 -48.58 7.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.76 0.314 . . . . 74.54 111.123 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.04 -6.74 14.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 73.43 110.906 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -47.72 155.52 0.79 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.576 0.703 . . . . 65.34 111.167 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 68.93 1.69 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.664 2.242 . . . . 70.31 112.394 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.94 155.29 43.96 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.67 0.747 . . . . 74.04 110.841 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 167.76 23.47 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.647 2.231 . . . . 74.4 112.359 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -21.68 33.09 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.708 2.272 . . . . 72.13 112.298 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.6 t -73.9 -26.57 60.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.258 -0.428 . . . . 72.34 110.882 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.54 -26.23 20.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 74.01 110.863 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 74.11 110.917 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.446 ' N ' ' HE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.805 0.336 . . . . 73.55 110.869 . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.3 t -143.3 -36.53 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 75.21 111.102 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.01 -12.07 83.58 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.771 -0.728 . . . . 54.0 112.487 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.446 ' HE1' ' N ' ' A' ' 1' ' ' LYS . 1.7 m-85 -85.78 -43.83 13.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.836 0.351 . . . . 74.24 110.868 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -68.4 -31.64 71.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.188 -0.46 . . . . 74.54 110.854 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.93 -31.04 62.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 74.44 110.884 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -110.86 -18.88 13.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.269 -0.423 . . . . 75.54 110.905 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -90.63 -45.68 8.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 74.12 110.91 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -63.66 -42.97 98.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.25 -0.432 . . . . 71.41 110.922 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.9 mmmm -65.51 -40.43 92.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 73.55 110.87 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -75.12 -26.04 58.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 74.52 110.918 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 21.2 mmm -82.96 -21.85 33.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 74.34 110.852 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -85.74 -35.99 20.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 74.25 110.875 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -77.16 -24.99 51.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 73.11 110.866 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.431 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 0.0 OUTLIER -80.17 -31.07 38.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 74.0 110.915 -179.935 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.23 -9.7 32.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.134 -0.485 . . . . 44.12 111.112 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.19 -11.38 55.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 75.53 110.956 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 119.85 42.68 0.51 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.728 -0.749 . . . . 72.53 112.481 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.431 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 5.3 tm0? -47.4 -25.36 1.01 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.802 0.334 . . . . 74.14 110.931 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -119.46 -11.76 10.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.436 . . . . 75.55 111.106 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -106.98 165.04 13.56 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.588 0.709 . . . . 71.5 111.101 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 -3.89 12.97 Favored 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.723 2.282 . . . . 72.55 112.335 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.36 -31.19 71.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 72.33 110.87 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -51.83 104.34 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 64.53 110.88 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.2 -7.65 12.63 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.785 -0.722 . . . . 75.45 112.495 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.8 t -91.53 -31.16 16.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.785 0.326 . . . . 74.32 111.172 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -111.81 -2.84 15.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 75.32 110.933 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.6 t -45.88 147.03 1.77 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.578 0.704 . . . . 74.55 111.165 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 65.0 1.77 Allowed 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.685 2.257 . . . . 61.2 112.365 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.48 155.37 20.08 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.681 0.753 . . . . 74.11 110.831 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 167.76 23.57 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.658 2.238 . . . . 73.01 112.341 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -35.83 11.96 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.672 2.248 . . . . 72.52 112.342 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 p -59.5 -28.29 66.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.445 . . . . 74.52 110.821 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.97 -26.45 13.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 65.03 110.863 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.0 tptm . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 73.34 110.868 179.927 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' LYS . . . . . 0.491 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.817 0.341 . . . . 73.120000000000005 110.865 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 54.7 t -155.01 -40.05 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 72.120000000000005 111.107 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.18 -11.82 81.77 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.744 -0.741 . . . . 70.219999999999999 112.45 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.491 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.4 m-85 -85.43 -43.02 13.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.878 0.371 . . . . 74.439999999999998 110.905 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.427 ' O ' ' N ' ' A' ' 9' ' ' TYR . 22.3 m-85 -67.26 -32.8 74.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 63.200000000000003 110.889 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.4 mmtt -54.07 -33.67 58.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 72.109999999999999 110.887 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -108.76 -19.53 13.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 65.209999999999994 110.892 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 40.8 mm-40 -89.39 -46.33 8.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 72.030000000000001 110.925 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.427 ' N ' ' O ' ' A' ' 5' ' ' PHE . 10.0 t80 -64.1 -42.99 96.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 72.549999999999997 110.932 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.1 ptmt -66.55 -32.28 73.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.099 -0.5 . . . . 74.510000000000005 110.89 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -76.15 -36.5 58.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 54.409999999999997 110.913 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.5 mmt -76.97 -21.5 54.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 73.239999999999995 110.848 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 6.2 tpt -85.27 -36.3 20.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 63.109999999999999 110.897 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -76.64 -25.81 54.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.198 -0.456 . . . . 73.219999999999999 110.876 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.41 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 0.6 OUTLIER -79.48 -30.97 42.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 72.439999999999998 110.919 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -94.75 -10.53 31.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 71.310000000000002 111.108 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -85.69 -10.3 55.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.205 -0.452 . . . . 74.5 110.919 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 120.24 42.85 0.49 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.778 -0.725 . . . . 72.450000000000003 112.501 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.41 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 6.5 tt0 -47.46 -25.61 1.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.793 0.33 . . . . 72.319999999999993 110.921 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.466 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -120.96 -11.25 9.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 74.150000000000006 111.157 179.92 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.724 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -106.74 164.81 14.08 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.572 0.701 . . . . 64.549999999999997 111.136 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.724 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.6 Cg_endo -69.74 -4.46 14.05 Favored 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.719 2.279 . . . . 64.120000000000005 112.382 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -64.66 -30.64 71.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.456 . . . . 44.530000000000001 110.897 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.3 t30 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.115 -0.493 . . . . 73.519999999999996 110.87 -179.941 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' LYS . . . . . 0.483 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.834 0.349 . . . . 71.439999999999998 110.9 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 53.1 t -155.12 -39.71 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.281 -0.418 . . . . 75.439999999999998 111.092 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.44 -11.82 82.4 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.717 -0.754 . . . . 72.099999999999994 112.514 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.483 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.5 m-85 -85.35 -43.93 13.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.891 0.377 . . . . 75.340000000000003 110.865 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.417 ' O ' ' N ' ' A' ' 9' ' ' TYR . 18.7 m-85 -67.2 -31.67 72.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 75.519999999999996 110.853 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.45 -34.43 61.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 70.319999999999993 110.923 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -108.71 -19.11 13.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 72.439999999999998 110.827 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -89.49 -46.35 8.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.444 . . . . 71.0 110.942 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.417 ' N ' ' O ' ' A' ' 5' ' ' PHE . 9.9 t80 -64.28 -43.08 95.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 63.109999999999999 110.955 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.51 -32.01 73.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 74.150000000000006 110.886 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -76.66 -34.42 58.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.227 -0.442 . . . . 62.109999999999999 110.9 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.3 mmm -77.46 -23.68 50.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 74.5 110.897 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.23 -36.79 24.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 73.439999999999998 110.901 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -75.92 -26.33 56.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 44.439999999999998 110.923 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.407 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 8.9 pt-20 -79.03 -30.74 44.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 74.109999999999999 110.848 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.13 -10.4 30.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 70.239999999999995 111.074 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -86.15 -9.49 56.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.251 -0.431 . . . . 73.349999999999994 110.921 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 119.62 42.46 0.53 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.687 -0.768 . . . . 43.310000000000002 112.463 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.407 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 10.9 tt0 -47.62 -25.59 1.21 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.783 0.325 . . . . 63.43 110.926 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.445 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -121.19 -10.88 9.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 74.200000000000003 111.055 179.973 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.756 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -106.14 165.26 13.33 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.557 0.694 . . . . 63.409999999999997 111.083 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.756 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.7 Cg_endo -69.72 -4.57 14.27 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.639 2.226 . . . . 53.119999999999997 112.296 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.07 -34.77 78.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 72.310000000000002 110.921 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.1 t30 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 65.420000000000002 110.879 -179.95 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' LYS . . . . . 0.486 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.849 0.357 . . . . 72.310000000000002 110.877 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 54.5 t -155.04 -39.55 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 70.310000000000002 111.148 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.93 -11.05 83.95 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.735 -0.745 . . . . 72.120000000000005 112.488 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.486 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.4 m-85 -86.37 -41.11 14.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.897 0.379 . . . . 74.319999999999993 110.898 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.411 ' O ' ' N ' ' A' ' 9' ' ' TYR . 20.5 m-85 -69.65 -32.41 71.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.483 . . . . 74.230000000000004 110.842 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.9 -32.33 60.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 74.430000000000007 110.861 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.55 -18.62 13.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 72.439999999999998 110.853 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -90.46 -46.23 8.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 63.310000000000002 110.894 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.411 ' N ' ' O ' ' A' ' 5' ' ' PHE . 10.0 t80 -64.29 -42.92 96.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.247 -0.433 . . . . 74.219999999999999 110.967 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.4 mmmt -69.27 -33.81 73.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.082 -0.508 . . . . 64.230000000000004 110.903 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -76.32 -35.44 58.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.26 -0.427 . . . . 72.040000000000006 110.837 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.3 ptm -77.78 -20.6 53.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 70.140000000000001 110.916 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.63 -36.68 20.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 74.230000000000004 110.861 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.79 -27.1 57.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 64.439999999999998 110.907 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -78.27 -31.48 49.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 71.010000000000005 110.902 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -94.91 -9.0 35.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 51.240000000000002 111.054 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -85.62 -11.08 54.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 73.040000000000006 110.869 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 120.97 43.26 0.45 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.765 -0.731 . . . . 72.329999999999998 112.502 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -47.44 -25.72 1.14 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.751 0.31 . . . . 74.420000000000002 110.892 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.453 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -121.49 -11.0 9.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 64.329999999999998 111.13 179.946 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.72 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -106.54 164.31 15.17 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.59 0.71 . . . . 63.299999999999997 111.081 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.72 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.5 Cg_endo -69.68 -5.51 16.32 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.698 2.265 . . . . 71.439999999999998 112.336 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -62.05 -33.74 74.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 62.119999999999997 110.892 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.2 t30 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 72.430000000000007 110.925 -179.95 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' LYS . . . . . 0.503 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 1.1 mttt . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.792 0.33 . . . . 54.409999999999997 110.908 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 54.4 t -154.73 -39.87 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.271 -0.422 . . . . 60.439999999999998 111.11 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.32 -12.39 76.52 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.725 -0.75 . . . . 31.210000000000001 112.507 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.503 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.5 m-85 -84.91 -41.98 15.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.883 0.373 . . . . 75.239999999999995 110.854 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.446 ' O ' ' N ' ' A' ' 9' ' ' TYR . 25.4 m-85 -67.18 -33.59 75.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 75.439999999999998 110.87 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.9 mmtt -53.99 -33.32 56.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 61.119999999999997 110.902 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 13.7 mmt85 -108.52 -19.8 13.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 75.200000000000003 110.908 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.1 mm100 -89.19 -46.39 8.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 73.230000000000004 110.917 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 5' ' ' PHE . 9.9 t80 -63.81 -43.04 97.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.223 -0.444 . . . . 75.129999999999995 110.938 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.5 ptmt -66.7 -32.42 73.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.136 -0.484 . . . . 74.109999999999999 110.888 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -76.47 -35.35 58.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 73.319999999999993 110.911 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 29.4 mtt -77.78 -21.73 51.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.099 -0.5 . . . . 74.439999999999998 110.888 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -85.27 -36.4 20.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.255 -0.43 . . . . 74.420000000000002 110.921 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.14 -26.02 55.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.247 -0.433 . . . . 65.310000000000002 110.881 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.41 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 18.8 pt-20 -78.96 -32.37 45.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.473 . . . . 74.439999999999998 110.895 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -93.38 -10.33 35.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.123 -0.49 . . . . 72.310000000000002 111.09 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -85.62 -10.47 55.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 74.329999999999998 110.896 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 120.18 42.42 0.51 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.698 -0.763 . . . . 75.239999999999995 112.485 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.41 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 11.9 tt0 -47.67 -25.56 1.24 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.804 0.335 . . . . 75.299999999999997 110.951 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.459 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -121.28 -11.16 9.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 73.549999999999997 111.117 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.722 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -106.74 164.6 14.52 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.571 0.7 . . . . 74.040000000000006 111.093 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.722 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.4 Cg_endo -69.77 -4.64 14.44 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.666 2.244 . . . . 43.210000000000001 112.366 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -62.71 -34.75 77.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.459 . . . . 72.230000000000004 110.895 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.2 t30 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 75.129999999999995 110.914 -179.946 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' LYS . . . . . 0.487 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.851 0.358 . . . . 35.310000000000002 110.895 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 53.7 t -155.03 -39.62 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 74.5 111.107 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.9 -11.03 83.9 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.737 -0.744 . . . . 71.430000000000007 112.478 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.487 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.4 m-85 -86.41 -41.13 14.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.881 0.372 . . . . 61.240000000000002 110.858 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.412 ' O ' ' N ' ' A' ' 9' ' ' TYR . 20.6 m-85 -69.55 -32.47 71.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 62.399999999999999 110.902 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.93 -32.18 60.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 64.450000000000003 110.912 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.57 -18.66 13.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.234 -0.439 . . . . 72.319999999999993 110.857 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 14.9 tp60 -90.49 -46.08 8.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 65.439999999999998 110.905 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.412 ' N ' ' O ' ' A' ' 5' ' ' PHE . 9.9 t80 -64.11 -43.14 96.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.185 -0.461 . . . . 73.340000000000003 110.942 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.1 mmtt -69.17 -34.08 74.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.078 -0.51 . . . . 61.399999999999999 110.889 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -80.02 -21.43 43.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 74.430000000000007 110.909 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.6 mmt -86.26 -27.19 24.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.476 . . . . 42.43 110.872 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.19 -30.36 22.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 65.400000000000006 110.909 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -82.09 -23.87 35.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 72.010000000000005 110.854 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.75 -31.27 32.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.445 . . . . 71.510000000000005 110.867 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -94.52 -9.3 35.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 55.130000000000003 111.072 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -85.43 -11.3 54.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 72.450000000000003 110.895 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 121.21 43.44 0.43 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.794 -0.717 . . . . 44.229999999999997 112.536 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.29 -25.7 1.04 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.773 0.32 . . . . 74.129999999999995 110.913 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.458 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -121.38 -10.97 9.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 74.209999999999994 111.172 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.706 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -106.42 164.16 15.49 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.539 0.685 . . . . 64.530000000000001 111.122 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.706 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.7 Cg_endo -69.75 -5.62 16.64 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.646 2.23 . . . . 74.519999999999996 112.346 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -62.05 -34.11 75.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.455 . . . . 73.420000000000002 110.912 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.3 t30 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.468 . . . . 70.540000000000006 110.809 -179.921 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' LYS . . . . . 0.487 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.775 0.322 . . . . 74.450000000000003 110.922 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 54.7 t -154.99 -39.73 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 62.43 111.095 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.78 -11.01 83.58 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.776 -0.726 . . . . 72.439999999999998 112.502 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.487 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.4 m-85 -86.48 -41.11 14.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.915 0.388 . . . . 70.319999999999993 110.882 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.427 ' O ' ' N ' ' A' ' 9' ' ' TYR . 21.4 m-85 -69.49 -32.56 71.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 74.439999999999998 110.893 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.68 -33.01 60.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 72.329999999999998 110.893 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.404 ' HA ' ' HD3' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -109.77 -18.5 13.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 75.209999999999994 110.858 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.7 tm0? -90.81 -45.41 8.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 72.340000000000003 110.935 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.427 ' N ' ' O ' ' A' ' 5' ' ' PHE . 9.1 t80 -66.31 -39.43 89.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.456 . . . . 74.420000000000002 110.987 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' A' ' 7' ' ' ARG . 5.0 ptmm? -68.23 -33.36 74.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.11 -0.496 . . . . 53.149999999999999 110.897 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.15 -25.91 36.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 62.509999999999998 110.868 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.41 -20.29 32.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 44.5 110.866 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.4 tpt -86.87 -35.89 18.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.254 -0.43 . . . . 70.299999999999997 110.852 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.429 ' HG2' HD22 ' A' ' 24' ' ' ASN . 3.1 mt-10 -77.11 -25.47 52.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.216 -0.447 . . . . 74.439999999999998 110.91 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.416 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 0.0 OUTLIER -79.37 -31.87 43.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 74.209999999999994 110.922 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -93.96 -10.56 33.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.112 -0.495 . . . . 72.209999999999994 111.13 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -85.53 -10.33 56.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 72.319999999999993 110.911 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 120.19 42.78 0.5 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.726 -0.749 . . . . 75.239999999999995 112.495 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.416 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 13.5 tt0 -47.51 -25.55 1.13 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.785 0.326 . . . . 61.049999999999997 110.942 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.461 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -121.01 -11.24 9.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 75.310000000000002 111.145 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.724 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -106.83 164.84 14.01 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.594 0.711 . . . . 43.5 111.114 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.724 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.3 Cg_endo -69.77 -4.53 14.21 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.663 2.242 . . . . 70.340000000000003 112.347 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -64.45 -30.84 71.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.192 -0.458 . . . . 65.430000000000007 110.879 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.429 HD22 ' HG2' ' A' ' 14' ' ' GLU . 1.3 t30 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 74.450000000000003 110.898 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' LYS . . . . . 0.488 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.783 0.325 . . . . 70.349999999999994 110.91 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 55.1 t -155.05 -39.76 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 71.200000000000003 111.104 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.72 -11.45 83.21 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.803 -0.713 . . . . 44.32 112.469 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.488 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.4 m-85 -85.77 -42.09 14.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.913 0.387 . . . . 73.010000000000005 110.896 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.424 ' O ' ' N ' ' A' ' 9' ' ' TYR . 20.2 m-85 -68.81 -32.93 73.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 63.420000000000002 110.837 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.76 -33.94 57.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 74.129999999999995 110.864 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -109.37 -18.68 13.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 74.5 110.887 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -90.2 -45.96 8.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 72.329999999999998 110.925 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.424 ' N ' ' O ' ' A' ' 5' ' ' PHE . 8.6 t80 -66.19 -37.86 86.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.46 . . . . 73.439999999999998 110.917 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.02 -33.42 73.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 64.430000000000007 110.911 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.04 -26.28 36.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 73.019999999999996 110.906 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.14 -20.29 32.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 43.549999999999997 110.843 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.8 tpt -86.64 -36.06 19.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.439 . . . . 62.149999999999999 110.904 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -76.93 -25.77 53.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.203 -0.453 . . . . 51.310000000000002 110.902 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.11 -31.81 44.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 73.219999999999999 110.887 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -94.11 -10.43 33.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.103 -0.498 . . . . 70.049999999999997 111.134 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -85.74 -10.2 55.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 52.210000000000001 110.884 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 120.02 42.42 0.52 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.732 -0.747 . . . . 64.140000000000001 112.477 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -47.66 -25.65 1.26 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.812 0.339 . . . . 62.530000000000001 110.954 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.459 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -121.35 -11.1 9.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 74.319999999999993 111.15 179.95 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.739 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -106.71 164.72 14.27 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.59 0.709 . . . . 61.030000000000001 111.074 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.739 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.5 Cg_endo -69.76 -4.71 14.58 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.708 2.272 . . . . 74.340000000000003 112.322 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.5 -34.44 76.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.232 -0.44 . . . . 73.219999999999999 110.918 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.2 t30 . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.139 -0.482 . . . . 75.129999999999995 110.905 -179.956 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' LYS . . . . . 0.502 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.804 0.335 . . . . 71.010000000000005 110.888 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 54.4 t -154.69 -39.84 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 63.509999999999998 111.087 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.49 -12.03 76.97 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.746 -0.74 . . . . 13.31 112.492 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.502 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.6 m-85 -85.31 -40.78 16.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.904 0.383 . . . . 74.310000000000002 110.87 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -68.95 -33.18 73.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.09 -0.505 . . . . 51.350000000000001 110.898 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.0 mmtp -54.68 -32.04 58.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 70.510000000000005 110.888 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.93 -17.91 13.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 73.049999999999997 110.882 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.95 -45.13 8.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 64.540000000000006 110.944 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -66.72 -41.39 88.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 75.430000000000007 110.906 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.7 mmtt -69.12 -39.26 79.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 73.109999999999999 110.919 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -77.14 -23.96 51.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 54.409999999999997 110.901 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 6.9 mmt -84.26 -22.68 30.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.468 . . . . 53.020000000000003 110.898 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 7.4 tpt -85.59 -35.76 20.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 71.299999999999997 110.868 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -77.56 -24.92 49.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.25 -0.432 . . . . 73.109999999999999 110.889 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.413 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 1.4 pp20? -80.2 -30.74 38.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 71.049999999999997 110.909 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.09 -10.57 30.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.109 -0.496 . . . . 72.230000000000004 111.056 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -85.93 -9.68 56.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 72.540000000000006 110.914 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 119.73 42.57 0.52 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.747 -0.74 . . . . 70.109999999999999 112.493 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.413 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 9.8 tt0 -47.59 -25.61 1.21 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.745 0.307 . . . . 72.329999999999998 110.876 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.453 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -121.05 -10.92 9.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.434 . . . . 54.32 111.118 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.753 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -106.11 165.27 13.31 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.589 0.709 . . . . 63.329999999999998 111.1 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.753 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.9 Cg_endo -69.78 -4.61 14.39 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.684 2.256 . . . . 40.240000000000002 112.327 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.06 -34.83 78.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.454 . . . . 74.209999999999994 110.898 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.1 t30 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 70.25 110.93 -179.983 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' LYS . . . . . 0.507 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 4.2 mtmt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.875 0.369 . . . . 73.420000000000002 110.915 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 55.8 t -154.61 -39.44 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 65.239999999999995 111.113 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.0 -12.51 75.4 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.746 -0.74 . . . . 63.109999999999999 112.487 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.507 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.5 m-85 -84.82 -41.94 15.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.892 0.377 . . . . 61.030000000000001 110.904 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.411 ' O ' ' N ' ' A' ' 9' ' ' TYR . 24.2 m-85 -67.22 -33.32 75.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 73.430000000000007 110.881 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.11 -33.44 57.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 74.420000000000002 110.913 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -108.54 -19.62 13.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 73.019999999999996 110.897 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -89.23 -46.42 8.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 74.120000000000005 110.884 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.411 ' N ' ' O ' ' A' ' 5' ' ' PHE . 9.7 t80 -64.27 -42.38 96.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 75.319999999999993 110.89 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.27 -30.34 69.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 73.540000000000006 110.905 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -77.92 -36.88 48.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.201 -0.454 . . . . 73.349999999999994 110.901 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -77.26 -20.85 54.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 62.210000000000001 110.877 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 10.1 tmm? -84.93 -37.03 21.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 65.420000000000002 110.91 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -74.54 -28.8 61.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.189 -0.459 . . . . 72.010000000000005 110.899 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.455 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 23.6 pt-20 -76.24 -32.68 59.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.117 -0.492 . . . . 55.219999999999999 110.836 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -93.75 -9.36 37.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 52.329999999999998 111.114 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -85.02 -11.48 55.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 75.430000000000007 110.902 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 119.68 42.56 0.53 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.736 -0.745 . . . . 55.119999999999997 112.505 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.455 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 4.8 tm0? -47.62 -25.4 1.15 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.806 0.336 . . . . 71.200000000000003 110.915 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.472 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -120.02 -11.73 10.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 73.140000000000001 111.133 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.719 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -107.12 164.76 14.13 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.557 0.694 . . . . 70.349999999999994 111.103 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.719 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.5 Cg_endo -69.79 -4.18 13.52 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.615 2.21 . . . . 73.530000000000001 112.35 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -64.18 -32.2 73.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 65.349999999999994 110.936 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.3 t30 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.094 -0.503 . . . . 75.430000000000007 110.894 -179.978 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' LYS . . . . . 0.49 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.792 0.329 . . . . 73.219999999999999 110.91 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.408 HG12 ' HE3' ' A' ' 6' ' ' LYS . 53.4 t -155.16 -39.73 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 75.530000000000001 111.145 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.68 -11.7 83.02 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.732 -0.747 . . . . 62.409999999999997 112.487 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.49 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.5 m-85 -85.39 -43.46 13.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.914 0.388 . . . . 74.439999999999998 110.855 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.409 ' O ' ' N ' ' A' ' 9' ' ' TYR . 20.9 m-85 -67.18 -32.69 73.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 74.230000000000004 110.837 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.408 ' HE3' HG12 ' A' ' 2' ' ' VAL . 0.4 OUTLIER -54.03 -33.8 58.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.13 -0.486 . . . . 64.209999999999994 110.904 179.949 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.84 -19.42 13.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 73.209999999999994 110.866 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -89.47 -46.4 8.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 73.420000000000002 110.895 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.409 ' N ' ' O ' ' A' ' 5' ' ' PHE . 9.9 t80 -63.99 -43.17 96.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 72.230000000000004 110.938 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.5 ptmt -66.25 -32.41 73.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.116 -0.493 . . . . 73.329999999999998 110.927 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -75.38 -36.61 60.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 62.409999999999997 110.854 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 22.4 mtm -74.87 -25.33 58.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 53.329999999999998 110.885 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.23 -37.57 32.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 73.510000000000005 110.898 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -72.58 -31.98 65.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 75.430000000000007 110.914 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.415 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 6.3 pt-20 -74.21 -31.23 62.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 75.150000000000006 110.859 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -94.38 -10.18 33.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 75.040000000000006 111.089 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -85.8 -10.18 55.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 74.319999999999993 110.885 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 119.98 42.28 0.52 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.757 -0.735 . . . . 63.219999999999999 112.496 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.415 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 25.0 tp60 -47.75 -25.7 1.33 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.793 0.33 . . . . 74.239999999999995 110.881 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.446 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -121.21 -10.89 9.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 74.209999999999994 111.127 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.743 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -106.5 165.15 13.46 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.618 0.723 . . . . 73.040000000000006 111.055 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.743 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.8 Cg_endo -69.81 -4.33 13.84 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.685 2.257 . . . . 74.450000000000003 112.383 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -64.27 -34.16 77.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 74.209999999999994 110.874 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.2 t30 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 75.219999999999999 110.896 -179.955 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' LYS . . . . . 0.505 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 1.4 mtmm . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.814 0.34 . . . . 64.109999999999999 110.935 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 55.5 t -154.46 -39.4 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 63.229999999999997 111.121 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.58 -11.6 77.12 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.739 -0.743 . . . . 70.140000000000001 112.493 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.505 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.6 m-85 -85.85 -39.48 16.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.901 0.382 . . . . 73.230000000000004 110.879 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.436 ' O ' ' N ' ' A' ' 9' ' ' TYR . 24.1 m-85 -69.62 -34.28 73.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 74.310000000000002 110.846 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.43 -31.22 54.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 74.530000000000001 110.888 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 10.7 mtp180 -110.38 -19.27 13.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 74.200000000000003 110.873 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -90.34 -46.26 8.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 64.230000000000004 110.9 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.436 ' N ' ' O ' ' A' ' 5' ' ' PHE . 9.7 t80 -63.52 -42.68 98.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.22 -0.446 . . . . 73.549999999999997 110.928 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.5 mmmt -70.73 -29.16 65.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 64.439999999999998 110.902 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -81.2 -30.02 34.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 75.129999999999995 110.913 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 5.0 ptt? -80.92 -24.8 37.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 64.5 110.871 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 8.8 ptt? -85.87 -33.9 21.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 51.130000000000003 110.856 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -79.14 -24.47 43.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 65.329999999999998 110.903 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.452 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 0.0 OUTLIER -80.8 -31.06 35.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 72.349999999999994 110.895 -179.911 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.02 -9.79 32.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 45.119999999999997 111.088 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -85.24 -11.39 54.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.431 . . . . 74.239999999999995 110.861 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 119.71 42.44 0.53 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.782 -0.723 . . . . 33.509999999999998 112.499 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.452 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 0.7 OUTLIER -47.67 -25.32 1.15 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.738 0.304 . . . . 73.040000000000006 110.923 -179.899 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.477 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -119.93 -11.63 10.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 63.0 111.157 179.94 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.724 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -106.96 164.74 14.18 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.556 0.693 . . . . 74.140000000000001 111.111 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.724 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.2 Cg_endo -69.83 -4.46 14.12 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.709 2.272 . . . . 65.340000000000003 112.307 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -63.01 -35.73 81.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.235 -0.439 . . . . 73.230000000000004 110.919 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.2 t30 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 70.340000000000003 110.918 -179.984 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' LYS . . . . . 0.504 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.851 0.358 . . . . 75.540000000000006 110.922 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 54.3 t -154.66 -39.94 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 62.229999999999997 111.126 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.3 -12.16 76.28 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.754 -0.736 . . . . 52.32 112.497 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.504 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.5 m-85 -85.24 -40.99 16.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.892 0.377 . . . . 71.209999999999994 110.893 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -68.48 -33.11 73.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 71.530000000000001 110.888 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.3 mmtt -53.9 -34.34 59.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 74.120000000000005 110.907 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -108.7 -18.79 13.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 74.420000000000002 110.84 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -89.37 -46.12 8.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 73.400000000000006 110.899 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -65.38 -40.69 93.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 75.310000000000002 110.881 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.64 -30.73 70.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.466 . . . . 74.400000000000006 110.875 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -74.85 -39.88 61.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 63.310000000000002 110.859 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 17.9 ptp -76.98 -20.66 55.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 70.129999999999995 110.859 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -84.69 -36.94 21.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 72.340000000000003 110.896 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.57 -30.37 61.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.226 -0.443 . . . . 54.210000000000001 110.918 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.421 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 12.7 pt-20 -75.37 -30.83 60.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.098 -0.501 . . . . 73.230000000000004 110.877 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -94.95 -9.73 33.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 71.310000000000002 111.104 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -87.94 -6.44 58.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 74.319999999999993 110.9 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 120.32 47.59 0.33 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.768 -0.73 . . . . 74.329999999999998 112.469 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.421 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -46.51 -25.0 0.6 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.788 0.328 . . . . 61.310000000000002 110.89 -179.866 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.463 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -118.78 -12.49 10.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 64.299999999999997 111.096 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.629 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -107.43 161.48 22.95 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.609 0.719 . . . . 54.229999999999997 111.09 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.629 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.7 Cg_endo -69.73 -5.92 17.35 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.667 2.245 . . . . 75.319999999999993 112.374 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -56.48 -32.34 64.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 74.549999999999997 110.89 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 74.019999999999996 110.855 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 1' ' ' LYS . . . . . 0.489 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.84 0.352 . . . . 73.120000000000005 110.885 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 54.5 t -155.09 -39.66 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 51.539999999999999 111.096 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.63 -11.49 82.97 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.738 -0.744 . . . . 70.150000000000006 112.488 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.489 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.4 m-85 -85.78 -42.46 14.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.884 0.373 . . . . 71.230000000000004 110.921 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.42 ' O ' ' HB3' ' A' ' 9' ' ' TYR . 18.1 m-85 -68.81 -31.62 70.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 72.230000000000004 110.902 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.6 mttt -54.41 -35.1 62.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 73.409999999999997 110.922 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -108.7 -18.13 13.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 55.310000000000002 110.904 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -90.15 -45.8 8.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 62.329999999999998 110.948 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.42 ' HB3' ' O ' ' A' ' 5' ' ' PHE . 9.7 t80 -64.9 -41.85 95.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.455 . . . . 72.109999999999999 110.891 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 11.6 pttm -65.42 -35.25 80.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 72.430000000000007 110.893 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.18 -25.54 42.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 63.350000000000001 110.897 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -83.17 -22.8 33.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 71.239999999999995 110.906 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 34.4 ttp -84.8 -36.28 21.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 73.120000000000005 110.866 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -77.36 -25.58 51.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.227 -0.442 . . . . 73.5 110.9 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.424 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 0.9 OUTLIER -79.48 -29.82 41.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 73.439999999999998 110.89 -179.972 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.6 -11.98 26.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 71.519999999999996 111.12 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -87.27 -6.55 58.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 74.400000000000006 110.899 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 117.47 45.4 0.52 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.735 -0.745 . . . . 63.340000000000003 112.485 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.424 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 4.7 tt0 -46.97 -24.66 0.65 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.759 0.314 . . . . 72.340000000000003 110.91 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.485 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -117.44 -13.26 10.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.247 -0.433 . . . . 72.129999999999995 111.121 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.665 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -108.51 162.68 19.1 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.576 0.703 . . . . 74.099999999999994 111.104 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.665 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.4 Cg_endo -69.75 -4.27 13.69 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.658 2.239 . . . . 73.430000000000007 112.341 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -56.47 -34.02 66.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 74.430000000000007 110.901 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.3 m120 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 52.409999999999997 110.888 -179.961 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' LYS . . . . . 0.492 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.8 0.333 . . . . 74.140000000000001 110.873 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 54.3 t -155.11 -39.7 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 65.010000000000005 111.119 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.73 -11.43 83.26 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.691 -0.766 . . . . 63.100000000000001 112.494 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.492 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.5 m-85 -85.71 -42.68 14.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.896 0.379 . . . . 72.0 110.892 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.418 ' O ' ' HB3' ' A' ' 9' ' ' TYR . 16.2 m-85 -69.17 -31.15 69.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 72.319999999999993 110.867 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.29 -32.94 62.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.159 -0.473 . . . . 74.450000000000003 110.903 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.22 -17.4 13.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 74.349999999999994 110.865 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -91.16 -44.94 8.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 73.409999999999997 110.897 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.418 ' HB3' ' O ' ' A' ' 5' ' ' PHE . 9.3 t80 -67.49 -41.38 84.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 73.310000000000002 110.88 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.2 mmtt -69.29 -39.13 78.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 75.140000000000001 110.864 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -76.71 -25.35 53.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.216 -0.447 . . . . 75.120000000000005 110.87 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.2 mmm -83.09 -23.19 33.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 71.129999999999995 110.819 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.402 ' O ' ' HB2' ' A' ' 17' ' ' ASN . 0.0 OUTLIER -83.78 -36.83 23.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.247 -0.433 . . . . 62.229999999999997 110.874 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -72.46 -31.85 65.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.199 -0.455 . . . . 74.450000000000003 110.905 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.422 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 21.5 pt-20 -73.02 -35.37 66.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 74.430000000000007 110.883 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -91.11 -8.67 48.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 74.430000000000007 111.147 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 13' ' ' MET . 2.6 m-20 -85.6 -11.3 54.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.241 -0.436 . . . . 74.549999999999997 110.868 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 121.52 42.78 0.45 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.744 -0.741 . . . . 55.009999999999998 112.499 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.422 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 3.5 tt0 -46.22 -25.91 0.69 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.78 0.324 . . . . 54.32 110.924 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.413 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -124.99 -10.01 6.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 74.409999999999997 111.205 179.923 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.755 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -107.11 165.49 12.75 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.619 0.723 . . . . 71.230000000000004 111.06 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.755 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.9 Cg_endo -69.72 -19.96 35.63 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.684 2.256 . . . . 65.200000000000003 112.36 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -51.02 -24.23 3.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 55.030000000000001 110.919 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.6 t30 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.091 -0.504 . . . . 75.019999999999996 110.838 -179.916 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' LYS . . . . . 0.454 ' N ' ' HE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.843 0.354 . . . . 63.130000000000003 110.93 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.3 t -143.4 -36.86 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 73.120000000000005 111.14 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.96 -11.67 81.28 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.757 -0.735 . . . . 73.030000000000001 112.45 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.454 ' HE1' ' N ' ' A' ' 1' ' ' LYS . 1.7 m-85 -86.16 -42.42 13.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.918 0.39 . . . . 64.230000000000004 110.87 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.409 ' O ' ' HB3' ' A' ' 9' ' ' TYR . 24.0 m-85 -69.51 -30.97 68.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 73.349999999999994 110.853 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.3 mmtm -55.53 -34.59 64.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.14 -0.482 . . . . 72.340000000000003 110.943 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 10.8 ptt180 -108.59 -18.19 13.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 72.129999999999995 110.859 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -89.62 -46.16 8.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 54.020000000000003 110.899 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.409 ' HB3' ' O ' ' A' ' 5' ' ' PHE . 9.6 t80 -65.15 -42.49 93.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 71.239999999999995 110.907 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.97 -29.61 68.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 72.409999999999997 110.893 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -78.22 -37.08 46.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.215 -0.448 . . . . 75.400000000000006 110.839 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.9 ppp? -77.28 -21.01 54.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.474 . . . . 42.109999999999999 110.901 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.2 tpt -85.16 -36.74 20.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 62.210000000000001 110.877 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -75.09 -28.02 60.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.226 -0.443 . . . . 74.310000000000002 110.91 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -76.95 -32.73 57.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.48 . . . . 74.299999999999997 110.915 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -93.06 -10.31 36.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 72.040000000000006 111.143 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -85.5 -10.47 55.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 61.420000000000002 110.905 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 120.11 42.3 0.52 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.688 -0.768 . . . . 70.340000000000003 112.512 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -47.76 -25.57 1.29 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.777 0.322 . . . . 75.109999999999999 110.94 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.461 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -121.33 -11.12 9.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.161 -0.472 . . . . 71.109999999999999 111.13 179.967 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.735 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -106.72 164.66 14.39 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.555 0.693 . . . . 73.430000000000007 111.098 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.735 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.6 Cg_endo -69.78 -4.72 14.6 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.698 2.265 . . . . 42.520000000000003 112.321 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -62.61 -34.74 77.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 73.340000000000003 110.899 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.2 t30 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 65.340000000000003 110.859 -179.945 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' LYS . . . . . 0.459 ' H2 ' ' HE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.787 0.327 . . . . 74.239999999999995 110.878 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.9 t -142.99 -36.7 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 75.150000000000006 111.119 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.29 -12.57 83.47 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.807 -0.711 . . . . 43.329999999999998 112.466 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.459 ' HE1' ' H2 ' ' A' ' 1' ' ' LYS . 1.6 m-85 -85.72 -45.41 11.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.848 0.356 . . . . 74.040000000000006 110.865 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.44 ' O ' ' HB3' ' A' ' 9' ' ' TYR . 21.5 m-85 -67.43 -29.36 68.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 71.319999999999993 110.884 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -55.98 -35.12 66.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 63.119999999999997 110.898 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.4 ptt85 -108.68 -18.31 13.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 73.209999999999994 110.891 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -89.25 -46.29 8.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.459 . . . . 70.299999999999997 110.914 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.44 ' HB3' ' O ' ' A' ' 5' ' ' PHE . 9.9 t80 -64.84 -42.2 95.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 73.420000000000002 110.925 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.08 -33.31 75.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.144 -0.48 . . . . 71.400000000000006 110.876 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -74.23 -37.6 63.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.438 . . . . 74.120000000000005 110.935 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.34 -24.7 59.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 73.120000000000005 110.93 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.23 -37.37 28.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 74.099999999999994 110.842 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -74.08 -29.14 61.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 72.150000000000006 110.864 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.415 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 6.2 pt-20 -76.81 -30.81 56.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 72.209999999999994 110.862 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -94.93 -10.28 31.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 64.209999999999994 111.104 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -86.02 -10.05 55.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 73.140000000000001 110.892 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 120.04 42.55 0.51 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.728 -0.749 . . . . 52.219999999999999 112.448 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.415 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 4.3 tp-100 -47.61 -25.6 1.21 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.782 0.325 . . . . 75.239999999999995 110.911 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.463 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -120.95 -11.16 9.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 62.340000000000003 111.134 179.932 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.738 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -106.68 165.02 13.66 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.623 0.725 . . . . 64.329999999999998 111.041 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.738 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.8 Cg_endo -69.76 -4.22 13.59 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.705 2.27 . . . . 75.439999999999998 112.345 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -65.17 -31.81 73.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.464 . . . . 72.239999999999995 110.863 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.2 t30 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 62.310000000000002 110.873 -179.934 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' LYS . . . . . 0.498 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 1.4 mtmm . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.789 0.328 . . . . 72.0 110.924 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 55.6 t -154.49 -39.44 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 70.219999999999999 111.135 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.04 -12.55 75.57 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.704 -0.76 . . . . 43.439999999999998 112.438 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.498 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.6 m-85 -84.8 -41.71 15.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.87 0.367 . . . . 72.109999999999999 110.884 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.438 ' O ' ' N ' ' A' ' 9' ' ' TYR . 24.3 m-85 -67.39 -33.73 75.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.467 . . . . 71.200000000000003 110.846 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.95 -32.71 54.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 75.310000000000002 110.905 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.0 ptt180 -109.21 -19.47 13.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.445 . . . . 63.240000000000002 110.92 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.433 ' HA ' ' HG2' ' A' ' 11' ' ' GLU . 0.8 OUTLIER -90.0 -45.34 9.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 75.049999999999997 110.919 -179.948 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.438 ' N ' ' O ' ' A' ' 5' ' ' PHE . 9.3 t80 -65.83 -40.16 91.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 74.340000000000003 110.961 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.2 ptmt -63.87 -40.32 96.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.094 -0.503 . . . . 65.549999999999997 110.889 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.433 ' HG2' ' HA ' ' A' ' 8' ' ' GLN . 9.6 pt-20 -77.11 -25.92 52.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 74.030000000000001 110.872 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.06 -22.11 33.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 64.430000000000007 110.895 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.7 tpt -85.03 -36.66 21.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 70.510000000000005 110.905 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -76.33 -26.66 55.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.271 -0.422 . . . . 71.299999999999997 110.891 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.443 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 22.9 pt-20 -78.43 -30.59 47.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 62.310000000000002 110.89 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -94.88 -11.58 28.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 72.109999999999999 111.115 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -87.24 -6.93 58.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.438 . . . . 62.399999999999999 110.913 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 117.98 45.58 0.49 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.709 -0.758 . . . . 32.5 112.511 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.443 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 6.1 tt0 -46.91 -24.66 0.63 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.755 0.312 . . . . 74.140000000000001 110.874 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.493 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -117.17 -13.29 10.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 34.100000000000001 111.128 179.949 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.651 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -108.72 162.48 19.85 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.568 0.699 . . . . 63.439999999999998 111.102 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.651 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.3 Cg_endo -69.82 -4.39 13.96 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.657 2.238 . . . . 71.530000000000001 112.342 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -56.73 -33.07 66.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.229 -0.441 . . . . 71.239999999999995 110.917 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.2 m120 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 70.430000000000007 110.871 -179.936 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' LYS . . . . . 0.431 ' N ' ' HE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.829 0.347 . . . . 73.510000000000005 110.902 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 41.1 t -142.99 -36.78 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 71.25 111.117 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.31 -12.03 83.81 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.711 -0.757 . . . . 71.319999999999993 112.512 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.431 ' HE1' ' N ' ' A' ' 1' ' ' LYS . 1.6 m-85 -86.24 -43.92 12.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.885 0.374 . . . . 71.019999999999996 110.888 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.451 ' O ' ' HB3' ' A' ' 9' ' ' TYR . 20.6 m-85 -69.17 -29.17 67.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.1 -0.5 . . . . 63.219999999999999 110.862 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.23 -35.77 67.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 71.420000000000002 110.862 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -108.4 -17.47 13.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 65.530000000000001 110.914 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -90.01 -45.96 8.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 65.030000000000001 110.91 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.451 ' HB3' ' O ' ' A' ' 5' ' ' PHE . 9.6 t80 -65.64 -41.73 92.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 74.150000000000006 110.915 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.4 ptmt -64.82 -33.8 76.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.127 -0.488 . . . . 72.420000000000002 110.85 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.49 -34.15 58.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 75.530000000000001 110.904 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.4 ptt? -77.91 -21.49 51.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 74.140000000000001 110.895 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.52 -36.94 21.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.431 . . . . 71.340000000000003 110.874 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -74.43 -29.05 61.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 70.239999999999995 110.901 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.404 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 23.4 pt-20 -76.17 -32.74 59.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 62.340000000000003 110.88 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -93.0 -10.3 36.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 60.140000000000001 111.115 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -85.47 -10.46 56.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 73.310000000000002 110.917 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 120.07 42.33 0.52 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.759 -0.734 . . . . 35.140000000000001 112.488 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.404 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 11.6 tt0 -47.74 -25.61 1.3 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.807 0.337 . . . . 73.319999999999993 110.931 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.453 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -121.36 -11.08 9.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.479 . . . . 74.519999999999996 111.166 179.97 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.727 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -106.74 164.61 14.5 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.581 0.705 . . . . 41.130000000000003 111.092 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.727 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 54.0 Cg_endo -69.68 -4.72 14.53 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.735 2.29 . . . . 74.420000000000002 112.343 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -62.55 -34.83 77.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.429 . . . . 73.120000000000005 110.903 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.2 t30 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.467 . . . . 70.310000000000002 110.898 -179.96 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' LYS . . . . . 0.543 ' H1 ' ' HD3' ' A' ' 1' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.78 0.324 . . . . 64.409999999999997 110.912 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.8 t -143.62 -36.84 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.431 . . . . 73.129999999999995 111.105 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.65 -11.45 83.03 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.734 -0.746 . . . . 72.439999999999998 112.5 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.476 ' HE1' ' H2 ' ' A' ' 1' ' ' LYS . 1.8 m-85 -86.16 -41.12 14.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.929 0.395 . . . . 75.140000000000001 110.902 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.414 ' O ' ' HB3' ' A' ' 9' ' ' TYR . 23.4 m-85 -70.8 -33.0 70.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 73.340000000000003 110.86 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 42.6 mmtt -56.02 -29.3 60.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.169 -0.469 . . . . 60.149999999999999 110.914 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.93 -18.79 12.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.446 . . . . 64.25 110.854 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -92.0 -45.49 8.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 51.420000000000002 110.91 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.414 ' HB3' ' O ' ' A' ' 5' ' ' PHE . 9.2 t80 -64.73 -38.6 91.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 72.209999999999994 110.913 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.7 mmtt -70.89 -37.37 72.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 72.040000000000006 110.905 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.15 -27.98 54.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 51.420000000000002 110.868 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -82.99 -19.95 36.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 74.409999999999997 110.902 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.73 -36.14 18.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 65.209999999999994 110.902 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -76.78 -25.99 53.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.239 -0.437 . . . . 55.43 110.902 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.411 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 1.0 OUTLIER -78.88 -31.87 45.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.105 -0.498 . . . . 71.239999999999995 110.901 -179.957 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -93.97 -10.49 33.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 55.420000000000002 111.119 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -85.59 -10.33 56.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 45.539999999999999 110.868 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 120.16 42.37 0.51 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.739 -0.744 . . . . 63.140000000000001 112.509 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.411 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 10.0 tt0 -47.57 -25.63 1.2 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.766 0.317 . . . . 75.209999999999994 110.925 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.463 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -121.23 -11.1 9.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 72.510000000000005 111.162 179.932 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.734 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -106.7 164.72 14.28 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.549 0.69 . . . . 53.200000000000003 111.129 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.734 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 54.0 Cg_endo -69.74 -4.72 14.59 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.733 2.289 . . . . 72.530000000000001 112.337 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -62.89 -34.33 77.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.238 -0.437 . . . . 54.439999999999998 110.859 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.2 t30 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 72.5 110.887 -179.936 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' LYS . . . . . 0.504 ' H1 ' ' HD3' ' A' ' 1' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.805 0.336 . . . . 73.549999999999997 110.869 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.3 t -143.3 -36.53 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 71.099999999999994 111.102 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.01 -12.07 83.58 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.771 -0.728 . . . . 52.140000000000001 112.487 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.446 ' HE1' ' N ' ' A' ' 1' ' ' LYS . 1.7 m-85 -85.78 -43.83 13.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.836 0.351 . . . . 72.219999999999999 110.868 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -68.4 -31.64 71.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.188 -0.46 . . . . 53.520000000000003 110.854 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.93 -31.04 62.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 74.439999999999998 110.884 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -110.86 -18.88 13.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.269 -0.423 . . . . 72.019999999999996 110.905 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -90.63 -45.68 8.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 74.120000000000005 110.91 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -63.66 -42.97 98.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.25 -0.432 . . . . 71.140000000000001 110.922 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.9 mmmm -65.51 -40.43 92.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 72.019999999999996 110.87 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -75.12 -26.04 58.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 71.120000000000005 110.918 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 21.2 mmm -82.96 -21.85 33.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 71.329999999999998 110.852 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -85.74 -35.99 20.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 72.120000000000005 110.875 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -77.16 -24.99 51.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 73.109999999999999 110.866 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.462 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 0.0 OUTLIER -80.17 -31.07 38.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 74.0 110.915 -179.935 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.23 -9.7 32.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.134 -0.485 . . . . 44.119999999999997 111.112 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -85.19 -11.38 55.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 75.530000000000001 110.956 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 119.85 42.68 0.51 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.728 -0.749 . . . . 72.530000000000001 112.481 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.462 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 5.3 tm0? -47.4 -25.36 1.01 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.802 0.334 . . . . 73.530000000000001 110.931 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.483 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -119.46 -11.76 10.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.436 . . . . 62.229999999999997 111.106 179.985 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.726 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -106.98 165.04 13.56 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.588 0.709 . . . . 71.5 111.101 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.726 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.4 Cg_endo -69.83 -3.89 12.97 Favored 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.723 2.282 . . . . 62.439999999999998 112.335 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.36 -31.19 71.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 72.329999999999998 110.87 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.3 t30 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 64.530000000000001 110.88 -179.952 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.491 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.817 0.341 . . . . 73.120000000000005 110.865 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 54.7 t -155.01 -40.05 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 72.120000000000005 111.107 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.18 -11.82 81.77 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.744 -0.741 . . . . 70.219999999999999 112.45 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.491 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.4 m-85 -85.43 -43.02 13.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.878 0.371 . . . . 74.439999999999998 110.905 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.427 ' O ' ' N ' ' A' ' 9' ' ' TYR . 22.3 m-85 -67.26 -32.8 74.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 63.200000000000003 110.889 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.4 mmtt -54.07 -33.67 58.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 72.109999999999999 110.887 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -108.76 -19.53 13.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 65.209999999999994 110.892 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 40.8 mm-40 -89.39 -46.33 8.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 72.030000000000001 110.925 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.427 ' N ' ' O ' ' A' ' 5' ' ' PHE . 10.0 t80 -64.1 -42.99 96.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 72.549999999999997 110.932 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.1 ptmt -66.55 -32.28 73.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.099 -0.5 . . . . 74.510000000000005 110.89 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -76.15 -36.5 58.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 54.409999999999997 110.913 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.5 mmt -76.97 -21.5 54.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 73.239999999999995 110.848 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 6.2 tpt -85.27 -36.3 20.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 63.109999999999999 110.897 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -76.64 -25.81 54.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.198 -0.456 . . . . 73.219999999999999 110.876 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.41 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 0.6 OUTLIER -79.48 -30.97 42.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 72.439999999999998 110.919 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -94.75 -10.53 31.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 71.310000000000002 111.108 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.69 -10.3 55.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.205 -0.452 . . . . 74.5 110.919 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 120.24 42.85 0.49 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.778 -0.725 . . . . 72.450000000000003 112.501 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.41 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 6.5 tt0 -47.46 -25.61 1.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.793 0.33 . . . . 72.319999999999993 110.921 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.466 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -120.96 -11.25 9.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 74.150000000000006 111.157 179.92 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.724 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -106.74 164.81 14.08 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.572 0.701 . . . . 64.549999999999997 111.136 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.724 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.6 Cg_endo -69.74 -4.46 14.05 Favored 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.719 2.279 . . . . 64.120000000000005 112.382 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -64.66 -30.64 71.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.456 . . . . 44.530000000000001 110.897 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -55.1 104.25 0.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.115 -0.493 . . . . 73.519999999999996 110.87 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.02 -12.83 12.92 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.714 -0.755 . . . . 73.439999999999998 112.537 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.1 m -91.25 -36.38 13.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.753 0.311 . . . . 74.420000000000002 111.173 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -111.17 -2.78 15.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 54.310000000000002 110.917 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.7 t -45.78 146.81 1.79 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.534 0.683 . . . . 30.440000000000001 111.16 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 64.96 1.84 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.694 2.263 . . . . 63.240000000000002 112.358 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.8 p -55.17 155.36 9.11 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.689 0.757 . . . . 73.409999999999997 110.853 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 167.72 23.59 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.744 2.296 . . . . 72.209999999999994 112.328 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -24.4 29.77 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.698 2.265 . . . . 44.009999999999998 112.338 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.13 -27.36 64.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.448 . . . . 72.129999999999995 110.818 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -102.94 -26.64 13.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 64.129999999999995 110.868 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.8 tttt . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.216 -0.447 . . . . 54.310000000000002 110.91 179.953 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.483 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.834 0.349 . . . . 71.439999999999998 110.9 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 53.1 t -155.12 -39.71 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.281 -0.418 . . . . 75.439999999999998 111.092 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.44 -11.82 82.4 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.717 -0.754 . . . . 72.099999999999994 112.514 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.483 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.5 m-85 -85.35 -43.93 13.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.891 0.377 . . . . 75.340000000000003 110.865 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.417 ' O ' ' N ' ' A' ' 9' ' ' TYR . 18.7 m-85 -67.2 -31.67 72.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 75.519999999999996 110.853 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.45 -34.43 61.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 70.319999999999993 110.923 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -108.71 -19.11 13.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 72.439999999999998 110.827 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -89.49 -46.35 8.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.444 . . . . 71.0 110.942 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.417 ' N ' ' O ' ' A' ' 5' ' ' PHE . 9.9 t80 -64.28 -43.08 95.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 63.109999999999999 110.955 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.51 -32.01 73.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 74.150000000000006 110.886 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -76.66 -34.42 58.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.227 -0.442 . . . . 62.109999999999999 110.9 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.3 mmm -77.46 -23.68 50.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 74.5 110.897 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.23 -36.79 24.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 73.439999999999998 110.901 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -75.92 -26.33 56.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 44.439999999999998 110.923 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.407 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 8.9 pt-20 -79.03 -30.74 44.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 74.109999999999999 110.848 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.13 -10.4 30.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 70.239999999999995 111.074 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.755 ' OD1' HG23 ' A' ' 28' ' ' THR . 0.7 OUTLIER -86.15 -9.49 56.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.251 -0.431 . . . . 73.349999999999994 110.921 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 119.62 42.46 0.53 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.687 -0.768 . . . . 43.310000000000002 112.463 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.407 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 10.9 tt0 -47.62 -25.59 1.21 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.783 0.325 . . . . 63.43 110.926 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.445 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -121.19 -10.88 9.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 74.200000000000003 111.055 179.973 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.756 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -106.14 165.26 13.33 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.557 0.694 . . . . 63.409999999999997 111.083 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.756 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.7 Cg_endo -69.72 -4.57 14.27 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.639 2.226 . . . . 53.119999999999997 112.296 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.07 -34.77 78.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 72.310000000000002 110.921 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -51.87 104.79 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 65.420000000000002 110.879 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.38 10.34 8.02 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.774 -0.727 . . . . 71.450000000000003 112.474 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 24.3 m -92.12 -54.77 3.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.747 0.308 . . . . 73.430000000000007 111.158 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -111.77 -8.42 14.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 61.340000000000003 110.93 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.755 HG23 ' OD1' ' A' ' 17' ' ' ASN . 0.0 OUTLIER -54.68 159.37 3.55 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.585 0.707 . . . . 61.43 111.15 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.665 ' HD2' HG22 ' A' ' 28' ' ' THR . 53.7 Cg_endo -69.75 66.57 1.76 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.671 2.247 . . . . 40.420000000000002 112.342 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.2 p -55.12 155.32 8.97 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.631 0.729 . . . . 51.109999999999999 110.894 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 167.74 23.61 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.703 2.269 . . . . 74.310000000000002 112.317 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 129.48 17.66 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.657 2.238 . . . . 71.439999999999998 112.379 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 p -79.94 -26.63 40.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 71.150000000000006 110.877 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -74.56 -27.01 60.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 73.439999999999998 110.919 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.5 tttt . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 75.400000000000006 110.908 179.969 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.486 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.849 0.357 . . . . 72.310000000000002 110.877 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 54.5 t -155.04 -39.55 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 70.310000000000002 111.148 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.93 -11.05 83.95 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.735 -0.745 . . . . 72.120000000000005 112.488 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.486 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.4 m-85 -86.37 -41.11 14.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.897 0.379 . . . . 74.319999999999993 110.898 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.411 ' O ' ' N ' ' A' ' 9' ' ' TYR . 20.5 m-85 -69.65 -32.41 71.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.483 . . . . 74.230000000000004 110.842 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.9 -32.33 60.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 74.430000000000007 110.861 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.55 -18.62 13.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 72.439999999999998 110.853 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -90.46 -46.23 8.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 63.310000000000002 110.894 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.411 ' N ' ' O ' ' A' ' 5' ' ' PHE . 10.0 t80 -64.29 -42.92 96.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.247 -0.433 . . . . 74.219999999999999 110.967 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.4 mmmt -69.27 -33.81 73.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.082 -0.508 . . . . 64.230000000000004 110.903 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -76.32 -35.44 58.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.26 -0.427 . . . . 72.040000000000006 110.837 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.3 ptm -77.78 -20.6 53.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 70.140000000000001 110.916 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.63 -36.68 20.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 74.230000000000004 110.861 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.79 -27.1 57.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 64.439999999999998 110.907 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -78.27 -31.48 49.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 71.010000000000005 110.902 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -94.91 -9.0 35.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 51.240000000000002 111.054 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.62 -11.08 54.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 73.040000000000006 110.869 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 120.97 43.26 0.45 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.765 -0.731 . . . . 72.329999999999998 112.502 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -47.44 -25.72 1.14 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.751 0.31 . . . . 74.420000000000002 110.892 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.453 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -121.49 -11.0 9.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 64.329999999999998 111.13 179.946 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.72 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -106.54 164.31 15.17 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.59 0.71 . . . . 63.299999999999997 111.081 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.72 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.5 Cg_endo -69.68 -5.51 16.32 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.698 2.265 . . . . 71.439999999999998 112.336 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -62.05 -33.74 74.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 62.119999999999997 110.892 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -55.95 104.1 0.12 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 72.430000000000007 110.925 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.58 -6.47 16.28 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.764 -0.731 . . . . 53.009999999999998 112.482 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.4 m -90.38 -48.41 7.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.728 0.299 . . . . 72.349999999999994 111.1 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -111.09 -6.58 14.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 74.329999999999998 110.93 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -47.73 155.49 0.79 Allowed Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.539 0.685 . . . . 73.329999999999998 111.151 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 68.91 1.66 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.67 2.247 . . . . 70.209999999999994 112.379 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.59 155.3 73.73 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.67 0.748 . . . . 61.130000000000003 110.857 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 167.7 23.62 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.708 2.272 . . . . 53.530000000000001 112.368 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 169.9 17.77 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.728 2.286 . . . . 75.530000000000001 112.321 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.2 m -73.34 -28.78 62.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 62.5 110.874 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -78.65 -26.39 45.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 72.010000000000005 110.904 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.9 tttt . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.477 . . . . 53.520000000000003 110.922 179.994 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.503 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 1.1 mttt . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.792 0.33 . . . . 54.409999999999997 110.908 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 54.4 t -154.73 -39.87 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.271 -0.422 . . . . 60.439999999999998 111.11 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.32 -12.39 76.52 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.725 -0.75 . . . . 31.210000000000001 112.507 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.503 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.5 m-85 -84.91 -41.98 15.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.883 0.373 . . . . 75.239999999999995 110.854 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.446 ' O ' ' N ' ' A' ' 9' ' ' TYR . 25.4 m-85 -67.18 -33.59 75.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 75.439999999999998 110.87 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.9 mmtt -53.99 -33.32 56.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 61.119999999999997 110.902 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 13.7 mmt85 -108.52 -19.8 13.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 75.200000000000003 110.908 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.1 mm100 -89.19 -46.39 8.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 73.230000000000004 110.917 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 5' ' ' PHE . 9.9 t80 -63.81 -43.04 97.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.223 -0.444 . . . . 75.129999999999995 110.938 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.5 ptmt -66.7 -32.42 73.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.136 -0.484 . . . . 74.109999999999999 110.888 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -76.47 -35.35 58.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 73.319999999999993 110.911 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 29.4 mtt -77.78 -21.73 51.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.099 -0.5 . . . . 74.439999999999998 110.888 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -85.27 -36.4 20.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.255 -0.43 . . . . 74.420000000000002 110.921 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.14 -26.02 55.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.247 -0.433 . . . . 65.310000000000002 110.881 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.41 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 18.8 pt-20 -78.96 -32.37 45.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.473 . . . . 74.439999999999998 110.895 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -93.38 -10.33 35.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.123 -0.49 . . . . 72.310000000000002 111.09 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.62 -10.47 55.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 74.329999999999998 110.896 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 120.18 42.42 0.51 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.698 -0.763 . . . . 75.239999999999995 112.485 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.41 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 11.9 tt0 -47.67 -25.56 1.24 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.804 0.335 . . . . 75.299999999999997 110.951 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.459 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -121.28 -11.16 9.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 73.549999999999997 111.117 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.722 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -106.74 164.6 14.52 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.571 0.7 . . . . 74.040000000000006 111.093 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.722 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.4 Cg_endo -69.77 -4.64 14.44 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.666 2.244 . . . . 43.210000000000001 112.366 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -62.71 -34.75 77.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.459 . . . . 72.230000000000004 110.895 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -54.41 104.01 0.1 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 75.129999999999995 110.914 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.69 -6.26 16.17 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.715 -0.755 . . . . 63.310000000000002 112.457 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 61.4 p -90.41 -48.45 7.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.775 0.321 . . . . 55.329999999999998 111.148 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -111.08 -6.71 14.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 72.239999999999995 110.928 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -47.76 155.51 0.8 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.597 0.713 . . . . 43.310000000000002 111.146 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 68.95 1.67 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.743 2.295 . . . . 63.329999999999998 112.332 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.3 m -58.02 155.34 24.79 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.671 0.748 . . . . 73.439999999999998 110.85 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 167.74 23.53 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.715 2.277 . . . . 62.310000000000002 112.338 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.81 -31.85 19.52 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.684 2.256 . . . . 73.439999999999998 112.373 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 50.0 m -63.31 -26.21 68.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 72.040000000000006 110.89 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -102.35 -26.3 13.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.107 -0.497 . . . . 73.519999999999996 110.895 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.5 tttm . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.155 -0.475 . . . . 74.120000000000005 110.884 179.987 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.487 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.851 0.358 . . . . 35.310000000000002 110.895 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 53.7 t -155.03 -39.62 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 74.5 111.107 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.9 -11.03 83.9 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.737 -0.744 . . . . 71.430000000000007 112.478 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.487 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.4 m-85 -86.41 -41.13 14.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.881 0.372 . . . . 61.240000000000002 110.858 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.412 ' O ' ' N ' ' A' ' 9' ' ' TYR . 20.6 m-85 -69.55 -32.47 71.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 62.399999999999999 110.902 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.93 -32.18 60.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 64.450000000000003 110.912 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.57 -18.66 13.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.234 -0.439 . . . . 72.319999999999993 110.857 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 14.9 tp60 -90.49 -46.08 8.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 65.439999999999998 110.905 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.412 ' N ' ' O ' ' A' ' 5' ' ' PHE . 9.9 t80 -64.11 -43.14 96.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.185 -0.461 . . . . 73.340000000000003 110.942 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.1 mmtt -69.17 -34.08 74.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.078 -0.51 . . . . 61.399999999999999 110.889 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -80.02 -21.43 43.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 74.430000000000007 110.909 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.6 mmt -86.26 -27.19 24.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.476 . . . . 42.43 110.872 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.19 -30.36 22.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 65.400000000000006 110.909 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -82.09 -23.87 35.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 72.010000000000005 110.854 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.75 -31.27 32.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.445 . . . . 71.510000000000005 110.867 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -94.52 -9.3 35.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 55.130000000000003 111.072 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.43 -11.3 54.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 72.450000000000003 110.895 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 121.21 43.44 0.43 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.794 -0.717 . . . . 44.229999999999997 112.536 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.29 -25.7 1.04 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.773 0.32 . . . . 74.129999999999995 110.913 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.458 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -121.38 -10.97 9.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 74.209999999999994 111.172 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.706 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -106.42 164.16 15.49 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.539 0.685 . . . . 64.530000000000001 111.122 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.706 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.7 Cg_endo -69.75 -5.62 16.64 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.646 2.23 . . . . 74.519999999999996 112.346 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -62.05 -34.11 75.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.455 . . . . 73.420000000000002 110.912 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -55.47 104.13 0.12 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.468 . . . . 70.540000000000006 110.809 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.48 -6.25 16.62 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.709 -0.758 . . . . 63.420000000000002 112.502 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 91.2 m -90.34 -48.47 7.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.794 0.33 . . . . 64.310000000000002 111.176 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -111.14 -6.34 14.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 74.200000000000003 110.931 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -47.76 155.45 0.8 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.581 0.705 . . . . 62.32 111.117 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 69.02 1.66 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.683 2.255 . . . . 40.0 112.319 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.7 155.35 21.97 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.652 0.739 . . . . 74.409999999999997 110.863 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 167.73 23.67 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.696 2.264 . . . . 73.010000000000005 112.318 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 87.65 0.55 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.685 2.257 . . . . 63.520000000000003 112.374 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 64.0 m -78.53 -26.72 45.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 73.450000000000003 110.854 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -108.85 -26.72 10.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 62.240000000000002 110.856 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 75.25 110.912 179.978 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.487 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.775 0.322 . . . . 74.450000000000003 110.922 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 54.7 t -154.99 -39.73 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 62.43 111.095 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.78 -11.01 83.58 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.776 -0.726 . . . . 72.439999999999998 112.502 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.487 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.4 m-85 -86.48 -41.11 14.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.915 0.388 . . . . 70.319999999999993 110.882 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.427 ' O ' ' N ' ' A' ' 9' ' ' TYR . 21.4 m-85 -69.49 -32.56 71.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 74.439999999999998 110.893 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.68 -33.01 60.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 72.329999999999998 110.893 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.404 ' HA ' ' HD3' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -109.77 -18.5 13.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 75.209999999999994 110.858 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.7 tm0? -90.81 -45.41 8.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 72.340000000000003 110.935 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.427 ' N ' ' O ' ' A' ' 5' ' ' PHE . 9.1 t80 -66.31 -39.43 89.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.456 . . . . 74.420000000000002 110.987 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' A' ' 7' ' ' ARG . 5.0 ptmm? -68.23 -33.36 74.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.11 -0.496 . . . . 53.149999999999999 110.897 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.15 -25.91 36.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 62.509999999999998 110.868 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.41 -20.29 32.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 44.5 110.866 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.4 tpt -86.87 -35.89 18.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.254 -0.43 . . . . 70.299999999999997 110.852 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.429 ' HG2' HD22 ' A' ' 24' ' ' ASN . 3.1 mt-10 -77.11 -25.47 52.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.216 -0.447 . . . . 74.439999999999998 110.91 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.416 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 0.0 OUTLIER -79.37 -31.87 43.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 74.209999999999994 110.922 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -93.96 -10.56 33.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.112 -0.495 . . . . 72.209999999999994 111.13 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.53 -10.33 56.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 72.319999999999993 110.911 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 120.19 42.78 0.5 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.726 -0.749 . . . . 75.239999999999995 112.495 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.416 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 13.5 tt0 -47.51 -25.55 1.13 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.785 0.326 . . . . 61.049999999999997 110.942 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.461 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -121.01 -11.24 9.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 75.310000000000002 111.145 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.724 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -106.83 164.84 14.01 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.594 0.711 . . . . 43.5 111.114 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.724 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.3 Cg_endo -69.77 -4.53 14.21 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.663 2.242 . . . . 70.340000000000003 112.347 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -64.45 -30.84 71.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.192 -0.458 . . . . 65.430000000000007 110.879 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.429 HD22 ' HG2' ' A' ' 14' ' ' GLU . 1.3 t30 -55.04 104.21 0.11 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 74.450000000000003 110.898 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.99 -12.83 12.96 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.704 -0.76 . . . . 62.039999999999999 112.508 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 10.6 m -91.31 -36.49 13.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.726 0.298 . . . . 65.450000000000003 111.102 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -111.18 -2.74 15.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 73.430000000000007 110.905 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.7 t -45.79 146.79 1.8 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.571 0.7 . . . . 65.519999999999996 111.137 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 64.97 1.79 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.661 2.241 . . . . 75.040000000000006 112.324 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.2 p -88.1 155.33 52.28 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.611 0.719 . . . . 74.030000000000001 110.894 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 167.75 23.49 Favored 'Trans proline' 0 N--CA 1.465 -0.189 0 C-N-CA 122.695 2.263 . . . . 73.140000000000001 112.377 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 171.57 14.26 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.697 2.265 . . . . 74.319999999999993 112.326 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.68 -26.87 45.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 64.209999999999994 110.88 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -86.26 -26.41 25.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.153 -0.476 . . . . 54.439999999999998 110.866 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.9 ttmm . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 72.230000000000004 110.915 179.999 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.488 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.783 0.325 . . . . 70.349999999999994 110.91 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 55.1 t -155.05 -39.76 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 71.200000000000003 111.104 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.72 -11.45 83.21 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.803 -0.713 . . . . 44.32 112.469 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.488 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.4 m-85 -85.77 -42.09 14.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.913 0.387 . . . . 73.010000000000005 110.896 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.424 ' O ' ' N ' ' A' ' 9' ' ' TYR . 20.2 m-85 -68.81 -32.93 73.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 63.420000000000002 110.837 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.76 -33.94 57.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 74.129999999999995 110.864 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -109.37 -18.68 13.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 74.5 110.887 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -90.2 -45.96 8.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 72.329999999999998 110.925 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.424 ' N ' ' O ' ' A' ' 5' ' ' PHE . 8.6 t80 -66.19 -37.86 86.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.46 . . . . 73.439999999999998 110.917 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.02 -33.42 73.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 64.430000000000007 110.911 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.04 -26.28 36.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 73.019999999999996 110.906 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.14 -20.29 32.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 43.549999999999997 110.843 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.8 tpt -86.64 -36.06 19.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.439 . . . . 62.149999999999999 110.904 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -76.93 -25.77 53.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.203 -0.453 . . . . 51.310000000000002 110.902 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.11 -31.81 44.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 73.219999999999999 110.887 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -94.11 -10.43 33.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.103 -0.498 . . . . 70.049999999999997 111.134 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.661 ' OD1' HG23 ' A' ' 28' ' ' THR . 0.7 OUTLIER -85.74 -10.2 55.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 52.210000000000001 110.884 -179.931 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 120.02 42.42 0.52 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.732 -0.747 . . . . 64.140000000000001 112.477 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -47.66 -25.65 1.26 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.812 0.339 . . . . 62.530000000000001 110.954 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.459 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -121.35 -11.1 9.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 74.319999999999993 111.15 179.95 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.739 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -106.71 164.72 14.27 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.59 0.709 . . . . 61.030000000000001 111.074 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.739 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.5 Cg_endo -69.76 -4.71 14.58 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.708 2.272 . . . . 74.340000000000003 112.322 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.5 -34.44 76.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.232 -0.44 . . . . 73.219999999999999 110.918 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -55.95 104.1 0.12 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.139 -0.482 . . . . 75.129999999999995 110.905 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.62 -14.61 13.01 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.753 -0.737 . . . . 72.409999999999997 112.494 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 27.6 p -94.17 -46.3 7.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.728 0.299 . . . . 64.230000000000004 111.136 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -85.96 -27.8 24.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 75.349999999999994 110.932 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.661 HG23 ' OD1' ' A' ' 17' ' ' ASN . 0.0 OUTLIER -50.94 161.42 0.69 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.554 0.692 . . . . 74.109999999999999 111.168 -179.937 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.627 ' HD2' HG22 ' A' ' 28' ' ' THR . 54.3 Cg_endo -69.73 64.43 1.79 Allowed 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.713 2.275 . . . . 73.120000000000005 112.387 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.01 155.32 8.58 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.71 0.766 . . . . 43.140000000000001 110.821 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 167.78 23.47 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.677 2.251 . . . . 74.230000000000004 112.309 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -171.48 0.48 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.698 2.265 . . . . 64.099999999999994 112.344 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 61.7 p -73.49 -26.29 60.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.427 . . . . 73.200000000000003 110.877 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -106.22 23.06 14.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.126 -0.488 . . . . 63.109999999999999 110.911 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.115 -0.493 . . . . 70.420000000000002 110.882 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.502 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.804 0.335 . . . . 71.010000000000005 110.888 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 54.4 t -154.69 -39.84 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 63.509999999999998 111.087 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.49 -12.03 76.97 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.746 -0.74 . . . . 13.31 112.492 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.502 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.6 m-85 -85.31 -40.78 16.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.904 0.383 . . . . 74.310000000000002 110.87 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -68.95 -33.18 73.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.09 -0.505 . . . . 51.350000000000001 110.898 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.0 mmtp -54.68 -32.04 58.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 70.510000000000005 110.888 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.93 -17.91 13.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 73.049999999999997 110.882 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.95 -45.13 8.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 64.540000000000006 110.944 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -66.72 -41.39 88.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 75.430000000000007 110.906 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.7 mmtt -69.12 -39.26 79.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 73.109999999999999 110.919 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -77.14 -23.96 51.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 54.409999999999997 110.901 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 6.9 mmt -84.26 -22.68 30.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.468 . . . . 53.020000000000003 110.898 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 7.4 tpt -85.59 -35.76 20.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 71.299999999999997 110.868 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -77.56 -24.92 49.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.25 -0.432 . . . . 73.109999999999999 110.889 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.413 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 1.4 pp20? -80.2 -30.74 38.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 71.049999999999997 110.909 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.09 -10.57 30.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.109 -0.496 . . . . 72.230000000000004 111.056 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.757 ' OD1' HG23 ' A' ' 28' ' ' THR . 0.7 OUTLIER -85.93 -9.68 56.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 72.540000000000006 110.914 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 119.73 42.57 0.52 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.747 -0.74 . . . . 70.109999999999999 112.493 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.413 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 9.8 tt0 -47.59 -25.61 1.21 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.745 0.307 . . . . 72.329999999999998 110.876 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.453 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -121.05 -10.92 9.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.434 . . . . 54.32 111.118 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.753 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -106.11 165.27 13.31 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.589 0.709 . . . . 63.329999999999998 111.1 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.753 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.9 Cg_endo -69.78 -4.61 14.39 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.684 2.256 . . . . 40.240000000000002 112.327 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.06 -34.83 78.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.454 . . . . 74.209999999999994 110.898 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -51.78 104.71 0.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 70.25 110.93 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.39 10.71 7.77 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.73 -0.748 . . . . 72.439999999999998 112.492 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 24.5 p -92.08 -54.89 3.65 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.762 0.315 . . . . 74.450000000000003 111.151 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -111.78 -8.36 14.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 72.519999999999996 110.907 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.757 HG23 ' OD1' ' A' ' 17' ' ' ASN . 0.0 OUTLIER -54.78 159.35 3.66 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.56 0.695 . . . . 74.439999999999998 111.14 -179.915 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.666 ' HD2' HG22 ' A' ' 28' ' ' THR . 53.9 Cg_endo -69.73 66.61 1.75 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.64 2.226 . . . . 61.109999999999999 112.37 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -55.02 155.33 8.58 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.64 0.733 . . . . 63.119999999999997 110.86 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 167.74 23.67 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.67 2.246 . . . . 73.129999999999995 112.309 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 -19.14 36.71 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.728 2.285 . . . . 62.420000000000002 112.353 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.6 p -80.98 -26.81 36.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.452 . . . . 73.010000000000005 110.849 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -99.26 -26.19 14.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 64.450000000000003 110.885 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 72.040000000000006 110.888 -179.985 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.507 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 4.2 mtmt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.875 0.369 . . . . 73.420000000000002 110.915 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 55.8 t -154.61 -39.44 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 65.239999999999995 111.113 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.0 -12.51 75.4 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.746 -0.74 . . . . 63.109999999999999 112.487 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.507 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.5 m-85 -84.82 -41.94 15.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.892 0.377 . . . . 61.030000000000001 110.904 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.411 ' O ' ' N ' ' A' ' 9' ' ' TYR . 24.2 m-85 -67.22 -33.32 75.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 73.430000000000007 110.881 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.11 -33.44 57.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 74.420000000000002 110.913 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -108.54 -19.62 13.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 73.019999999999996 110.897 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -89.23 -46.42 8.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 74.120000000000005 110.884 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.411 ' N ' ' O ' ' A' ' 5' ' ' PHE . 9.7 t80 -64.27 -42.38 96.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 75.319999999999993 110.89 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.27 -30.34 69.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 73.540000000000006 110.905 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -77.92 -36.88 48.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.201 -0.454 . . . . 73.349999999999994 110.901 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -77.26 -20.85 54.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 62.210000000000001 110.877 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 10.1 tmm? -84.93 -37.03 21.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 65.420000000000002 110.91 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -74.54 -28.8 61.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.189 -0.459 . . . . 72.010000000000005 110.899 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.455 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 23.6 pt-20 -76.24 -32.68 59.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.117 -0.492 . . . . 55.219999999999999 110.836 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -93.75 -9.36 37.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 52.329999999999998 111.114 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.02 -11.48 55.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 75.430000000000007 110.902 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 119.68 42.56 0.53 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.736 -0.745 . . . . 55.119999999999997 112.505 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.455 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 4.8 tm0? -47.62 -25.4 1.15 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.806 0.336 . . . . 71.200000000000003 110.915 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.472 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -120.02 -11.73 10.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 73.140000000000001 111.133 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.719 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -107.12 164.76 14.13 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.557 0.694 . . . . 70.349999999999994 111.103 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.719 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.5 Cg_endo -69.79 -4.18 13.52 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.615 2.21 . . . . 73.530000000000001 112.35 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -64.18 -32.2 73.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 65.349999999999994 110.936 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -55.19 104.17 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.094 -0.503 . . . . 75.430000000000007 110.894 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.82 -13.25 13.1 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.731 -0.747 . . . . 74.209999999999994 112.489 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 59.0 p -91.5 -37.16 13.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.687 0.279 . . . . 62.549999999999997 111.115 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -111.11 -2.6 15.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 74.140000000000001 110.912 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.7 t -45.73 146.87 1.74 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.6 0.714 . . . . 71.109999999999999 111.099 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 64.98 1.83 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.68 2.253 . . . . 71.010000000000005 112.339 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.15 155.29 9.17 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.7 0.762 . . . . 71.219999999999999 110.832 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 167.7 23.69 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.682 2.255 . . . . 72.409999999999997 112.368 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 167.54 24.05 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.668 2.245 . . . . 51.119999999999997 112.36 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.08 -28.85 65.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.444 . . . . 63.310000000000002 110.886 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -79.33 -26.4 42.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.095 -0.502 . . . . 75.019999999999996 110.888 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 71.519999999999996 110.877 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.49 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.792 0.329 . . . . 73.219999999999999 110.91 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.408 HG12 ' HE3' ' A' ' 6' ' ' LYS . 53.4 t -155.16 -39.73 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 75.530000000000001 111.145 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.68 -11.7 83.02 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.732 -0.747 . . . . 62.409999999999997 112.487 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.49 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.5 m-85 -85.39 -43.46 13.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.914 0.388 . . . . 74.439999999999998 110.855 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.409 ' O ' ' N ' ' A' ' 9' ' ' TYR . 20.9 m-85 -67.18 -32.69 73.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 74.230000000000004 110.837 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.408 ' HE3' HG12 ' A' ' 2' ' ' VAL . 0.4 OUTLIER -54.03 -33.8 58.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.13 -0.486 . . . . 64.209999999999994 110.904 179.949 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.84 -19.42 13.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 73.209999999999994 110.866 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -89.47 -46.4 8.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 73.420000000000002 110.895 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.409 ' N ' ' O ' ' A' ' 5' ' ' PHE . 9.9 t80 -63.99 -43.17 96.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 72.230000000000004 110.938 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.5 ptmt -66.25 -32.41 73.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.116 -0.493 . . . . 73.329999999999998 110.927 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -75.38 -36.61 60.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 62.409999999999997 110.854 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 22.4 mtm -74.87 -25.33 58.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 53.329999999999998 110.885 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.23 -37.57 32.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 73.510000000000005 110.898 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -72.58 -31.98 65.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 75.430000000000007 110.914 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.415 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 6.3 pt-20 -74.21 -31.23 62.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 75.150000000000006 110.859 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -94.38 -10.18 33.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 75.040000000000006 111.089 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.8 -10.18 55.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 74.319999999999993 110.885 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 119.98 42.28 0.52 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.757 -0.735 . . . . 63.219999999999999 112.496 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.415 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 25.0 tp60 -47.75 -25.7 1.33 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.793 0.33 . . . . 74.239999999999995 110.881 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.446 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -121.21 -10.89 9.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 74.209999999999994 111.127 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.743 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -106.5 165.15 13.46 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.618 0.723 . . . . 73.040000000000006 111.055 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.743 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.8 Cg_endo -69.81 -4.33 13.84 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.685 2.257 . . . . 74.450000000000003 112.383 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -64.27 -34.16 77.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 74.209999999999994 110.874 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -51.91 103.87 0.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 75.219999999999999 110.896 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.463 ' HA2' ' CG2' ' A' ' 28' ' ' THR . . . 118.1 23.99 3.41 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.752 -0.737 . . . . 65.420000000000002 112.492 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 90.9 m -93.1 -66.74 0.9 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.775 0.321 . . . . 52.210000000000001 111.148 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -117.11 -3.18 11.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 74.519999999999996 110.93 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.463 ' CG2' ' HA2' ' A' ' 25' ' ' GLY . 0.7 OUTLIER -46.27 148.19 1.65 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.608 0.718 . . . . 74.5 111.13 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 65.32 1.78 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.644 2.23 . . . . 74.030000000000001 112.368 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.1 p -73.85 155.34 88.83 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.649 0.738 . . . . 64.420000000000002 110.87 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 167.8 23.36 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.655 2.237 . . . . 74.230000000000004 112.36 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 170.45 16.54 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.697 2.264 . . . . 63.420000000000002 112.364 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 57.8 m -68.76 -19.9 64.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 65.209999999999994 110.867 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -95.33 23.14 6.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 73.129999999999995 110.912 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.48 . . . . 64.109999999999999 110.901 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.505 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 1.4 mtmm . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.814 0.34 . . . . 64.109999999999999 110.935 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 55.5 t -154.46 -39.4 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 63.229999999999997 111.121 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.58 -11.6 77.12 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.739 -0.743 . . . . 70.140000000000001 112.493 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.505 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.6 m-85 -85.85 -39.48 16.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.901 0.382 . . . . 73.230000000000004 110.879 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.436 ' O ' ' N ' ' A' ' 9' ' ' TYR . 24.1 m-85 -69.62 -34.28 73.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 74.310000000000002 110.846 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.43 -31.22 54.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 74.530000000000001 110.888 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 10.7 mtp180 -110.38 -19.27 13.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 74.200000000000003 110.873 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -90.34 -46.26 8.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 64.230000000000004 110.9 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.436 ' N ' ' O ' ' A' ' 5' ' ' PHE . 9.7 t80 -63.52 -42.68 98.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.22 -0.446 . . . . 73.549999999999997 110.928 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.5 mmmt -70.73 -29.16 65.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 64.439999999999998 110.902 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -81.2 -30.02 34.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 75.129999999999995 110.913 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 5.0 ptt? -80.92 -24.8 37.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 64.5 110.871 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 8.8 ptt? -85.87 -33.9 21.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 51.130000000000003 110.856 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -79.14 -24.47 43.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 65.329999999999998 110.903 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.452 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 0.0 OUTLIER -80.8 -31.06 35.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 72.349999999999994 110.895 -179.911 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.02 -9.79 32.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 45.119999999999997 111.088 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.24 -11.39 54.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.431 . . . . 74.239999999999995 110.861 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 119.71 42.44 0.53 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.782 -0.723 . . . . 33.509999999999998 112.499 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.452 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 0.7 OUTLIER -47.67 -25.32 1.15 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.738 0.304 . . . . 73.040000000000006 110.923 -179.899 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.477 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -119.93 -11.63 10.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 63.0 111.157 179.94 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.724 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -106.96 164.74 14.18 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.556 0.693 . . . . 74.140000000000001 111.111 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.724 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.2 Cg_endo -69.83 -4.46 14.12 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.709 2.272 . . . . 65.340000000000003 112.307 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -63.01 -35.73 81.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.235 -0.439 . . . . 73.230000000000004 110.919 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -53.96 104.12 0.1 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 70.340000000000003 110.918 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.77 -6.48 15.88 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.743 -0.742 . . . . 31.25 112.5 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 86.7 m -90.46 -48.38 7.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.734 0.302 . . . . 72.150000000000006 111.171 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -111.08 -6.81 14.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 73.099999999999994 110.884 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -47.75 155.49 0.8 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.541 0.686 . . . . 73.120000000000005 111.131 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 68.92 1.67 Allowed 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.666 2.244 . . . . 72.450000000000003 112.39 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.4 m -60.92 155.35 54.18 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.626 0.727 . . . . 70.439999999999998 110.878 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 167.71 23.69 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.664 2.243 . . . . 72.219999999999999 112.33 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 -18.42 37.33 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.707 2.271 . . . . 65.109999999999999 112.336 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 60.1 m -57.64 -27.72 63.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 33.409999999999997 110.854 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.6 -26.47 29.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.117 -0.492 . . . . 72.230000000000004 110.885 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.6 tttm . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 73.219999999999999 110.91 179.983 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.504 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.851 0.358 . . . . 75.540000000000006 110.922 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 54.3 t -154.66 -39.94 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 62.229999999999997 111.126 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.3 -12.16 76.28 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.754 -0.736 . . . . 52.32 112.497 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.504 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.5 m-85 -85.24 -40.99 16.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.892 0.377 . . . . 71.209999999999994 110.893 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -68.48 -33.11 73.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 71.530000000000001 110.888 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.3 mmtt -53.9 -34.34 59.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 74.120000000000005 110.907 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -108.7 -18.79 13.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 74.420000000000002 110.84 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -89.37 -46.12 8.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 73.400000000000006 110.899 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -65.38 -40.69 93.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 75.310000000000002 110.881 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.64 -30.73 70.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.466 . . . . 74.400000000000006 110.875 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -74.85 -39.88 61.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 63.310000000000002 110.859 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 17.9 ptp -76.98 -20.66 55.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 70.129999999999995 110.859 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -84.69 -36.94 21.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 72.340000000000003 110.896 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.57 -30.37 61.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.226 -0.443 . . . . 54.210000000000001 110.918 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.421 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 12.7 pt-20 -75.37 -30.83 60.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.098 -0.501 . . . . 73.230000000000004 110.877 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -94.95 -9.73 33.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 71.310000000000002 111.104 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -87.94 -6.44 58.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 74.319999999999993 110.9 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 120.32 47.59 0.33 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.768 -0.73 . . . . 74.329999999999998 112.469 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.421 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -46.51 -25.0 0.6 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.788 0.328 . . . . 61.310000000000002 110.89 -179.866 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.463 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -118.78 -12.49 10.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 64.299999999999997 111.096 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.629 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -107.43 161.48 22.95 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.609 0.719 . . . . 54.229999999999997 111.09 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.629 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.7 Cg_endo -69.73 -5.92 17.35 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.667 2.245 . . . . 75.319999999999993 112.374 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -56.48 -32.34 64.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 74.549999999999997 110.89 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -50.45 103.6 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 74.019999999999996 110.855 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.13 4.75 15.84 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.74 -0.743 . . . . 74.239999999999995 112.495 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 62.9 m -90.19 -44.32 9.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.756 0.312 . . . . 74.239999999999995 111.153 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.16 -3.57 15.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 71.409999999999997 110.941 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -47.77 155.36 0.81 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.591 0.71 . . . . 72.129999999999995 111.098 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 69.64 1.63 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.673 2.248 . . . . 74.310000000000002 112.362 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.75 155.36 31.07 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.634 0.73 . . . . 73.129999999999995 110.881 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.83 167.71 23.75 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.693 2.262 . . . . 70.209999999999994 112.298 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 137.01 34.63 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.689 2.259 . . . . 71.519999999999996 112.35 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.3 t -68.59 -30.15 68.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 51.420000000000002 110.845 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -74.23 -26.78 60.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 75.310000000000002 110.866 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.7 mttt . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 74.329999999999998 110.891 179.933 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.489 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.84 0.352 . . . . 73.120000000000005 110.885 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 54.5 t -155.09 -39.66 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 51.539999999999999 111.096 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.63 -11.49 82.97 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.738 -0.744 . . . . 70.150000000000006 112.488 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.489 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.4 m-85 -85.78 -42.46 14.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.884 0.373 . . . . 71.230000000000004 110.921 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.42 ' O ' ' HB3' ' A' ' 9' ' ' TYR . 18.1 m-85 -68.81 -31.62 70.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 72.230000000000004 110.902 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.6 mttt -54.41 -35.1 62.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 73.409999999999997 110.922 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -108.7 -18.13 13.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 55.310000000000002 110.904 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -90.15 -45.8 8.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 62.329999999999998 110.948 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.42 ' HB3' ' O ' ' A' ' 5' ' ' PHE . 9.7 t80 -64.9 -41.85 95.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.455 . . . . 72.109999999999999 110.891 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 11.6 pttm -65.42 -35.25 80.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 72.430000000000007 110.893 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.18 -25.54 42.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 63.350000000000001 110.897 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -83.17 -22.8 33.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 71.239999999999995 110.906 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 34.4 ttp -84.8 -36.28 21.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 73.120000000000005 110.866 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -77.36 -25.58 51.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.227 -0.442 . . . . 73.5 110.9 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.424 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 0.9 OUTLIER -79.48 -29.82 41.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 73.439999999999998 110.89 -179.972 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.6 -11.98 26.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 71.519999999999996 111.12 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -87.27 -6.55 58.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 74.400000000000006 110.899 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 117.47 45.4 0.52 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.735 -0.745 . . . . 63.340000000000003 112.485 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.424 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 4.7 tt0 -46.97 -24.66 0.65 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.759 0.314 . . . . 72.340000000000003 110.91 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.485 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -117.44 -13.26 10.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.247 -0.433 . . . . 72.129999999999995 111.121 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.665 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -108.51 162.68 19.1 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.576 0.703 . . . . 74.099999999999994 111.104 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.665 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.4 Cg_endo -69.75 -4.27 13.69 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.658 2.239 . . . . 73.430000000000007 112.341 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -56.47 -34.02 66.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 74.430000000000007 110.901 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -49.96 103.68 0.06 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 52.409999999999997 110.888 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.29 4.26 16.11 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.765 -0.731 . . . . 75.140000000000001 112.52 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.0 m -90.18 -50.55 5.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.772 0.32 . . . . 63.32 111.142 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -111.06 -3.65 15.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 53.450000000000003 110.935 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -47.87 155.33 0.84 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.585 0.707 . . . . 72.299999999999997 111.153 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 69.48 1.63 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.692 2.261 . . . . 65.109999999999999 112.375 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.27 155.34 57.42 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.645 0.736 . . . . 72.230000000000004 110.856 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 167.75 23.55 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.708 2.272 . . . . 73.319999999999993 112.336 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 89.09 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.74 2.294 . . . . 65.519999999999996 112.324 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.07 -31.94 34.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 74.430000000000007 110.884 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.0 -26.98 61.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.475 . . . . 71.129999999999995 110.861 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 74.299999999999997 110.942 179.956 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.492 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.8 0.333 . . . . 74.140000000000001 110.873 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 54.3 t -155.11 -39.7 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 65.010000000000005 111.119 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.73 -11.43 83.26 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.691 -0.766 . . . . 63.100000000000001 112.494 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.492 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.5 m-85 -85.71 -42.68 14.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.896 0.379 . . . . 72.0 110.892 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.418 ' O ' ' HB3' ' A' ' 9' ' ' TYR . 16.2 m-85 -69.17 -31.15 69.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 72.319999999999993 110.867 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.29 -32.94 62.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.159 -0.473 . . . . 74.450000000000003 110.903 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.22 -17.4 13.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 74.349999999999994 110.865 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -91.16 -44.94 8.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 73.409999999999997 110.897 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.418 ' HB3' ' O ' ' A' ' 5' ' ' PHE . 9.3 t80 -67.49 -41.38 84.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 73.310000000000002 110.88 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.2 mmtt -69.29 -39.13 78.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 75.140000000000001 110.864 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -76.71 -25.35 53.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.216 -0.447 . . . . 75.120000000000005 110.87 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.2 mmm -83.09 -23.19 33.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 71.129999999999995 110.819 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.402 ' O ' ' HB2' ' A' ' 17' ' ' ASN . 0.0 OUTLIER -83.78 -36.83 23.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.247 -0.433 . . . . 62.229999999999997 110.874 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -72.46 -31.85 65.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.199 -0.455 . . . . 74.450000000000003 110.905 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.422 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 21.5 pt-20 -73.02 -35.37 66.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 74.430000000000007 110.883 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -91.11 -8.67 48.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 74.430000000000007 111.147 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 13' ' ' MET . 0.6 OUTLIER -85.6 -11.3 54.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.241 -0.436 . . . . 74.549999999999997 110.868 -179.946 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 121.52 42.78 0.45 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.744 -0.741 . . . . 55.009999999999998 112.499 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.422 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 3.5 tt0 -46.22 -25.91 0.69 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.78 0.324 . . . . 54.32 110.924 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.413 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -124.99 -10.01 6.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 74.409999999999997 111.205 179.923 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.755 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -107.11 165.49 12.75 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.619 0.723 . . . . 71.230000000000004 111.06 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.755 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.9 Cg_endo -69.72 -19.96 35.63 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.684 2.256 . . . . 65.200000000000003 112.36 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -51.02 -24.23 3.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 55.030000000000001 110.919 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -69.3 104.85 2.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.091 -0.504 . . . . 75.019999999999996 110.838 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.79 -12.81 13.27 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.782 -0.723 . . . . 63.399999999999999 112.545 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.0 m -90.36 -43.31 10.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.745 0.307 . . . . 75.230000000000004 111.193 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -111.15 -8.69 14.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 74.230000000000004 110.931 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -47.54 155.64 0.73 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.614 0.721 . . . . 64.420000000000002 111.146 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 68.64 1.69 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.68 2.253 . . . . 74.0 112.335 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.41 155.3 75.58 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.625 0.726 . . . . 74.409999999999997 110.874 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.71 167.74 23.49 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.674 2.249 . . . . 61.229999999999997 112.403 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 130.69 19.71 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.698 2.266 . . . . 74.319999999999993 112.332 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 46.6 m -91.4 -31.56 15.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 63.240000000000002 110.864 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -94.09 -26.79 16.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 73.319999999999993 110.892 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 73.439999999999998 110.924 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.454 ' N ' ' HE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.843 0.354 . . . . 63.130000000000003 110.93 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.3 t -143.4 -36.86 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 73.120000000000005 111.14 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.96 -11.67 81.28 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.757 -0.735 . . . . 73.030000000000001 112.45 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.454 ' HE1' ' N ' ' A' ' 1' ' ' LYS . 1.7 m-85 -86.16 -42.42 13.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.918 0.39 . . . . 64.230000000000004 110.87 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.409 ' O ' ' HB3' ' A' ' 9' ' ' TYR . 24.0 m-85 -69.51 -30.97 68.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 73.349999999999994 110.853 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.3 mmtm -55.53 -34.59 64.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.14 -0.482 . . . . 72.340000000000003 110.943 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 10.8 ptt180 -108.59 -18.19 13.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 72.129999999999995 110.859 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -89.62 -46.16 8.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 54.020000000000003 110.899 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.409 ' HB3' ' O ' ' A' ' 5' ' ' PHE . 9.6 t80 -65.15 -42.49 93.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 71.239999999999995 110.907 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.97 -29.61 68.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 72.409999999999997 110.893 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -78.22 -37.08 46.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.215 -0.448 . . . . 75.400000000000006 110.839 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.9 ppp? -77.28 -21.01 54.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.474 . . . . 42.109999999999999 110.901 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.2 tpt -85.16 -36.74 20.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 62.210000000000001 110.877 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -75.09 -28.02 60.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.226 -0.443 . . . . 74.310000000000002 110.91 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -76.95 -32.73 57.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.48 . . . . 74.299999999999997 110.915 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -93.06 -10.31 36.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 72.040000000000006 111.143 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.5 -10.47 55.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 61.420000000000002 110.905 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 120.11 42.3 0.52 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.688 -0.768 . . . . 70.340000000000003 112.512 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -47.76 -25.57 1.29 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.777 0.322 . . . . 75.109999999999999 110.94 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.461 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -121.33 -11.12 9.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.161 -0.472 . . . . 71.109999999999999 111.13 179.967 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.735 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -106.72 164.66 14.39 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.555 0.693 . . . . 73.430000000000007 111.098 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.735 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.6 Cg_endo -69.78 -4.72 14.6 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.698 2.265 . . . . 42.520000000000003 112.321 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -62.61 -34.74 77.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 73.340000000000003 110.899 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -54.57 104.13 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 65.340000000000003 110.859 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.7 -6.51 16.0 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.725 -0.75 . . . . 54.109999999999999 112.456 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.2 p -90.43 -48.4 7.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.703 0.287 . . . . 71.420000000000002 111.105 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -111.05 -6.81 14.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 74.319999999999993 110.951 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -47.79 155.54 0.8 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.631 0.729 . . . . 71.319999999999993 111.118 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 68.94 1.68 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.67 2.247 . . . . 54.0 112.345 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -92.95 155.32 41.51 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.662 0.744 . . . . 72.019999999999996 110.85 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 167.74 23.49 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.69 2.26 . . . . 64.329999999999998 112.374 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 -21.52 33.42 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.705 2.27 . . . . 65.109999999999999 112.365 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.63 -29.27 68.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 72.200000000000003 110.827 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.41 -26.23 51.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.125 -0.489 . . . . 63.210000000000001 110.917 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.118 -0.492 . . . . 73.129999999999995 110.926 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.459 ' H2 ' ' HE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.787 0.327 . . . . 74.239999999999995 110.878 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.9 t -142.99 -36.7 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 75.150000000000006 111.119 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.29 -12.57 83.47 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.807 -0.711 . . . . 43.329999999999998 112.466 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.459 ' HE1' ' H2 ' ' A' ' 1' ' ' LYS . 1.6 m-85 -85.72 -45.41 11.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.848 0.356 . . . . 74.040000000000006 110.865 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.44 ' O ' ' HB3' ' A' ' 9' ' ' TYR . 21.5 m-85 -67.43 -29.36 68.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 71.319999999999993 110.884 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -55.98 -35.12 66.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 63.119999999999997 110.898 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.4 ptt85 -108.68 -18.31 13.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 73.209999999999994 110.891 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -89.25 -46.29 8.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.459 . . . . 70.299999999999997 110.914 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.44 ' HB3' ' O ' ' A' ' 5' ' ' PHE . 9.9 t80 -64.84 -42.2 95.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 73.420000000000002 110.925 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.08 -33.31 75.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.144 -0.48 . . . . 71.400000000000006 110.876 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -74.23 -37.6 63.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.438 . . . . 74.120000000000005 110.935 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.34 -24.7 59.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 73.120000000000005 110.93 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.23 -37.37 28.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 74.099999999999994 110.842 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -74.08 -29.14 61.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 72.150000000000006 110.864 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.415 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 6.2 pt-20 -76.81 -30.81 56.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 72.209999999999994 110.862 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -94.93 -10.28 31.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 64.209999999999994 111.104 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -86.02 -10.05 55.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 73.140000000000001 110.892 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 120.04 42.55 0.51 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.728 -0.749 . . . . 52.219999999999999 112.448 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.415 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 4.3 tp-100 -47.61 -25.6 1.21 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.782 0.325 . . . . 75.239999999999995 110.911 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.463 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -120.95 -11.16 9.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 62.340000000000003 111.134 179.932 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.738 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -106.68 165.02 13.66 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.623 0.725 . . . . 64.329999999999998 111.041 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.738 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.8 Cg_endo -69.76 -4.22 13.59 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.705 2.27 . . . . 75.439999999999998 112.345 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.641 ' O ' HG22 ' A' ' 26' ' ' THR . 3.8 mt-10 -65.17 -31.81 73.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.464 . . . . 72.239999999999995 110.863 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -52.58 104.19 0.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 62.310000000000002 110.873 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.87 -7.03 13.32 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.747 -0.74 . . . . 74.329999999999998 112.551 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.641 HG22 ' O ' ' A' ' 23' ' ' GLU . 7.0 t -90.77 -31.88 16.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.749 0.309 . . . . 73.310000000000002 111.121 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -111.9 -12.52 13.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 64.420000000000002 110.923 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -47.35 155.84 0.67 Allowed Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.61 0.719 . . . . 71.219999999999999 111.177 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 67.74 1.73 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.716 2.277 . . . . 73.319999999999993 112.343 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.9 155.29 54.31 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.692 0.758 . . . . 74.439999999999998 110.885 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 167.75 23.48 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.693 2.262 . . . . 73.340000000000003 112.353 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -19.06 36.48 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.716 2.277 . . . . 63.329999999999998 112.363 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.3 t -68.35 -31.74 71.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 74.450000000000003 110.81 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -90.2 -26.86 19.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 74.219999999999999 110.884 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.3 mttt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.49 . . . . 73.439999999999998 110.928 -179.993 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.498 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 1.4 mtmm . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.789 0.328 . . . . 72.0 110.924 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 55.6 t -154.49 -39.44 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 70.219999999999999 111.135 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.04 -12.55 75.57 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.704 -0.76 . . . . 43.439999999999998 112.438 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.498 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.6 m-85 -84.8 -41.71 15.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.87 0.367 . . . . 72.109999999999999 110.884 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.438 ' O ' ' N ' ' A' ' 9' ' ' TYR . 24.3 m-85 -67.39 -33.73 75.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.467 . . . . 71.200000000000003 110.846 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.95 -32.71 54.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 75.310000000000002 110.905 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.0 ptt180 -109.21 -19.47 13.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.445 . . . . 63.240000000000002 110.92 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.433 ' HA ' ' HG2' ' A' ' 11' ' ' GLU . 0.8 OUTLIER -90.0 -45.34 9.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 75.049999999999997 110.919 -179.948 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.438 ' N ' ' O ' ' A' ' 5' ' ' PHE . 9.3 t80 -65.83 -40.16 91.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 74.340000000000003 110.961 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.2 ptmt -63.87 -40.32 96.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.094 -0.503 . . . . 65.549999999999997 110.889 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.433 ' HG2' ' HA ' ' A' ' 8' ' ' GLN . 9.6 pt-20 -77.11 -25.92 52.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 74.030000000000001 110.872 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.06 -22.11 33.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 64.430000000000007 110.895 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.7 tpt -85.03 -36.66 21.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 70.510000000000005 110.905 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -76.33 -26.66 55.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.271 -0.422 . . . . 71.299999999999997 110.891 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.443 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 22.9 pt-20 -78.43 -30.59 47.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 62.310000000000002 110.89 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -94.88 -11.58 28.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 72.109999999999999 111.115 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -87.24 -6.93 58.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.438 . . . . 62.399999999999999 110.913 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 117.98 45.58 0.49 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.709 -0.758 . . . . 32.5 112.511 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.443 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 6.1 tt0 -46.91 -24.66 0.63 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.755 0.312 . . . . 74.140000000000001 110.874 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.493 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -117.17 -13.29 10.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 34.100000000000001 111.128 179.949 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.651 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -108.72 162.48 19.85 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.568 0.699 . . . . 63.439999999999998 111.102 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.651 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.3 Cg_endo -69.82 -4.39 13.96 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.657 2.238 . . . . 71.530000000000001 112.342 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -56.73 -33.07 66.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.229 -0.441 . . . . 71.239999999999995 110.917 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -49.58 103.55 0.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 70.430000000000007 110.871 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.438 ' HA2' ' CG2' ' A' ' 28' ' ' THR . . . 116.71 32.95 1.49 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.701 -0.761 . . . . 25.129999999999999 112.484 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 93.1 m -92.76 -69.69 0.73 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.759 0.314 . . . . 72.409999999999997 111.108 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.43 -2.72 11.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 42.020000000000003 110.949 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.438 ' CG2' ' HA2' ' A' ' 25' ' ' GLY . 0.7 OUTLIER -46.98 148.22 1.99 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.573 0.701 . . . . 72.439999999999998 111.095 -179.905 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 65.34 1.81 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.662 2.241 . . . . 63.219999999999999 112.36 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.3 p -68.63 155.32 93.21 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.679 0.752 . . . . 73.329999999999998 110.857 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 167.7 23.77 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.689 2.259 . . . . 74.109999999999999 112.304 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 171.08 15.05 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.706 2.271 . . . . 75.329999999999998 112.367 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 31.3 p -59.46 -35.28 73.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.237 -0.438 . . . . 74.319999999999993 110.843 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -63.5 -26.04 68.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.103 -0.498 . . . . 71.099999999999994 110.875 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.7 mtmt . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 72.120000000000005 110.934 179.989 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.431 ' N ' ' HE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.829 0.347 . . . . 73.510000000000005 110.902 . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 41.1 t -142.99 -36.78 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 71.25 111.117 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.31 -12.03 83.81 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.711 -0.757 . . . . 71.319999999999993 112.512 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.431 ' HE1' ' N ' ' A' ' 1' ' ' LYS . 1.6 m-85 -86.24 -43.92 12.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.885 0.374 . . . . 71.019999999999996 110.888 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.451 ' O ' ' HB3' ' A' ' 9' ' ' TYR . 20.6 m-85 -69.17 -29.17 67.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.1 -0.5 . . . . 63.219999999999999 110.862 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.23 -35.77 67.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 71.420000000000002 110.862 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -108.4 -17.47 13.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 65.530000000000001 110.914 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -90.01 -45.96 8.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 65.030000000000001 110.91 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.451 ' HB3' ' O ' ' A' ' 5' ' ' PHE . 9.6 t80 -65.64 -41.73 92.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 74.150000000000006 110.915 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.4 ptmt -64.82 -33.8 76.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.127 -0.488 . . . . 72.420000000000002 110.85 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.49 -34.15 58.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 75.530000000000001 110.904 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.4 ptt? -77.91 -21.49 51.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 74.140000000000001 110.895 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.52 -36.94 21.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.431 . . . . 71.340000000000003 110.874 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -74.43 -29.05 61.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 70.239999999999995 110.901 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.404 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 23.4 pt-20 -76.17 -32.74 59.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 62.340000000000003 110.88 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -93.0 -10.3 36.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 60.140000000000001 111.115 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.47 -10.46 56.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 73.310000000000002 110.917 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 120.07 42.33 0.52 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.759 -0.734 . . . . 35.140000000000001 112.488 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.404 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 11.6 tt0 -47.74 -25.61 1.3 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.807 0.337 . . . . 73.319999999999993 110.931 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.453 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -121.36 -11.08 9.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.479 . . . . 74.519999999999996 111.166 179.97 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.727 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -106.74 164.61 14.5 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.581 0.705 . . . . 41.130000000000003 111.092 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.727 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 54.0 Cg_endo -69.68 -4.72 14.53 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.735 2.29 . . . . 74.420000000000002 112.343 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -62.55 -34.83 77.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.429 . . . . 73.120000000000005 110.903 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -54.49 104.01 0.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.467 . . . . 70.310000000000002 110.898 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.68 -6.48 16.07 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.745 -0.741 . . . . 74.209999999999994 112.48 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 24.6 m -90.36 -48.45 7.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.747 0.308 . . . . 73.209999999999994 111.138 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -111.03 -6.81 14.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 72.329999999999998 110.932 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -47.83 155.52 0.81 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.612 0.72 . . . . 75.109999999999999 111.11 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 68.91 1.7 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.655 2.236 . . . . 63.439999999999998 112.361 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.2 m -55.71 155.35 11.14 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.67 0.748 . . . . 72.310000000000002 110.873 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 167.71 23.64 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.725 2.283 . . . . 64.430000000000007 112.338 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 177.69 5.32 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.728 2.285 . . . . 62.439999999999998 112.337 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.23 -27.36 24.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 71.109999999999999 110.851 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -70.85 -26.17 63.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 74.109999999999999 110.854 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.3 ttmt . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.195 -0.457 . . . . 74.409999999999997 110.893 179.971 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.543 ' H1 ' ' HD3' ' A' ' 1' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.78 0.324 . . . . 64.409999999999997 110.912 . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.8 t -143.62 -36.84 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.431 . . . . 73.129999999999995 111.105 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.65 -11.45 83.03 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.734 -0.746 . . . . 72.439999999999998 112.5 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.476 ' HE1' ' H2 ' ' A' ' 1' ' ' LYS . 1.8 m-85 -86.16 -41.12 14.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.929 0.395 . . . . 75.140000000000001 110.902 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.414 ' O ' ' HB3' ' A' ' 9' ' ' TYR . 23.4 m-85 -70.8 -33.0 70.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 73.340000000000003 110.86 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 42.6 mmtt -56.02 -29.3 60.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.169 -0.469 . . . . 60.149999999999999 110.914 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.93 -18.79 12.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.446 . . . . 64.25 110.854 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -92.0 -45.49 8.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 51.420000000000002 110.91 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.414 ' HB3' ' O ' ' A' ' 5' ' ' PHE . 9.2 t80 -64.73 -38.6 91.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 72.209999999999994 110.913 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.7 mmtt -70.89 -37.37 72.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 72.040000000000006 110.905 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.15 -27.98 54.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 51.420000000000002 110.868 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -82.99 -19.95 36.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 74.409999999999997 110.902 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.73 -36.14 18.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 65.209999999999994 110.902 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -76.78 -25.99 53.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.239 -0.437 . . . . 55.43 110.902 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.411 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 1.0 OUTLIER -78.88 -31.87 45.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.105 -0.498 . . . . 71.239999999999995 110.901 -179.957 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -93.97 -10.49 33.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 55.420000000000002 111.119 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.59 -10.33 56.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 45.539999999999999 110.868 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 120.16 42.37 0.51 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.739 -0.744 . . . . 63.140000000000001 112.509 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.411 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 10.0 tt0 -47.57 -25.63 1.2 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.766 0.317 . . . . 75.209999999999994 110.925 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.463 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -121.23 -11.1 9.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 72.510000000000005 111.162 179.932 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.734 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -106.7 164.72 14.28 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.549 0.69 . . . . 53.200000000000003 111.129 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.734 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 54.0 Cg_endo -69.74 -4.72 14.59 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.733 2.289 . . . . 72.530000000000001 112.337 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -62.89 -34.33 77.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.238 -0.437 . . . . 54.439999999999998 110.859 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -54.49 104.11 0.1 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 72.5 110.887 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.62 -5.78 16.59 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.71 -0.757 . . . . 45.109999999999999 112.514 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 66.5 p -90.39 -48.58 7.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.76 0.314 . . . . 74.540000000000006 111.123 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.04 -6.74 14.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 73.430000000000007 110.906 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -47.72 155.52 0.79 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.576 0.703 . . . . 65.340000000000003 111.167 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 68.93 1.69 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.664 2.242 . . . . 53.039999999999999 112.394 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.94 155.29 43.96 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.67 0.747 . . . . 55.109999999999999 110.841 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 167.76 23.47 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.647 2.231 . . . . 70.319999999999993 112.359 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -21.68 33.09 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.708 2.272 . . . . 64.109999999999999 112.298 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.6 t -73.9 -26.57 60.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.258 -0.428 . . . . 63.130000000000003 110.882 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.54 -26.23 20.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 74.010000000000005 110.863 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 74.109999999999999 110.917 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.504 ' H1 ' ' HD3' ' A' ' 1' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.805 0.336 . . . . 73.549999999999997 110.869 . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.3 t -143.3 -36.53 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 71.099999999999994 111.102 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.01 -12.07 83.58 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.771 -0.728 . . . . 52.140000000000001 112.487 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.446 ' HE1' ' N ' ' A' ' 1' ' ' LYS . 1.7 m-85 -85.78 -43.83 13.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.836 0.351 . . . . 72.219999999999999 110.868 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -68.4 -31.64 71.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.188 -0.46 . . . . 53.520000000000003 110.854 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.93 -31.04 62.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 74.439999999999998 110.884 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -110.86 -18.88 13.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.269 -0.423 . . . . 72.019999999999996 110.905 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -90.63 -45.68 8.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 74.120000000000005 110.91 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -63.66 -42.97 98.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.25 -0.432 . . . . 71.140000000000001 110.922 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.9 mmmm -65.51 -40.43 92.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 72.019999999999996 110.87 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -75.12 -26.04 58.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 71.120000000000005 110.918 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 21.2 mmm -82.96 -21.85 33.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 71.329999999999998 110.852 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -85.74 -35.99 20.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 72.120000000000005 110.875 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -77.16 -24.99 51.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 73.109999999999999 110.866 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.462 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 0.0 OUTLIER -80.17 -31.07 38.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 74.0 110.915 -179.935 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.23 -9.7 32.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.134 -0.485 . . . . 44.119999999999997 111.112 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -85.19 -11.38 55.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 75.530000000000001 110.956 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 119.85 42.68 0.51 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.728 -0.749 . . . . 72.530000000000001 112.481 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.462 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 5.3 tm0? -47.4 -25.36 1.01 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.802 0.334 . . . . 73.530000000000001 110.931 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.483 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -119.46 -11.76 10.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.436 . . . . 62.229999999999997 111.106 179.985 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.726 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -106.98 165.04 13.56 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.588 0.709 . . . . 71.5 111.101 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.726 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.4 Cg_endo -69.83 -3.89 12.97 Favored 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.723 2.282 . . . . 62.439999999999998 112.335 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.649 ' O ' HG22 ' A' ' 26' ' ' THR . 0.6 OUTLIER -66.36 -31.19 71.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 72.329999999999998 110.87 -179.984 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -51.83 104.34 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 64.530000000000001 110.88 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.2 -7.65 12.63 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.785 -0.722 . . . . 60.119999999999997 112.495 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.649 HG22 ' O ' ' A' ' 23' ' ' GLU . 6.8 t -91.53 -31.16 16.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.785 0.326 . . . . 74.319999999999993 111.172 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -111.81 -2.84 15.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 75.319999999999993 110.933 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.6 t -45.88 147.03 1.77 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.578 0.704 . . . . 74.549999999999997 111.165 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 65.0 1.77 Allowed 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.685 2.257 . . . . 61.200000000000003 112.365 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.48 155.37 20.08 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.681 0.753 . . . . 74.109999999999999 110.831 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 167.76 23.57 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.658 2.238 . . . . 73.010000000000005 112.341 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -35.83 11.96 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.672 2.248 . . . . 72.519999999999996 112.342 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 p -59.5 -28.29 66.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.445 . . . . 74.519999999999996 110.821 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.97 -26.45 13.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 64.430000000000007 110.863 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.0 tptm . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 63.119999999999997 110.868 179.927 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . 0.491 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.817 0.341 . . . . 73.12 110.865 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 54.7 t -155.01 -40.05 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 72.12 111.107 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.18 -11.82 81.77 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.744 -0.741 . . . . 70.22 112.45 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.491 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.4 m-85 -85.43 -43.02 13.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.878 0.371 . . . . 74.44 110.905 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.427 ' O ' ' N ' ' A' ' 9' ' ' TYR . 22.3 m-85 -67.26 -32.8 74.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 63.2 110.889 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.4 mmtt -54.07 -33.67 58.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 72.11 110.887 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -108.76 -19.53 13.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 65.21 110.892 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 40.8 mm-40 -89.39 -46.33 8.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 72.03 110.925 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.427 ' N ' ' O ' ' A' ' 5' ' ' PHE . 10.0 t80 -64.1 -42.99 96.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 72.55 110.932 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.1 ptmt -66.55 -32.28 73.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.099 -0.5 . . . . 74.51 110.89 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -76.15 -36.5 58.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 54.41 110.913 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.5 mmt -76.97 -21.5 54.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 73.24 110.848 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 6.2 tpt -85.27 -36.3 20.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 63.11 110.897 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -76.64 -25.81 54.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.198 -0.456 . . . . 73.22 110.876 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.41 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 0.6 OUTLIER -79.48 -30.97 42.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 72.44 110.919 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -94.75 -10.53 31.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 71.31 111.108 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.69 -10.3 55.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.205 -0.452 . . . . 74.5 110.919 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 120.24 42.85 0.49 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.778 -0.725 . . . . 72.45 112.501 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.41 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 6.5 tt0 -47.46 -25.61 1.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.793 0.33 . . . . 72.32 110.921 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.466 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -120.96 -11.25 9.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 74.15 111.157 179.92 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.724 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -106.74 164.81 14.08 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.572 0.701 . . . . 64.55 111.136 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.724 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.6 Cg_endo -69.74 -4.46 14.05 Favored 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.719 2.279 . . . . 64.12 112.382 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -64.66 -30.64 71.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.456 . . . . 44.53 110.897 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.115 -0.493 . . . . 73.52 110.87 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . 0.483 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.834 0.349 . . . . 71.44 110.9 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 53.1 t -155.12 -39.71 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.281 -0.418 . . . . 75.44 111.092 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.44 -11.82 82.4 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.717 -0.754 . . . . 72.1 112.514 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.483 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.5 m-85 -85.35 -43.93 13.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.891 0.377 . . . . 75.34 110.865 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.417 ' O ' ' N ' ' A' ' 9' ' ' TYR . 18.7 m-85 -67.2 -31.67 72.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 75.52 110.853 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.45 -34.43 61.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 70.32 110.923 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -108.71 -19.11 13.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 72.44 110.827 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -89.49 -46.35 8.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.444 . . . . 71.0 110.942 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.417 ' N ' ' O ' ' A' ' 5' ' ' PHE . 9.9 t80 -64.28 -43.08 95.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 63.11 110.955 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.51 -32.01 73.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 74.15 110.886 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -76.66 -34.42 58.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.227 -0.442 . . . . 62.11 110.9 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.3 mmm -77.46 -23.68 50.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 74.5 110.897 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.23 -36.79 24.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 73.44 110.901 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -75.92 -26.33 56.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 44.44 110.923 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.407 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 8.9 pt-20 -79.03 -30.74 44.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 74.11 110.848 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.13 -10.4 30.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 70.24 111.074 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -86.15 -9.49 56.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.251 -0.431 . . . . 73.35 110.921 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 119.62 42.46 0.53 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.687 -0.768 . . . . 43.31 112.463 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.407 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 10.9 tt0 -47.62 -25.59 1.21 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.783 0.325 . . . . 63.43 110.926 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.445 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -121.19 -10.88 9.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 74.2 111.055 179.973 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.756 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -106.14 165.26 13.33 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.557 0.694 . . . . 63.41 111.083 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.756 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.7 Cg_endo -69.72 -4.57 14.27 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.639 2.226 . . . . 53.12 112.296 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.07 -34.77 78.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 72.31 110.921 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 65.42 110.879 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . 0.486 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.849 0.357 . . . . 72.31 110.877 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 54.5 t -155.04 -39.55 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 70.31 111.148 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.93 -11.05 83.95 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.735 -0.745 . . . . 72.12 112.488 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.486 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.4 m-85 -86.37 -41.11 14.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.897 0.379 . . . . 74.32 110.898 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.411 ' O ' ' N ' ' A' ' 9' ' ' TYR . 20.5 m-85 -69.65 -32.41 71.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.483 . . . . 74.23 110.842 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.9 -32.33 60.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 74.43 110.861 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.55 -18.62 13.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 72.44 110.853 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -90.46 -46.23 8.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 63.31 110.894 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.411 ' N ' ' O ' ' A' ' 5' ' ' PHE . 10.0 t80 -64.29 -42.92 96.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.247 -0.433 . . . . 74.22 110.967 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.4 mmmt -69.27 -33.81 73.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.082 -0.508 . . . . 64.23 110.903 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -76.32 -35.44 58.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.26 -0.427 . . . . 72.04 110.837 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.3 ptm -77.78 -20.6 53.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 70.14 110.916 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.63 -36.68 20.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 74.23 110.861 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.79 -27.1 57.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 64.44 110.907 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -78.27 -31.48 49.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 71.01 110.902 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -94.91 -9.0 35.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 51.24 111.054 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.62 -11.08 54.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 73.04 110.869 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 120.97 43.26 0.45 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.765 -0.731 . . . . 72.33 112.502 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -47.44 -25.72 1.14 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.751 0.31 . . . . 74.42 110.892 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.453 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -121.49 -11.0 9.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 64.33 111.13 179.946 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.72 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -106.54 164.31 15.17 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.59 0.71 . . . . 63.3 111.081 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.72 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.5 Cg_endo -69.68 -5.51 16.32 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.698 2.265 . . . . 71.44 112.336 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -62.05 -33.74 74.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 62.12 110.892 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 72.43 110.925 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . 0.503 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 1.1 mttt . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.792 0.33 . . . . 54.41 110.908 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 54.4 t -154.73 -39.87 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.271 -0.422 . . . . 60.44 111.11 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.32 -12.39 76.52 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.725 -0.75 . . . . 31.21 112.507 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.503 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.5 m-85 -84.91 -41.98 15.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.883 0.373 . . . . 75.24 110.854 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.446 ' O ' ' N ' ' A' ' 9' ' ' TYR . 25.4 m-85 -67.18 -33.59 75.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 75.44 110.87 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.9 mmtt -53.99 -33.32 56.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 61.12 110.902 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 13.7 mmt85 -108.52 -19.8 13.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 75.2 110.908 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.1 mm100 -89.19 -46.39 8.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 73.23 110.917 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 5' ' ' PHE . 9.9 t80 -63.81 -43.04 97.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.223 -0.444 . . . . 75.13 110.938 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.5 ptmt -66.7 -32.42 73.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.136 -0.484 . . . . 74.11 110.888 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -76.47 -35.35 58.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 73.32 110.911 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 29.4 mtt -77.78 -21.73 51.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.099 -0.5 . . . . 74.44 110.888 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -85.27 -36.4 20.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.255 -0.43 . . . . 74.42 110.921 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.14 -26.02 55.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.247 -0.433 . . . . 65.31 110.881 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.41 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 18.8 pt-20 -78.96 -32.37 45.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.473 . . . . 74.44 110.895 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -93.38 -10.33 35.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.123 -0.49 . . . . 72.31 111.09 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.62 -10.47 55.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 74.33 110.896 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 120.18 42.42 0.51 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.698 -0.763 . . . . 75.24 112.485 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.41 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 11.9 tt0 -47.67 -25.56 1.24 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.804 0.335 . . . . 75.3 110.951 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.459 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -121.28 -11.16 9.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 73.55 111.117 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.722 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -106.74 164.6 14.52 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.571 0.7 . . . . 74.04 111.093 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.722 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.4 Cg_endo -69.77 -4.64 14.44 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.666 2.244 . . . . 43.21 112.366 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -62.71 -34.75 77.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.459 . . . . 72.23 110.895 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 75.13 110.914 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . 0.487 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.851 0.358 . . . . 35.31 110.895 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 53.7 t -155.03 -39.62 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 74.5 111.107 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.9 -11.03 83.9 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.737 -0.744 . . . . 71.43 112.478 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.487 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.4 m-85 -86.41 -41.13 14.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.881 0.372 . . . . 61.24 110.858 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.412 ' O ' ' N ' ' A' ' 9' ' ' TYR . 20.6 m-85 -69.55 -32.47 71.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 62.4 110.902 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.93 -32.18 60.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 64.45 110.912 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.57 -18.66 13.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.234 -0.439 . . . . 72.32 110.857 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 14.9 tp60 -90.49 -46.08 8.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 65.44 110.905 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.412 ' N ' ' O ' ' A' ' 5' ' ' PHE . 9.9 t80 -64.11 -43.14 96.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.185 -0.461 . . . . 73.34 110.942 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.1 mmtt -69.17 -34.08 74.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.078 -0.51 . . . . 61.4 110.889 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -80.02 -21.43 43.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 74.43 110.909 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.6 mmt -86.26 -27.19 24.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.476 . . . . 42.43 110.872 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.19 -30.36 22.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 65.4 110.909 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -82.09 -23.87 35.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 72.01 110.854 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.75 -31.27 32.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.445 . . . . 71.51 110.867 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -94.52 -9.3 35.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 55.13 111.072 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.43 -11.3 54.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 72.45 110.895 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 121.21 43.44 0.43 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.794 -0.717 . . . . 44.23 112.536 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.29 -25.7 1.04 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.773 0.32 . . . . 74.13 110.913 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.458 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -121.38 -10.97 9.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 74.21 111.172 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.706 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -106.42 164.16 15.49 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.539 0.685 . . . . 64.53 111.122 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.706 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.7 Cg_endo -69.75 -5.62 16.64 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.646 2.23 . . . . 74.52 112.346 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -62.05 -34.11 75.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.455 . . . . 73.42 110.912 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.468 . . . . 70.54 110.809 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . 0.487 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.775 0.322 . . . . 74.45 110.922 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 54.7 t -154.99 -39.73 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 62.43 111.095 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.78 -11.01 83.58 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.776 -0.726 . . . . 72.44 112.502 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.487 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.4 m-85 -86.48 -41.11 14.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.915 0.388 . . . . 70.32 110.882 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.427 ' O ' ' N ' ' A' ' 9' ' ' TYR . 21.4 m-85 -69.49 -32.56 71.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 74.44 110.893 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.68 -33.01 60.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 72.33 110.893 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.404 ' HA ' ' HD3' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -109.77 -18.5 13.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 75.21 110.858 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.7 tm0? -90.81 -45.41 8.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 72.34 110.935 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.427 ' N ' ' O ' ' A' ' 5' ' ' PHE . 9.1 t80 -66.31 -39.43 89.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.456 . . . . 74.42 110.987 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' A' ' 7' ' ' ARG . 5.0 ptmm? -68.23 -33.36 74.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.11 -0.496 . . . . 53.15 110.897 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.15 -25.91 36.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 62.51 110.868 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.41 -20.29 32.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 44.5 110.866 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.4 tpt -86.87 -35.89 18.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.254 -0.43 . . . . 70.3 110.852 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -77.11 -25.47 52.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.216 -0.447 . . . . 74.44 110.91 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.416 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 0.0 OUTLIER -79.37 -31.87 43.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 74.21 110.922 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -93.96 -10.56 33.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.112 -0.495 . . . . 72.21 111.13 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.53 -10.33 56.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 72.32 110.911 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 120.19 42.78 0.5 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.726 -0.749 . . . . 75.24 112.495 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.416 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 13.5 tt0 -47.51 -25.55 1.13 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.785 0.326 . . . . 61.05 110.942 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.461 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -121.01 -11.24 9.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 75.31 111.145 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.724 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -106.83 164.84 14.01 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.594 0.711 . . . . 43.5 111.114 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.724 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.3 Cg_endo -69.77 -4.53 14.21 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.663 2.242 . . . . 70.34 112.347 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -64.45 -30.84 71.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.192 -0.458 . . . . 65.43 110.879 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 74.45 110.898 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . 0.488 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.783 0.325 . . . . 70.35 110.91 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 55.1 t -155.05 -39.76 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 71.2 111.104 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.72 -11.45 83.21 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.803 -0.713 . . . . 44.32 112.469 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.488 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.4 m-85 -85.77 -42.09 14.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.913 0.387 . . . . 73.01 110.896 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.424 ' O ' ' N ' ' A' ' 9' ' ' TYR . 20.2 m-85 -68.81 -32.93 73.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 63.42 110.837 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.76 -33.94 57.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 74.13 110.864 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -109.37 -18.68 13.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 74.5 110.887 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -90.2 -45.96 8.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 72.33 110.925 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.424 ' N ' ' O ' ' A' ' 5' ' ' PHE . 8.6 t80 -66.19 -37.86 86.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.46 . . . . 73.44 110.917 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.02 -33.42 73.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 64.43 110.911 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.04 -26.28 36.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 73.02 110.906 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.14 -20.29 32.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 43.55 110.843 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.8 tpt -86.64 -36.06 19.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.439 . . . . 62.15 110.904 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -76.93 -25.77 53.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.203 -0.453 . . . . 51.31 110.902 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.11 -31.81 44.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 73.22 110.887 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -94.11 -10.43 33.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.103 -0.498 . . . . 70.05 111.134 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.74 -10.2 55.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 52.21 110.884 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 120.02 42.42 0.52 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.732 -0.747 . . . . 64.14 112.477 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -47.66 -25.65 1.26 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.812 0.339 . . . . 62.53 110.954 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.459 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -121.35 -11.1 9.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 74.32 111.15 179.95 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.739 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -106.71 164.72 14.27 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.59 0.709 . . . . 61.03 111.074 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.739 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.5 Cg_endo -69.76 -4.71 14.58 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.708 2.272 . . . . 74.34 112.322 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.5 -34.44 76.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.232 -0.44 . . . . 73.22 110.918 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.139 -0.482 . . . . 75.13 110.905 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . 0.502 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.804 0.335 . . . . 71.01 110.888 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 54.4 t -154.69 -39.84 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 63.51 111.087 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.49 -12.03 76.97 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.746 -0.74 . . . . 13.31 112.492 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.502 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.6 m-85 -85.31 -40.78 16.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.904 0.383 . . . . 74.31 110.87 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -68.95 -33.18 73.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.09 -0.505 . . . . 51.35 110.898 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.0 mmtp -54.68 -32.04 58.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 70.51 110.888 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.93 -17.91 13.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 73.05 110.882 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.95 -45.13 8.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 64.54 110.944 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -66.72 -41.39 88.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 75.43 110.906 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.7 mmtt -69.12 -39.26 79.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 73.11 110.919 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -77.14 -23.96 51.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 54.41 110.901 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 6.9 mmt -84.26 -22.68 30.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.468 . . . . 53.02 110.898 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 7.4 tpt -85.59 -35.76 20.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 71.3 110.868 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -77.56 -24.92 49.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.25 -0.432 . . . . 73.11 110.889 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.413 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 1.4 pp20? -80.2 -30.74 38.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 71.05 110.909 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.09 -10.57 30.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.109 -0.496 . . . . 72.23 111.056 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.93 -9.68 56.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 72.54 110.914 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 119.73 42.57 0.52 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.747 -0.74 . . . . 70.11 112.493 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.413 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 9.8 tt0 -47.59 -25.61 1.21 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.745 0.307 . . . . 72.33 110.876 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.453 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -121.05 -10.92 9.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.434 . . . . 54.32 111.118 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.753 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -106.11 165.27 13.31 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.589 0.709 . . . . 63.33 111.1 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.753 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.9 Cg_endo -69.78 -4.61 14.39 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.684 2.256 . . . . 40.24 112.327 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.06 -34.83 78.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.454 . . . . 74.21 110.898 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 70.25 110.93 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . 0.507 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 4.2 mtmt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.875 0.369 . . . . 73.42 110.915 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 55.8 t -154.61 -39.44 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 65.24 111.113 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.0 -12.51 75.4 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.746 -0.74 . . . . 63.11 112.487 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.507 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.5 m-85 -84.82 -41.94 15.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.892 0.377 . . . . 61.03 110.904 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.411 ' O ' ' N ' ' A' ' 9' ' ' TYR . 24.2 m-85 -67.22 -33.32 75.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 73.43 110.881 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.11 -33.44 57.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 74.42 110.913 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -108.54 -19.62 13.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 73.02 110.897 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -89.23 -46.42 8.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 74.12 110.884 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.411 ' N ' ' O ' ' A' ' 5' ' ' PHE . 9.7 t80 -64.27 -42.38 96.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 75.32 110.89 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.27 -30.34 69.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 73.54 110.905 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -77.92 -36.88 48.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.201 -0.454 . . . . 73.35 110.901 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -77.26 -20.85 54.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 62.21 110.877 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 10.1 tmm? -84.93 -37.03 21.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 65.42 110.91 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -74.54 -28.8 61.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.189 -0.459 . . . . 72.01 110.899 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.455 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 23.6 pt-20 -76.24 -32.68 59.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.117 -0.492 . . . . 55.22 110.836 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -93.75 -9.36 37.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 52.33 111.114 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.02 -11.48 55.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 75.43 110.902 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 119.68 42.56 0.53 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.736 -0.745 . . . . 55.12 112.505 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.455 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 4.8 tm0? -47.62 -25.4 1.15 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.806 0.336 . . . . 71.2 110.915 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.472 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -120.02 -11.73 10.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 73.14 111.133 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.719 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -107.12 164.76 14.13 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.557 0.694 . . . . 70.35 111.103 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.719 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.5 Cg_endo -69.79 -4.18 13.52 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.615 2.21 . . . . 73.53 112.35 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -64.18 -32.2 73.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 65.35 110.936 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.094 -0.503 . . . . 75.43 110.894 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . 0.49 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.792 0.329 . . . . 73.22 110.91 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.408 HG12 ' HE3' ' A' ' 6' ' ' LYS . 53.4 t -155.16 -39.73 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 75.53 111.145 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.68 -11.7 83.02 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.732 -0.747 . . . . 62.41 112.487 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.49 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.5 m-85 -85.39 -43.46 13.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.914 0.388 . . . . 74.44 110.855 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.409 ' O ' ' N ' ' A' ' 9' ' ' TYR . 20.9 m-85 -67.18 -32.69 73.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 74.23 110.837 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.408 ' HE3' HG12 ' A' ' 2' ' ' VAL . 0.4 OUTLIER -54.03 -33.8 58.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.13 -0.486 . . . . 64.21 110.904 179.949 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.84 -19.42 13.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 73.21 110.866 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -89.47 -46.4 8.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 73.42 110.895 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.409 ' N ' ' O ' ' A' ' 5' ' ' PHE . 9.9 t80 -63.99 -43.17 96.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 72.23 110.938 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.5 ptmt -66.25 -32.41 73.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.116 -0.493 . . . . 73.33 110.927 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -75.38 -36.61 60.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 62.41 110.854 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 22.4 mtm -74.87 -25.33 58.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 53.33 110.885 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.23 -37.57 32.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 73.51 110.898 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -72.58 -31.98 65.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 75.43 110.914 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.415 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 6.3 pt-20 -74.21 -31.23 62.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 75.15 110.859 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -94.38 -10.18 33.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 75.04 111.089 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.8 -10.18 55.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 74.32 110.885 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 119.98 42.28 0.52 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.757 -0.735 . . . . 63.22 112.496 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.415 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 25.0 tp60 -47.75 -25.7 1.33 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.793 0.33 . . . . 74.24 110.881 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.446 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -121.21 -10.89 9.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 74.21 111.127 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.743 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -106.5 165.15 13.46 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.618 0.723 . . . . 73.04 111.055 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.743 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.8 Cg_endo -69.81 -4.33 13.84 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.685 2.257 . . . . 74.45 112.383 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -64.27 -34.16 77.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 74.21 110.874 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 75.22 110.896 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . 0.505 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 1.4 mtmm . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.814 0.34 . . . . 64.11 110.935 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 55.5 t -154.46 -39.4 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 63.23 111.121 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.58 -11.6 77.12 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.739 -0.743 . . . . 70.14 112.493 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.505 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.6 m-85 -85.85 -39.48 16.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.901 0.382 . . . . 73.23 110.879 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.436 ' O ' ' N ' ' A' ' 9' ' ' TYR . 24.1 m-85 -69.62 -34.28 73.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 74.31 110.846 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.43 -31.22 54.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 74.53 110.888 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 10.7 mtp180 -110.38 -19.27 13.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 74.2 110.873 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -90.34 -46.26 8.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 64.23 110.9 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.436 ' N ' ' O ' ' A' ' 5' ' ' PHE . 9.7 t80 -63.52 -42.68 98.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.22 -0.446 . . . . 73.55 110.928 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.5 mmmt -70.73 -29.16 65.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 64.44 110.902 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -81.2 -30.02 34.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 75.13 110.913 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 5.0 ptt? -80.92 -24.8 37.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 64.5 110.871 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 8.8 ptt? -85.87 -33.9 21.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 51.13 110.856 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -79.14 -24.47 43.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 65.33 110.903 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.452 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 0.0 OUTLIER -80.8 -31.06 35.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 72.35 110.895 -179.911 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.02 -9.79 32.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 45.12 111.088 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.24 -11.39 54.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.431 . . . . 74.24 110.861 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 119.71 42.44 0.53 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.782 -0.723 . . . . 33.51 112.499 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.452 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 0.7 OUTLIER -47.67 -25.32 1.15 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.738 0.304 . . . . 73.04 110.923 -179.899 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.477 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -119.93 -11.63 10.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 63.0 111.157 179.94 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.724 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -106.96 164.74 14.18 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.556 0.693 . . . . 74.14 111.111 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.724 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.2 Cg_endo -69.83 -4.46 14.12 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.709 2.272 . . . . 65.34 112.307 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -63.01 -35.73 81.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.235 -0.439 . . . . 73.23 110.919 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 70.34 110.918 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . 0.504 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.851 0.358 . . . . 75.54 110.922 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 54.3 t -154.66 -39.94 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 62.23 111.126 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.3 -12.16 76.28 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.754 -0.736 . . . . 52.32 112.497 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.504 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.5 m-85 -85.24 -40.99 16.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.892 0.377 . . . . 71.21 110.893 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -68.48 -33.11 73.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 71.53 110.888 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.3 mmtt -53.9 -34.34 59.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 74.12 110.907 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -108.7 -18.79 13.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 74.42 110.84 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -89.37 -46.12 8.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 73.4 110.899 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -65.38 -40.69 93.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 75.31 110.881 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.64 -30.73 70.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.466 . . . . 74.4 110.875 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -74.85 -39.88 61.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 63.31 110.859 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 17.9 ptp -76.98 -20.66 55.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 70.13 110.859 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -84.69 -36.94 21.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 72.34 110.896 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.57 -30.37 61.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.226 -0.443 . . . . 54.21 110.918 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.421 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 12.7 pt-20 -75.37 -30.83 60.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.098 -0.501 . . . . 73.23 110.877 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -94.95 -9.73 33.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 71.31 111.104 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -87.94 -6.44 58.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 74.32 110.9 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 120.32 47.59 0.33 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.768 -0.73 . . . . 74.33 112.469 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.421 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -46.51 -25.0 0.6 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.788 0.328 . . . . 61.31 110.89 -179.866 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.463 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -118.78 -12.49 10.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 64.3 111.096 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.629 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -107.43 161.48 22.95 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.609 0.719 . . . . 54.23 111.09 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.629 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.7 Cg_endo -69.73 -5.92 17.35 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.667 2.245 . . . . 75.32 112.374 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -56.48 -32.34 64.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 74.55 110.89 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 74.02 110.855 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . 0.489 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.84 0.352 . . . . 73.12 110.885 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 54.5 t -155.09 -39.66 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 51.54 111.096 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.63 -11.49 82.97 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.738 -0.744 . . . . 70.15 112.488 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.489 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.4 m-85 -85.78 -42.46 14.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.884 0.373 . . . . 71.23 110.921 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.42 ' O ' ' HB3' ' A' ' 9' ' ' TYR . 18.1 m-85 -68.81 -31.62 70.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 72.23 110.902 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.6 mttt -54.41 -35.1 62.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 73.41 110.922 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -108.7 -18.13 13.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 55.31 110.904 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -90.15 -45.8 8.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 62.33 110.948 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.42 ' HB3' ' O ' ' A' ' 5' ' ' PHE . 9.7 t80 -64.9 -41.85 95.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.455 . . . . 72.11 110.891 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 11.6 pttm -65.42 -35.25 80.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 72.43 110.893 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.18 -25.54 42.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 63.35 110.897 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -83.17 -22.8 33.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 71.24 110.906 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 34.4 ttp -84.8 -36.28 21.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 73.12 110.866 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -77.36 -25.58 51.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.227 -0.442 . . . . 73.5 110.9 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.424 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 0.9 OUTLIER -79.48 -29.82 41.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 73.44 110.89 -179.972 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.6 -11.98 26.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 71.52 111.12 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -87.27 -6.55 58.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 74.4 110.899 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 117.47 45.4 0.52 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.735 -0.745 . . . . 63.34 112.485 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.424 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 4.7 tt0 -46.97 -24.66 0.65 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.759 0.314 . . . . 72.34 110.91 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.485 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -117.44 -13.26 10.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.247 -0.433 . . . . 72.13 111.121 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.665 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -108.51 162.68 19.1 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.576 0.703 . . . . 74.1 111.104 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.665 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.4 Cg_endo -69.75 -4.27 13.69 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.658 2.239 . . . . 73.43 112.341 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -56.47 -34.02 66.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 74.43 110.901 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.3 m120 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 52.41 110.888 -179.961 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . 0.492 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.8 0.333 . . . . 74.14 110.873 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 54.3 t -155.11 -39.7 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 65.01 111.119 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.73 -11.43 83.26 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.691 -0.766 . . . . 63.1 112.494 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.492 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.5 m-85 -85.71 -42.68 14.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.896 0.379 . . . . 72.0 110.892 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.418 ' O ' ' HB3' ' A' ' 9' ' ' TYR . 16.2 m-85 -69.17 -31.15 69.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 72.32 110.867 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.29 -32.94 62.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.159 -0.473 . . . . 74.45 110.903 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.22 -17.4 13.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 74.35 110.865 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -91.16 -44.94 8.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 73.41 110.897 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.418 ' HB3' ' O ' ' A' ' 5' ' ' PHE . 9.3 t80 -67.49 -41.38 84.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 73.31 110.88 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.2 mmtt -69.29 -39.13 78.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 75.14 110.864 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -76.71 -25.35 53.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.216 -0.447 . . . . 75.12 110.87 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.2 mmm -83.09 -23.19 33.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 71.13 110.819 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.402 ' O ' ' HB2' ' A' ' 17' ' ' ASN . 0.0 OUTLIER -83.78 -36.83 23.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.247 -0.433 . . . . 62.23 110.874 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -72.46 -31.85 65.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.199 -0.455 . . . . 74.45 110.905 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.422 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 21.5 pt-20 -73.02 -35.37 66.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 74.43 110.883 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -91.11 -8.67 48.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 74.43 111.147 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 13' ' ' MET . 0.6 OUTLIER -85.6 -11.3 54.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.241 -0.436 . . . . 74.55 110.868 -179.946 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.425 ' N ' HD22 ' A' ' 24' ' ' ASN . . . 121.52 42.78 0.45 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.744 -0.741 . . . . 55.01 112.499 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.422 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 3.5 tt0 -46.22 -25.91 0.69 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.78 0.324 . . . . 54.32 110.924 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.413 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -124.99 -10.01 6.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 74.41 111.205 179.923 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.755 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -107.11 165.49 12.75 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.619 0.723 . . . . 71.23 111.06 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.755 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.9 Cg_endo -69.72 -19.96 35.63 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.684 2.256 . . . . 65.2 112.36 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -51.02 -24.23 3.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 55.03 110.919 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.425 HD22 ' N ' ' A' ' 18' ' ' GLY . 1.5 t-20 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.091 -0.504 . . . . 75.02 110.838 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . 0.454 ' N ' ' HE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.843 0.354 . . . . 63.13 110.93 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.3 t -143.4 -36.86 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 73.12 111.14 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.96 -11.67 81.28 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.757 -0.735 . . . . 73.03 112.45 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.454 ' HE1' ' N ' ' A' ' 1' ' ' LYS . 1.7 m-85 -86.16 -42.42 13.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.918 0.39 . . . . 64.23 110.87 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.409 ' O ' ' HB3' ' A' ' 9' ' ' TYR . 24.0 m-85 -69.51 -30.97 68.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 73.35 110.853 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.3 mmtm -55.53 -34.59 64.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.14 -0.482 . . . . 72.34 110.943 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 10.8 ptt180 -108.59 -18.19 13.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 72.13 110.859 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -89.62 -46.16 8.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 54.02 110.899 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.409 ' HB3' ' O ' ' A' ' 5' ' ' PHE . 9.6 t80 -65.15 -42.49 93.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 71.24 110.907 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.97 -29.61 68.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 72.41 110.893 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -78.22 -37.08 46.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.215 -0.448 . . . . 75.4 110.839 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.9 ppp? -77.28 -21.01 54.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.474 . . . . 42.11 110.901 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.2 tpt -85.16 -36.74 20.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 62.21 110.877 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -75.09 -28.02 60.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.226 -0.443 . . . . 74.31 110.91 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -76.95 -32.73 57.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.48 . . . . 74.3 110.915 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -93.06 -10.31 36.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 72.04 111.143 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.5 -10.47 55.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 61.42 110.905 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 120.11 42.3 0.52 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.688 -0.768 . . . . 70.34 112.512 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -47.76 -25.57 1.29 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.777 0.322 . . . . 75.11 110.94 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.461 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -121.33 -11.12 9.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.161 -0.472 . . . . 71.11 111.13 179.967 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.735 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -106.72 164.66 14.39 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.555 0.693 . . . . 73.43 111.098 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.735 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.6 Cg_endo -69.78 -4.72 14.6 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.698 2.265 . . . . 42.52 112.321 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -62.61 -34.74 77.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 73.34 110.899 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 65.34 110.859 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . 0.459 ' H2 ' ' HE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.787 0.327 . . . . 74.24 110.878 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.9 t -142.99 -36.7 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 75.15 111.119 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.29 -12.57 83.47 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.807 -0.711 . . . . 43.33 112.466 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.459 ' HE1' ' H2 ' ' A' ' 1' ' ' LYS . 1.6 m-85 -85.72 -45.41 11.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.848 0.356 . . . . 74.04 110.865 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.44 ' O ' ' HB3' ' A' ' 9' ' ' TYR . 21.5 m-85 -67.43 -29.36 68.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 71.32 110.884 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -55.98 -35.12 66.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 63.12 110.898 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.4 ptt85 -108.68 -18.31 13.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 73.21 110.891 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -89.25 -46.29 8.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.459 . . . . 70.3 110.914 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.44 ' HB3' ' O ' ' A' ' 5' ' ' PHE . 9.9 t80 -64.84 -42.2 95.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 73.42 110.925 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.08 -33.31 75.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.144 -0.48 . . . . 71.4 110.876 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -74.23 -37.6 63.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.438 . . . . 74.12 110.935 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.34 -24.7 59.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 73.12 110.93 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.23 -37.37 28.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 74.1 110.842 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -74.08 -29.14 61.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 72.15 110.864 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.415 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 6.2 pt-20 -76.81 -30.81 56.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 72.21 110.862 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -94.93 -10.28 31.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 64.21 111.104 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -86.02 -10.05 55.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 73.14 110.892 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 120.04 42.55 0.51 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.728 -0.749 . . . . 52.22 112.448 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.415 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 4.3 tp-100 -47.61 -25.6 1.21 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.782 0.325 . . . . 75.24 110.911 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.463 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -120.95 -11.16 9.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 62.34 111.134 179.932 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.738 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -106.68 165.02 13.66 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.623 0.725 . . . . 64.33 111.041 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.738 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.8 Cg_endo -69.76 -4.22 13.59 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.705 2.27 . . . . 75.44 112.345 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -65.17 -31.81 73.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.464 . . . . 72.24 110.863 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 62.31 110.873 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . 0.498 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 1.4 mtmm . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.789 0.328 . . . . 72.0 110.924 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 55.6 t -154.49 -39.44 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 70.22 111.135 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.04 -12.55 75.57 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.704 -0.76 . . . . 43.44 112.438 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.498 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.6 m-85 -84.8 -41.71 15.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.87 0.367 . . . . 72.11 110.884 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.438 ' O ' ' N ' ' A' ' 9' ' ' TYR . 24.3 m-85 -67.39 -33.73 75.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.467 . . . . 71.2 110.846 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.95 -32.71 54.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 75.31 110.905 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.0 ptt180 -109.21 -19.47 13.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.445 . . . . 63.24 110.92 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.433 ' HA ' ' HG2' ' A' ' 11' ' ' GLU . 0.8 OUTLIER -90.0 -45.34 9.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 75.05 110.919 -179.948 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.438 ' N ' ' O ' ' A' ' 5' ' ' PHE . 9.3 t80 -65.83 -40.16 91.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 74.34 110.961 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.2 ptmt -63.87 -40.32 96.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.094 -0.503 . . . . 65.55 110.889 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.433 ' HG2' ' HA ' ' A' ' 8' ' ' GLN . 9.6 pt-20 -77.11 -25.92 52.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 74.03 110.872 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.06 -22.11 33.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 64.43 110.895 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.7 tpt -85.03 -36.66 21.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 70.51 110.905 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -76.33 -26.66 55.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.271 -0.422 . . . . 71.3 110.891 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.443 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 22.9 pt-20 -78.43 -30.59 47.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 62.31 110.89 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -94.88 -11.58 28.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 72.11 111.115 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -87.24 -6.93 58.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.438 . . . . 62.4 110.913 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 117.98 45.58 0.49 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.709 -0.758 . . . . 32.5 112.511 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.443 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 6.1 tt0 -46.91 -24.66 0.63 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.755 0.312 . . . . 74.14 110.874 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.493 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -117.17 -13.29 10.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 34.1 111.128 179.949 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.651 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -108.72 162.48 19.85 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.568 0.699 . . . . 63.44 111.102 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.651 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.3 Cg_endo -69.82 -4.39 13.96 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.657 2.238 . . . . 71.53 112.342 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -56.73 -33.07 66.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.229 -0.441 . . . . 71.24 110.917 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.2 m120 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 70.43 110.871 -179.936 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . 0.431 ' N ' ' HE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.829 0.347 . . . . 73.51 110.902 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 41.1 t -142.99 -36.78 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 71.25 111.117 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.31 -12.03 83.81 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.711 -0.757 . . . . 71.32 112.512 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.431 ' HE1' ' N ' ' A' ' 1' ' ' LYS . 1.6 m-85 -86.24 -43.92 12.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.885 0.374 . . . . 71.02 110.888 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.451 ' O ' ' HB3' ' A' ' 9' ' ' TYR . 20.6 m-85 -69.17 -29.17 67.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.1 -0.5 . . . . 63.22 110.862 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.23 -35.77 67.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 71.42 110.862 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -108.4 -17.47 13.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 65.53 110.914 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -90.01 -45.96 8.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 65.03 110.91 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.451 ' HB3' ' O ' ' A' ' 5' ' ' PHE . 9.6 t80 -65.64 -41.73 92.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 74.15 110.915 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.4 ptmt -64.82 -33.8 76.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.127 -0.488 . . . . 72.42 110.85 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.49 -34.15 58.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 75.53 110.904 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.4 ptt? -77.91 -21.49 51.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 74.14 110.895 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.52 -36.94 21.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.431 . . . . 71.34 110.874 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -74.43 -29.05 61.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 70.24 110.901 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.404 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 23.4 pt-20 -76.17 -32.74 59.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 62.34 110.88 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -93.0 -10.3 36.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 60.14 111.115 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.47 -10.46 56.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 73.31 110.917 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 120.07 42.33 0.52 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.759 -0.734 . . . . 35.14 112.488 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.404 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 11.6 tt0 -47.74 -25.61 1.3 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.807 0.337 . . . . 73.32 110.931 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.453 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -121.36 -11.08 9.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.479 . . . . 74.52 111.166 179.97 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.727 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -106.74 164.61 14.5 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.581 0.705 . . . . 41.13 111.092 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.727 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 54.0 Cg_endo -69.68 -4.72 14.53 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.735 2.29 . . . . 74.42 112.343 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -62.55 -34.83 77.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.429 . . . . 73.12 110.903 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.467 . . . . 70.31 110.898 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . 0.543 ' HD3' ' H1 ' ' A' ' 1' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.78 0.324 . . . . 64.41 110.912 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.8 t -143.62 -36.84 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.431 . . . . 73.13 111.105 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.65 -11.45 83.03 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.734 -0.746 . . . . 72.44 112.5 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.476 ' HE1' ' H2 ' ' A' ' 1' ' ' LYS . 1.8 m-85 -86.16 -41.12 14.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.929 0.395 . . . . 75.14 110.902 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.414 ' O ' ' HB3' ' A' ' 9' ' ' TYR . 23.4 m-85 -70.8 -33.0 70.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 73.34 110.86 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 42.6 mmtt -56.02 -29.3 60.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.169 -0.469 . . . . 60.15 110.914 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.93 -18.79 12.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.446 . . . . 64.25 110.854 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -92.0 -45.49 8.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 51.42 110.91 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.414 ' HB3' ' O ' ' A' ' 5' ' ' PHE . 9.2 t80 -64.73 -38.6 91.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 72.21 110.913 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.7 mmtt -70.89 -37.37 72.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 72.04 110.905 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.15 -27.98 54.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 51.42 110.868 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -82.99 -19.95 36.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 74.41 110.902 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.73 -36.14 18.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 65.21 110.902 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -76.78 -25.99 53.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.239 -0.437 . . . . 55.43 110.902 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.411 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 1.0 OUTLIER -78.88 -31.87 45.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.105 -0.498 . . . . 71.24 110.901 -179.957 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -93.97 -10.49 33.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 55.42 111.119 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.59 -10.33 56.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 45.54 110.868 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 120.16 42.37 0.51 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.739 -0.744 . . . . 63.14 112.509 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.411 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 10.0 tt0 -47.57 -25.63 1.2 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.766 0.317 . . . . 75.21 110.925 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.463 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -121.23 -11.1 9.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 72.51 111.162 179.932 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.734 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -106.7 164.72 14.28 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.549 0.69 . . . . 53.2 111.129 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.734 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 54.0 Cg_endo -69.74 -4.72 14.59 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.733 2.289 . . . . 72.53 112.337 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -62.89 -34.33 77.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.238 -0.437 . . . . 54.44 110.859 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 72.5 110.887 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . 0.504 ' HD3' ' H1 ' ' A' ' 1' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.805 0.336 . . . . 73.55 110.869 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.3 t -143.3 -36.53 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 71.1 111.102 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.01 -12.07 83.58 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.771 -0.728 . . . . 52.14 112.487 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.446 ' HE1' ' N ' ' A' ' 1' ' ' LYS . 1.7 m-85 -85.78 -43.83 13.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.836 0.351 . . . . 72.22 110.868 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -68.4 -31.64 71.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.188 -0.46 . . . . 53.52 110.854 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.93 -31.04 62.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 74.44 110.884 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -110.86 -18.88 13.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.269 -0.423 . . . . 72.02 110.905 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -90.63 -45.68 8.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 74.12 110.91 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -63.66 -42.97 98.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.25 -0.432 . . . . 71.14 110.922 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.9 mmmm -65.51 -40.43 92.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 72.02 110.87 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -75.12 -26.04 58.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 71.12 110.918 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 21.2 mmm -82.96 -21.85 33.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 71.33 110.852 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -85.74 -35.99 20.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 72.12 110.875 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -77.16 -24.99 51.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 73.11 110.866 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.462 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 0.0 OUTLIER -80.17 -31.07 38.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 74.0 110.915 -179.935 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.23 -9.7 32.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.134 -0.485 . . . . 44.12 111.112 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.19 -11.38 55.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 75.53 110.956 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 119.85 42.68 0.51 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.728 -0.749 . . . . 72.53 112.481 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.462 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 5.3 tm0? -47.4 -25.36 1.01 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.802 0.334 . . . . 73.53 110.931 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.483 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -119.46 -11.76 10.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.436 . . . . 62.23 111.106 179.985 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.726 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -106.98 165.04 13.56 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.588 0.709 . . . . 71.5 111.101 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.726 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.4 Cg_endo -69.83 -3.89 12.97 Favored 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.723 2.282 . . . . 62.44 112.335 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.36 -31.19 71.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 72.33 110.87 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 64.53 110.88 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.491 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.817 0.341 . . . . 73.12 110.865 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 54.7 t -155.01 -40.05 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 72.12 111.107 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.18 -11.82 81.77 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.744 -0.741 . . . . 70.22 112.45 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.491 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.4 m-85 -85.43 -43.02 13.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.878 0.371 . . . . 74.44 110.905 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.427 ' O ' ' N ' ' A' ' 9' ' ' TYR . 22.3 m-85 -67.26 -32.8 74.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 63.2 110.889 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.4 mmtt -54.07 -33.67 58.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 72.11 110.887 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -108.76 -19.53 13.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 65.21 110.892 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 40.8 mm-40 -89.39 -46.33 8.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 72.03 110.925 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.427 ' N ' ' O ' ' A' ' 5' ' ' PHE . 10.0 t80 -64.1 -42.99 96.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 72.55 110.932 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.1 ptmt -66.55 -32.28 73.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.099 -0.5 . . . . 74.51 110.89 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -76.15 -36.5 58.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 54.41 110.913 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.5 mmt -76.97 -21.5 54.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 73.24 110.848 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 6.2 tpt -85.27 -36.3 20.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 63.11 110.897 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -76.64 -25.81 54.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.198 -0.456 . . . . 73.22 110.876 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.41 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 0.6 OUTLIER -79.48 -30.97 42.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 72.44 110.919 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -94.75 -10.53 31.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 71.31 111.108 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.69 -10.3 55.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.205 -0.452 . . . . 74.5 110.919 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 120.24 42.85 0.49 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.778 -0.725 . . . . 72.45 112.501 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.41 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 6.5 tt0 -47.46 -25.61 1.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.793 0.33 . . . . 72.32 110.921 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.466 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -120.96 -11.25 9.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 74.15 111.157 179.92 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.724 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -106.74 164.81 14.08 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.572 0.701 . . . . 64.55 111.136 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.724 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.6 Cg_endo -69.74 -4.46 14.05 Favored 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.719 2.279 . . . . 64.12 112.382 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -64.66 -30.64 71.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.456 . . . . 44.53 110.897 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.1 104.25 0.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.115 -0.493 . . . . 73.52 110.87 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.02 -12.83 12.92 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.714 -0.755 . . . . 73.44 112.537 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.1 m -91.25 -36.38 13.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.753 0.311 . . . . 74.42 111.173 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -111.17 -2.78 15.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 54.31 110.917 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.7 t -45.78 146.81 1.79 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.534 0.683 . . . . 30.44 111.16 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 64.96 1.84 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.694 2.263 . . . . 63.24 112.358 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.8 p -55.17 155.36 9.11 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.689 0.757 . . . . 73.41 110.853 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 167.72 23.59 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.744 2.296 . . . . 72.21 112.328 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -24.4 29.77 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.698 2.265 . . . . 44.01 112.338 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.13 -27.36 64.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.448 . . . . 72.13 110.818 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -102.94 -26.64 13.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 64.13 110.868 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.8 tttt . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.216 -0.447 . . . . 54.31 110.91 179.953 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.483 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.834 0.349 . . . . 71.44 110.9 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 53.1 t -155.12 -39.71 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.281 -0.418 . . . . 75.44 111.092 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.44 -11.82 82.4 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.717 -0.754 . . . . 72.1 112.514 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.483 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.5 m-85 -85.35 -43.93 13.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.891 0.377 . . . . 75.34 110.865 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.417 ' O ' ' N ' ' A' ' 9' ' ' TYR . 18.7 m-85 -67.2 -31.67 72.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 75.52 110.853 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.45 -34.43 61.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 70.32 110.923 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -108.71 -19.11 13.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 72.44 110.827 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -89.49 -46.35 8.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.444 . . . . 71.0 110.942 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.417 ' N ' ' O ' ' A' ' 5' ' ' PHE . 9.9 t80 -64.28 -43.08 95.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 63.11 110.955 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.51 -32.01 73.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 74.15 110.886 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -76.66 -34.42 58.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.227 -0.442 . . . . 62.11 110.9 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.3 mmm -77.46 -23.68 50.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 74.5 110.897 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.23 -36.79 24.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 73.44 110.901 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -75.92 -26.33 56.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 44.44 110.923 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.407 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 8.9 pt-20 -79.03 -30.74 44.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 74.11 110.848 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.13 -10.4 30.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 70.24 111.074 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.755 ' OD1' HG23 ' A' ' 28' ' ' THR . 0.7 OUTLIER -86.15 -9.49 56.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.251 -0.431 . . . . 73.35 110.921 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 119.62 42.46 0.53 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.687 -0.768 . . . . 43.31 112.463 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.407 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 10.9 tt0 -47.62 -25.59 1.21 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.783 0.325 . . . . 63.43 110.926 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.445 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -121.19 -10.88 9.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 74.2 111.055 179.973 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.756 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -106.14 165.26 13.33 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.557 0.694 . . . . 63.41 111.083 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.756 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.7 Cg_endo -69.72 -4.57 14.27 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.639 2.226 . . . . 53.12 112.296 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.07 -34.77 78.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 72.31 110.921 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -51.87 104.79 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 65.42 110.879 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.38 10.34 8.02 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.774 -0.727 . . . . 71.45 112.474 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 24.3 m -92.12 -54.77 3.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.747 0.308 . . . . 73.43 111.158 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -111.77 -8.42 14.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 61.34 110.93 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.755 HG23 ' OD1' ' A' ' 17' ' ' ASN . 0.0 OUTLIER -54.68 159.37 3.55 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.585 0.707 . . . . 61.43 111.15 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.665 ' HD2' HG22 ' A' ' 28' ' ' THR . 53.7 Cg_endo -69.75 66.57 1.76 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.671 2.247 . . . . 40.42 112.342 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.2 p -55.12 155.32 8.97 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.631 0.729 . . . . 51.11 110.894 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 167.74 23.61 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.703 2.269 . . . . 74.31 112.317 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 129.48 17.66 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.657 2.238 . . . . 71.44 112.379 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 p -79.94 -26.63 40.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 71.15 110.877 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -74.56 -27.01 60.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 73.44 110.919 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.5 tttt . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 75.4 110.908 179.969 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.486 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.849 0.357 . . . . 72.31 110.877 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 54.5 t -155.04 -39.55 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 70.31 111.148 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.93 -11.05 83.95 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.735 -0.745 . . . . 72.12 112.488 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.486 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.4 m-85 -86.37 -41.11 14.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.897 0.379 . . . . 74.32 110.898 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.411 ' O ' ' N ' ' A' ' 9' ' ' TYR . 20.5 m-85 -69.65 -32.41 71.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.483 . . . . 74.23 110.842 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.9 -32.33 60.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 74.43 110.861 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.55 -18.62 13.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 72.44 110.853 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -90.46 -46.23 8.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 63.31 110.894 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.411 ' N ' ' O ' ' A' ' 5' ' ' PHE . 10.0 t80 -64.29 -42.92 96.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.247 -0.433 . . . . 74.22 110.967 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.4 mmmt -69.27 -33.81 73.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.082 -0.508 . . . . 64.23 110.903 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -76.32 -35.44 58.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.26 -0.427 . . . . 72.04 110.837 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.3 ptm -77.78 -20.6 53.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 70.14 110.916 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.63 -36.68 20.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 74.23 110.861 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.79 -27.1 57.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 64.44 110.907 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -78.27 -31.48 49.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 71.01 110.902 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -94.91 -9.0 35.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 51.24 111.054 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.62 -11.08 54.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 73.04 110.869 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 120.97 43.26 0.45 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.765 -0.731 . . . . 72.33 112.502 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -47.44 -25.72 1.14 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.751 0.31 . . . . 74.42 110.892 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.453 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -121.49 -11.0 9.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 64.33 111.13 179.946 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.72 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -106.54 164.31 15.17 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.59 0.71 . . . . 63.3 111.081 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.72 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.5 Cg_endo -69.68 -5.51 16.32 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.698 2.265 . . . . 71.44 112.336 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -62.05 -33.74 74.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 62.12 110.892 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.95 104.1 0.12 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 72.43 110.925 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.58 -6.47 16.28 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.764 -0.731 . . . . 53.01 112.482 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.4 m -90.38 -48.41 7.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.728 0.299 . . . . 72.35 111.1 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -111.09 -6.58 14.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 74.33 110.93 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -47.73 155.49 0.79 Allowed Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.539 0.685 . . . . 73.33 111.151 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 68.91 1.66 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.67 2.247 . . . . 70.21 112.379 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.59 155.3 73.73 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.67 0.748 . . . . 61.13 110.857 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 167.7 23.62 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.708 2.272 . . . . 53.53 112.368 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 169.9 17.77 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.728 2.286 . . . . 75.53 112.321 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.2 m -73.34 -28.78 62.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 62.5 110.874 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -78.65 -26.39 45.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 72.01 110.904 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.9 tttt . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.477 . . . . 53.52 110.922 179.994 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.503 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 1.1 mttt . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.792 0.33 . . . . 54.41 110.908 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 54.4 t -154.73 -39.87 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.271 -0.422 . . . . 60.44 111.11 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.32 -12.39 76.52 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.725 -0.75 . . . . 31.21 112.507 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.503 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.5 m-85 -84.91 -41.98 15.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.883 0.373 . . . . 75.24 110.854 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.446 ' O ' ' N ' ' A' ' 9' ' ' TYR . 25.4 m-85 -67.18 -33.59 75.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 75.44 110.87 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.9 mmtt -53.99 -33.32 56.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 61.12 110.902 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 13.7 mmt85 -108.52 -19.8 13.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 75.2 110.908 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.1 mm100 -89.19 -46.39 8.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 73.23 110.917 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 5' ' ' PHE . 9.9 t80 -63.81 -43.04 97.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.223 -0.444 . . . . 75.13 110.938 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.5 ptmt -66.7 -32.42 73.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.136 -0.484 . . . . 74.11 110.888 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -76.47 -35.35 58.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 73.32 110.911 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 29.4 mtt -77.78 -21.73 51.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.099 -0.5 . . . . 74.44 110.888 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -85.27 -36.4 20.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.255 -0.43 . . . . 74.42 110.921 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.14 -26.02 55.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.247 -0.433 . . . . 65.31 110.881 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.41 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 18.8 pt-20 -78.96 -32.37 45.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.473 . . . . 74.44 110.895 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -93.38 -10.33 35.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.123 -0.49 . . . . 72.31 111.09 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.62 -10.47 55.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 74.33 110.896 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 120.18 42.42 0.51 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.698 -0.763 . . . . 75.24 112.485 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.41 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 11.9 tt0 -47.67 -25.56 1.24 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.804 0.335 . . . . 75.3 110.951 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.459 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -121.28 -11.16 9.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 73.55 111.117 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.722 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -106.74 164.6 14.52 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.571 0.7 . . . . 74.04 111.093 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.722 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.4 Cg_endo -69.77 -4.64 14.44 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.666 2.244 . . . . 43.21 112.366 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -62.71 -34.75 77.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.459 . . . . 72.23 110.895 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -54.41 104.01 0.1 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 75.13 110.914 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.69 -6.26 16.17 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.715 -0.755 . . . . 63.31 112.457 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 61.4 p -90.41 -48.45 7.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.775 0.321 . . . . 55.33 111.148 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -111.08 -6.71 14.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 72.24 110.928 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -47.76 155.51 0.8 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.597 0.713 . . . . 43.31 111.146 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 68.95 1.67 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.743 2.295 . . . . 63.33 112.332 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.3 m -58.02 155.34 24.79 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.671 0.748 . . . . 73.44 110.85 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 167.74 23.53 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.715 2.277 . . . . 62.31 112.338 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.81 -31.85 19.52 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.684 2.256 . . . . 73.44 112.373 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 50.0 m -63.31 -26.21 68.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 72.04 110.89 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -102.35 -26.3 13.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.107 -0.497 . . . . 73.52 110.895 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.5 tttm . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.155 -0.475 . . . . 74.12 110.884 179.987 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.487 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.851 0.358 . . . . 35.31 110.895 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 53.7 t -155.03 -39.62 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 74.5 111.107 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.9 -11.03 83.9 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.737 -0.744 . . . . 71.43 112.478 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.487 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.4 m-85 -86.41 -41.13 14.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.881 0.372 . . . . 61.24 110.858 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.412 ' O ' ' N ' ' A' ' 9' ' ' TYR . 20.6 m-85 -69.55 -32.47 71.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 62.4 110.902 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.93 -32.18 60.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 64.45 110.912 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.57 -18.66 13.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.234 -0.439 . . . . 72.32 110.857 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 14.9 tp60 -90.49 -46.08 8.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 65.44 110.905 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.412 ' N ' ' O ' ' A' ' 5' ' ' PHE . 9.9 t80 -64.11 -43.14 96.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.185 -0.461 . . . . 73.34 110.942 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.1 mmtt -69.17 -34.08 74.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.078 -0.51 . . . . 61.4 110.889 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -80.02 -21.43 43.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 74.43 110.909 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.6 mmt -86.26 -27.19 24.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.476 . . . . 42.43 110.872 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.19 -30.36 22.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 65.4 110.909 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -82.09 -23.87 35.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 72.01 110.854 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.75 -31.27 32.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.445 . . . . 71.51 110.867 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -94.52 -9.3 35.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 55.13 111.072 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.43 -11.3 54.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 72.45 110.895 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 121.21 43.44 0.43 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.794 -0.717 . . . . 44.23 112.536 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.29 -25.7 1.04 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.773 0.32 . . . . 74.13 110.913 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.458 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -121.38 -10.97 9.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 74.21 111.172 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.706 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -106.42 164.16 15.49 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.539 0.685 . . . . 64.53 111.122 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.706 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.7 Cg_endo -69.75 -5.62 16.64 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.646 2.23 . . . . 74.52 112.346 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -62.05 -34.11 75.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.455 . . . . 73.42 110.912 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.47 104.13 0.12 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.468 . . . . 70.54 110.809 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.48 -6.25 16.62 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.709 -0.758 . . . . 63.42 112.502 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 91.2 m -90.34 -48.47 7.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.794 0.33 . . . . 64.31 111.176 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -111.14 -6.34 14.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 74.2 110.931 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -47.76 155.45 0.8 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.581 0.705 . . . . 62.32 111.117 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 69.02 1.66 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.683 2.255 . . . . 40.0 112.319 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.7 155.35 21.97 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.652 0.739 . . . . 74.41 110.863 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 167.73 23.67 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.696 2.264 . . . . 73.01 112.318 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 87.65 0.55 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.685 2.257 . . . . 63.52 112.374 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 64.0 m -78.53 -26.72 45.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 73.45 110.854 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -108.85 -26.72 10.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 62.24 110.856 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 75.25 110.912 179.978 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.487 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.775 0.322 . . . . 74.45 110.922 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 54.7 t -154.99 -39.73 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 62.43 111.095 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.78 -11.01 83.58 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.776 -0.726 . . . . 72.44 112.502 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.487 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.4 m-85 -86.48 -41.11 14.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.915 0.388 . . . . 70.32 110.882 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.427 ' O ' ' N ' ' A' ' 9' ' ' TYR . 21.4 m-85 -69.49 -32.56 71.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 74.44 110.893 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.68 -33.01 60.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 72.33 110.893 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.404 ' HA ' ' HD3' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -109.77 -18.5 13.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 75.21 110.858 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.7 tm0? -90.81 -45.41 8.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 72.34 110.935 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.427 ' N ' ' O ' ' A' ' 5' ' ' PHE . 9.1 t80 -66.31 -39.43 89.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.456 . . . . 74.42 110.987 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' A' ' 7' ' ' ARG . 5.0 ptmm? -68.23 -33.36 74.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.11 -0.496 . . . . 53.15 110.897 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.15 -25.91 36.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 62.51 110.868 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.41 -20.29 32.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 44.5 110.866 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.4 tpt -86.87 -35.89 18.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.254 -0.43 . . . . 70.3 110.852 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -77.11 -25.47 52.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.216 -0.447 . . . . 74.44 110.91 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.416 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 0.0 OUTLIER -79.37 -31.87 43.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 74.21 110.922 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -93.96 -10.56 33.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.112 -0.495 . . . . 72.21 111.13 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.53 -10.33 56.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 72.32 110.911 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 120.19 42.78 0.5 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.726 -0.749 . . . . 75.24 112.495 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.416 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 13.5 tt0 -47.51 -25.55 1.13 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.785 0.326 . . . . 61.05 110.942 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.461 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -121.01 -11.24 9.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 75.31 111.145 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.724 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -106.83 164.84 14.01 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.594 0.711 . . . . 43.5 111.114 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.724 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.3 Cg_endo -69.77 -4.53 14.21 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.663 2.242 . . . . 70.34 112.347 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -64.45 -30.84 71.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.192 -0.458 . . . . 65.43 110.879 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.04 104.21 0.11 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 74.45 110.898 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.99 -12.83 12.96 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.704 -0.76 . . . . 62.04 112.508 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 10.6 m -91.31 -36.49 13.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.726 0.298 . . . . 65.45 111.102 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -111.18 -2.74 15.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 73.43 110.905 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.7 t -45.79 146.79 1.8 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.571 0.7 . . . . 65.52 111.137 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 64.97 1.79 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.661 2.241 . . . . 75.04 112.324 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.2 p -88.1 155.33 52.28 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.611 0.719 . . . . 74.03 110.894 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 167.75 23.49 Favored 'Trans proline' 0 N--CA 1.465 -0.189 0 C-N-CA 122.695 2.263 . . . . 73.14 112.377 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 171.57 14.26 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.697 2.265 . . . . 74.32 112.326 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.68 -26.87 45.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 64.21 110.88 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -86.26 -26.41 25.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.153 -0.476 . . . . 54.44 110.866 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.9 ttmm . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 72.23 110.915 179.999 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.488 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.783 0.325 . . . . 70.35 110.91 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 55.1 t -155.05 -39.76 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 71.2 111.104 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.72 -11.45 83.21 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.803 -0.713 . . . . 44.32 112.469 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.488 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.4 m-85 -85.77 -42.09 14.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.913 0.387 . . . . 73.01 110.896 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.424 ' O ' ' N ' ' A' ' 9' ' ' TYR . 20.2 m-85 -68.81 -32.93 73.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 63.42 110.837 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.76 -33.94 57.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 74.13 110.864 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -109.37 -18.68 13.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 74.5 110.887 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -90.2 -45.96 8.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 72.33 110.925 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.424 ' N ' ' O ' ' A' ' 5' ' ' PHE . 8.6 t80 -66.19 -37.86 86.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.46 . . . . 73.44 110.917 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.02 -33.42 73.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 64.43 110.911 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.04 -26.28 36.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 73.02 110.906 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.14 -20.29 32.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 43.55 110.843 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.8 tpt -86.64 -36.06 19.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.439 . . . . 62.15 110.904 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -76.93 -25.77 53.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.203 -0.453 . . . . 51.31 110.902 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.11 -31.81 44.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 73.22 110.887 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -94.11 -10.43 33.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.103 -0.498 . . . . 70.05 111.134 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.661 ' OD1' HG23 ' A' ' 28' ' ' THR . 0.7 OUTLIER -85.74 -10.2 55.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 52.21 110.884 -179.931 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 120.02 42.42 0.52 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.732 -0.747 . . . . 64.14 112.477 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -47.66 -25.65 1.26 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.812 0.339 . . . . 62.53 110.954 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.459 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -121.35 -11.1 9.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 74.32 111.15 179.95 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.739 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -106.71 164.72 14.27 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.59 0.709 . . . . 61.03 111.074 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.739 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.5 Cg_endo -69.76 -4.71 14.58 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.708 2.272 . . . . 74.34 112.322 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.5 -34.44 76.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.232 -0.44 . . . . 73.22 110.918 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.95 104.1 0.12 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.139 -0.482 . . . . 75.13 110.905 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.62 -14.61 13.01 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.753 -0.737 . . . . 72.41 112.494 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 27.6 p -94.17 -46.3 7.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.728 0.299 . . . . 64.23 111.136 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -85.96 -27.8 24.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 75.35 110.932 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.661 HG23 ' OD1' ' A' ' 17' ' ' ASN . 0.0 OUTLIER -50.94 161.42 0.69 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.554 0.692 . . . . 74.11 111.168 -179.937 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.627 ' HD2' HG22 ' A' ' 28' ' ' THR . 54.3 Cg_endo -69.73 64.43 1.79 Allowed 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.713 2.275 . . . . 73.12 112.387 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.01 155.32 8.58 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.71 0.766 . . . . 43.14 110.821 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 167.78 23.47 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.677 2.251 . . . . 74.23 112.309 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -171.48 0.48 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.698 2.265 . . . . 64.1 112.344 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 61.7 p -73.49 -26.29 60.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.427 . . . . 73.2 110.877 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -106.22 23.06 14.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.126 -0.488 . . . . 63.11 110.911 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.115 -0.493 . . . . 70.42 110.882 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.502 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.804 0.335 . . . . 71.01 110.888 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 54.4 t -154.69 -39.84 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 63.51 111.087 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.49 -12.03 76.97 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.746 -0.74 . . . . 13.31 112.492 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.502 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.6 m-85 -85.31 -40.78 16.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.904 0.383 . . . . 74.31 110.87 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -68.95 -33.18 73.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.09 -0.505 . . . . 51.35 110.898 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.0 mmtp -54.68 -32.04 58.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 70.51 110.888 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.93 -17.91 13.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 73.05 110.882 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.95 -45.13 8.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 64.54 110.944 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -66.72 -41.39 88.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 75.43 110.906 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.7 mmtt -69.12 -39.26 79.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 73.11 110.919 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -77.14 -23.96 51.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 54.41 110.901 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 6.9 mmt -84.26 -22.68 30.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.468 . . . . 53.02 110.898 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 7.4 tpt -85.59 -35.76 20.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 71.3 110.868 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -77.56 -24.92 49.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.25 -0.432 . . . . 73.11 110.889 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.413 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 1.4 pp20? -80.2 -30.74 38.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 71.05 110.909 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.09 -10.57 30.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.109 -0.496 . . . . 72.23 111.056 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.757 ' OD1' HG23 ' A' ' 28' ' ' THR . 0.7 OUTLIER -85.93 -9.68 56.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 72.54 110.914 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 119.73 42.57 0.52 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.747 -0.74 . . . . 70.11 112.493 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.413 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 9.8 tt0 -47.59 -25.61 1.21 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.745 0.307 . . . . 72.33 110.876 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.453 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -121.05 -10.92 9.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.434 . . . . 54.32 111.118 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.753 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -106.11 165.27 13.31 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.589 0.709 . . . . 63.33 111.1 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.753 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.9 Cg_endo -69.78 -4.61 14.39 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.684 2.256 . . . . 40.24 112.327 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.06 -34.83 78.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.454 . . . . 74.21 110.898 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -51.78 104.71 0.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 70.25 110.93 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.39 10.71 7.77 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.73 -0.748 . . . . 72.44 112.492 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 24.5 p -92.08 -54.89 3.65 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.762 0.315 . . . . 74.45 111.151 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -111.78 -8.36 14.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 72.52 110.907 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.757 HG23 ' OD1' ' A' ' 17' ' ' ASN . 0.0 OUTLIER -54.78 159.35 3.66 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.56 0.695 . . . . 74.44 111.14 -179.915 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.666 ' HD2' HG22 ' A' ' 28' ' ' THR . 53.9 Cg_endo -69.73 66.61 1.75 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.64 2.226 . . . . 61.11 112.37 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -55.02 155.33 8.58 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.64 0.733 . . . . 63.12 110.86 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 167.74 23.67 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.67 2.246 . . . . 73.13 112.309 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 -19.14 36.71 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.728 2.285 . . . . 62.42 112.353 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.6 p -80.98 -26.81 36.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.452 . . . . 73.01 110.849 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -99.26 -26.19 14.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 64.45 110.885 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 72.04 110.888 -179.985 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.507 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 4.2 mtmt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.875 0.369 . . . . 73.42 110.915 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 55.8 t -154.61 -39.44 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 65.24 111.113 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.0 -12.51 75.4 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.746 -0.74 . . . . 63.11 112.487 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.507 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.5 m-85 -84.82 -41.94 15.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.892 0.377 . . . . 61.03 110.904 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.411 ' O ' ' N ' ' A' ' 9' ' ' TYR . 24.2 m-85 -67.22 -33.32 75.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 73.43 110.881 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.11 -33.44 57.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 74.42 110.913 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -108.54 -19.62 13.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 73.02 110.897 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -89.23 -46.42 8.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 74.12 110.884 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.411 ' N ' ' O ' ' A' ' 5' ' ' PHE . 9.7 t80 -64.27 -42.38 96.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 75.32 110.89 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.27 -30.34 69.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 73.54 110.905 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -77.92 -36.88 48.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.201 -0.454 . . . . 73.35 110.901 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -77.26 -20.85 54.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 62.21 110.877 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 10.1 tmm? -84.93 -37.03 21.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 65.42 110.91 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -74.54 -28.8 61.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.189 -0.459 . . . . 72.01 110.899 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.455 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 23.6 pt-20 -76.24 -32.68 59.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.117 -0.492 . . . . 55.22 110.836 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -93.75 -9.36 37.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 52.33 111.114 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.02 -11.48 55.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 75.43 110.902 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 119.68 42.56 0.53 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.736 -0.745 . . . . 55.12 112.505 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.455 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 4.8 tm0? -47.62 -25.4 1.15 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.806 0.336 . . . . 71.2 110.915 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.472 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -120.02 -11.73 10.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 73.14 111.133 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.719 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -107.12 164.76 14.13 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.557 0.694 . . . . 70.35 111.103 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.719 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.5 Cg_endo -69.79 -4.18 13.52 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.615 2.21 . . . . 73.53 112.35 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -64.18 -32.2 73.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 65.35 110.936 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.19 104.17 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.094 -0.503 . . . . 75.43 110.894 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.82 -13.25 13.1 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.731 -0.747 . . . . 74.21 112.489 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 59.0 p -91.5 -37.16 13.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.687 0.279 . . . . 62.55 111.115 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -111.11 -2.6 15.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 74.14 110.912 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.7 t -45.73 146.87 1.74 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.6 0.714 . . . . 71.11 111.099 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 64.98 1.83 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.68 2.253 . . . . 71.01 112.339 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.15 155.29 9.17 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.7 0.762 . . . . 71.22 110.832 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 167.7 23.69 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.682 2.255 . . . . 72.41 112.368 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 167.54 24.05 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.668 2.245 . . . . 51.12 112.36 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.08 -28.85 65.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.444 . . . . 63.31 110.886 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -79.33 -26.4 42.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.095 -0.502 . . . . 75.02 110.888 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 71.52 110.877 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.49 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.792 0.329 . . . . 73.22 110.91 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.408 HG12 ' HE3' ' A' ' 6' ' ' LYS . 53.4 t -155.16 -39.73 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 75.53 111.145 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.68 -11.7 83.02 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.732 -0.747 . . . . 62.41 112.487 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.49 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.5 m-85 -85.39 -43.46 13.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.914 0.388 . . . . 74.44 110.855 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.409 ' O ' ' N ' ' A' ' 9' ' ' TYR . 20.9 m-85 -67.18 -32.69 73.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 74.23 110.837 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.408 ' HE3' HG12 ' A' ' 2' ' ' VAL . 0.4 OUTLIER -54.03 -33.8 58.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.13 -0.486 . . . . 64.21 110.904 179.949 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.84 -19.42 13.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 73.21 110.866 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -89.47 -46.4 8.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 73.42 110.895 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.409 ' N ' ' O ' ' A' ' 5' ' ' PHE . 9.9 t80 -63.99 -43.17 96.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 72.23 110.938 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.5 ptmt -66.25 -32.41 73.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.116 -0.493 . . . . 73.33 110.927 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -75.38 -36.61 60.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 62.41 110.854 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 22.4 mtm -74.87 -25.33 58.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 53.33 110.885 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.23 -37.57 32.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 73.51 110.898 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -72.58 -31.98 65.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 75.43 110.914 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.415 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 6.3 pt-20 -74.21 -31.23 62.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 75.15 110.859 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -94.38 -10.18 33.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 75.04 111.089 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.8 -10.18 55.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 74.32 110.885 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 119.98 42.28 0.52 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.757 -0.735 . . . . 63.22 112.496 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.415 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 25.0 tp60 -47.75 -25.7 1.33 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.793 0.33 . . . . 74.24 110.881 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.446 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -121.21 -10.89 9.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 74.21 111.127 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.743 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -106.5 165.15 13.46 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.618 0.723 . . . . 73.04 111.055 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.743 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.8 Cg_endo -69.81 -4.33 13.84 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.685 2.257 . . . . 74.45 112.383 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -64.27 -34.16 77.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 74.21 110.874 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -51.91 103.87 0.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 75.22 110.896 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.463 ' HA2' ' CG2' ' A' ' 28' ' ' THR . . . 118.1 23.99 3.41 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.752 -0.737 . . . . 65.42 112.492 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 90.9 m -93.1 -66.74 0.9 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.775 0.321 . . . . 52.21 111.148 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -117.11 -3.18 11.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 74.52 110.93 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.463 ' CG2' ' HA2' ' A' ' 25' ' ' GLY . 0.7 OUTLIER -46.27 148.19 1.65 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.608 0.718 . . . . 74.5 111.13 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 65.32 1.78 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.644 2.23 . . . . 74.03 112.368 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.1 p -73.85 155.34 88.83 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.649 0.738 . . . . 64.42 110.87 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 167.8 23.36 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.655 2.237 . . . . 74.23 112.36 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 170.45 16.54 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.697 2.264 . . . . 63.42 112.364 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 57.8 m -68.76 -19.9 64.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 65.21 110.867 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -95.33 23.14 6.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 73.13 110.912 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.48 . . . . 64.11 110.901 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.505 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 1.4 mtmm . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.814 0.34 . . . . 64.11 110.935 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 55.5 t -154.46 -39.4 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 63.23 111.121 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.58 -11.6 77.12 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.739 -0.743 . . . . 70.14 112.493 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.505 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.6 m-85 -85.85 -39.48 16.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.901 0.382 . . . . 73.23 110.879 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.436 ' O ' ' N ' ' A' ' 9' ' ' TYR . 24.1 m-85 -69.62 -34.28 73.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 74.31 110.846 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.43 -31.22 54.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 74.53 110.888 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 10.7 mtp180 -110.38 -19.27 13.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 74.2 110.873 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -90.34 -46.26 8.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 64.23 110.9 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.436 ' N ' ' O ' ' A' ' 5' ' ' PHE . 9.7 t80 -63.52 -42.68 98.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.22 -0.446 . . . . 73.55 110.928 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.5 mmmt -70.73 -29.16 65.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 64.44 110.902 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -81.2 -30.02 34.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 75.13 110.913 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 5.0 ptt? -80.92 -24.8 37.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 64.5 110.871 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 8.8 ptt? -85.87 -33.9 21.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 51.13 110.856 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -79.14 -24.47 43.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 65.33 110.903 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.452 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 0.0 OUTLIER -80.8 -31.06 35.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 72.35 110.895 -179.911 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.02 -9.79 32.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 45.12 111.088 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.24 -11.39 54.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.431 . . . . 74.24 110.861 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 119.71 42.44 0.53 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.782 -0.723 . . . . 33.51 112.499 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.452 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 0.7 OUTLIER -47.67 -25.32 1.15 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.738 0.304 . . . . 73.04 110.923 -179.899 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.477 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -119.93 -11.63 10.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 63.0 111.157 179.94 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.724 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -106.96 164.74 14.18 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.556 0.693 . . . . 74.14 111.111 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.724 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.2 Cg_endo -69.83 -4.46 14.12 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.709 2.272 . . . . 65.34 112.307 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -63.01 -35.73 81.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.235 -0.439 . . . . 73.23 110.919 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -53.96 104.12 0.1 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 70.34 110.918 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.77 -6.48 15.88 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.743 -0.742 . . . . 31.25 112.5 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 86.7 m -90.46 -48.38 7.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.734 0.302 . . . . 72.15 111.171 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -111.08 -6.81 14.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 73.1 110.884 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -47.75 155.49 0.8 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.541 0.686 . . . . 73.12 111.131 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 68.92 1.67 Allowed 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.666 2.244 . . . . 72.45 112.39 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.4 m -60.92 155.35 54.18 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.626 0.727 . . . . 70.44 110.878 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 167.71 23.69 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.664 2.243 . . . . 72.22 112.33 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 -18.42 37.33 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.707 2.271 . . . . 65.11 112.336 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 60.1 m -57.64 -27.72 63.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 33.41 110.854 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.6 -26.47 29.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.117 -0.492 . . . . 72.23 110.885 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.6 tttm . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 73.22 110.91 179.983 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.504 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.851 0.358 . . . . 75.54 110.922 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 54.3 t -154.66 -39.94 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 62.23 111.126 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.3 -12.16 76.28 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.754 -0.736 . . . . 52.32 112.497 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.504 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.5 m-85 -85.24 -40.99 16.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.892 0.377 . . . . 71.21 110.893 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -68.48 -33.11 73.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 71.53 110.888 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.3 mmtt -53.9 -34.34 59.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 74.12 110.907 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -108.7 -18.79 13.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 74.42 110.84 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -89.37 -46.12 8.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 73.4 110.899 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -65.38 -40.69 93.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 75.31 110.881 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.64 -30.73 70.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.466 . . . . 74.4 110.875 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -74.85 -39.88 61.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 63.31 110.859 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 17.9 ptp -76.98 -20.66 55.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 70.13 110.859 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -84.69 -36.94 21.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 72.34 110.896 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.57 -30.37 61.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.226 -0.443 . . . . 54.21 110.918 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.421 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 12.7 pt-20 -75.37 -30.83 60.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.098 -0.501 . . . . 73.23 110.877 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -94.95 -9.73 33.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 71.31 111.104 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -87.94 -6.44 58.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 74.32 110.9 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 120.32 47.59 0.33 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.768 -0.73 . . . . 74.33 112.469 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.421 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -46.51 -25.0 0.6 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.788 0.328 . . . . 61.31 110.89 -179.866 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.463 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -118.78 -12.49 10.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 64.3 111.096 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.629 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -107.43 161.48 22.95 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.609 0.719 . . . . 54.23 111.09 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.629 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.7 Cg_endo -69.73 -5.92 17.35 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.667 2.245 . . . . 75.32 112.374 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -56.48 -32.34 64.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 74.55 110.89 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -50.45 103.6 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 74.02 110.855 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.13 4.75 15.84 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.74 -0.743 . . . . 74.24 112.495 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 62.9 m -90.19 -44.32 9.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.756 0.312 . . . . 74.24 111.153 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.16 -3.57 15.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 71.41 110.941 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -47.77 155.36 0.81 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.591 0.71 . . . . 72.13 111.098 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 69.64 1.63 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.673 2.248 . . . . 74.31 112.362 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.75 155.36 31.07 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.634 0.73 . . . . 73.13 110.881 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.83 167.71 23.75 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.693 2.262 . . . . 70.21 112.298 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 137.01 34.63 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.689 2.259 . . . . 71.52 112.35 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.3 t -68.59 -30.15 68.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 51.42 110.845 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -74.23 -26.78 60.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 75.31 110.866 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.7 mttt . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 74.33 110.891 179.933 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.489 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.84 0.352 . . . . 73.12 110.885 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 54.5 t -155.09 -39.66 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 51.54 111.096 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.63 -11.49 82.97 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.738 -0.744 . . . . 70.15 112.488 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.489 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.4 m-85 -85.78 -42.46 14.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.884 0.373 . . . . 71.23 110.921 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.42 ' O ' ' HB3' ' A' ' 9' ' ' TYR . 18.1 m-85 -68.81 -31.62 70.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 72.23 110.902 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.6 mttt -54.41 -35.1 62.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 73.41 110.922 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -108.7 -18.13 13.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 55.31 110.904 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -90.15 -45.8 8.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 62.33 110.948 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.42 ' HB3' ' O ' ' A' ' 5' ' ' PHE . 9.7 t80 -64.9 -41.85 95.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.455 . . . . 72.11 110.891 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 11.6 pttm -65.42 -35.25 80.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 72.43 110.893 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.18 -25.54 42.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 63.35 110.897 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -83.17 -22.8 33.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 71.24 110.906 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 34.4 ttp -84.8 -36.28 21.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 73.12 110.866 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -77.36 -25.58 51.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.227 -0.442 . . . . 73.5 110.9 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.424 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 0.9 OUTLIER -79.48 -29.82 41.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 73.44 110.89 -179.972 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.6 -11.98 26.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 71.52 111.12 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -87.27 -6.55 58.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 74.4 110.899 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 117.47 45.4 0.52 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.735 -0.745 . . . . 63.34 112.485 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.424 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 4.7 tt0 -46.97 -24.66 0.65 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.759 0.314 . . . . 72.34 110.91 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.485 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -117.44 -13.26 10.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.247 -0.433 . . . . 72.13 111.121 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.665 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -108.51 162.68 19.1 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.576 0.703 . . . . 74.1 111.104 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.665 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.4 Cg_endo -69.75 -4.27 13.69 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.658 2.239 . . . . 73.43 112.341 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -56.47 -34.02 66.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 74.43 110.901 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -49.96 103.68 0.06 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 52.41 110.888 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.29 4.26 16.11 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.765 -0.731 . . . . 75.14 112.52 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.0 m -90.18 -50.55 5.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.772 0.32 . . . . 63.32 111.142 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -111.06 -3.65 15.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 53.45 110.935 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -47.87 155.33 0.84 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.585 0.707 . . . . 72.3 111.153 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 69.48 1.63 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.692 2.261 . . . . 65.11 112.375 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.27 155.34 57.42 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.645 0.736 . . . . 72.23 110.856 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 167.75 23.55 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.708 2.272 . . . . 73.32 112.336 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 89.09 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.74 2.294 . . . . 65.52 112.324 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.07 -31.94 34.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 74.43 110.884 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.0 -26.98 61.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.475 . . . . 71.13 110.861 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 74.3 110.942 179.956 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.492 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.8 0.333 . . . . 74.14 110.873 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 54.3 t -155.11 -39.7 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 65.01 111.119 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.73 -11.43 83.26 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.691 -0.766 . . . . 63.1 112.494 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.492 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.5 m-85 -85.71 -42.68 14.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.896 0.379 . . . . 72.0 110.892 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.418 ' O ' ' HB3' ' A' ' 9' ' ' TYR . 16.2 m-85 -69.17 -31.15 69.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 72.32 110.867 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.29 -32.94 62.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.159 -0.473 . . . . 74.45 110.903 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.22 -17.4 13.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 74.35 110.865 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -91.16 -44.94 8.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 73.41 110.897 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.418 ' HB3' ' O ' ' A' ' 5' ' ' PHE . 9.3 t80 -67.49 -41.38 84.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 73.31 110.88 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.2 mmtt -69.29 -39.13 78.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 75.14 110.864 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -76.71 -25.35 53.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.216 -0.447 . . . . 75.12 110.87 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.2 mmm -83.09 -23.19 33.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 71.13 110.819 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.402 ' O ' ' HB2' ' A' ' 17' ' ' ASN . 0.0 OUTLIER -83.78 -36.83 23.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.247 -0.433 . . . . 62.23 110.874 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -72.46 -31.85 65.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.199 -0.455 . . . . 74.45 110.905 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.422 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 21.5 pt-20 -73.02 -35.37 66.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 74.43 110.883 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -91.11 -8.67 48.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 74.43 111.147 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 13' ' ' MET . 0.6 OUTLIER -85.6 -11.3 54.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.241 -0.436 . . . . 74.55 110.868 -179.946 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.425 ' N ' HD22 ' A' ' 24' ' ' ASN . . . 121.52 42.78 0.45 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.744 -0.741 . . . . 55.01 112.499 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.422 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 3.5 tt0 -46.22 -25.91 0.69 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.78 0.324 . . . . 54.32 110.924 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.413 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -124.99 -10.01 6.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 74.41 111.205 179.923 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.755 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -107.11 165.49 12.75 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.619 0.723 . . . . 71.23 111.06 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.755 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.9 Cg_endo -69.72 -19.96 35.63 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.684 2.256 . . . . 65.2 112.36 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -51.02 -24.23 3.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 55.03 110.919 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.425 HD22 ' N ' ' A' ' 18' ' ' GLY . 1.5 t-20 -69.3 104.85 2.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.091 -0.504 . . . . 75.02 110.838 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.79 -12.81 13.27 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.782 -0.723 . . . . 63.4 112.545 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.0 m -90.36 -43.31 10.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.745 0.307 . . . . 75.23 111.193 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -111.15 -8.69 14.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 74.23 110.931 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -47.54 155.64 0.73 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.614 0.721 . . . . 64.42 111.146 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 68.64 1.69 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.68 2.253 . . . . 74.0 112.335 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.41 155.3 75.58 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.625 0.726 . . . . 74.41 110.874 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.71 167.74 23.49 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.674 2.249 . . . . 61.23 112.403 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 130.69 19.71 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.698 2.266 . . . . 74.32 112.332 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 46.6 m -91.4 -31.56 15.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 63.24 110.864 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -94.09 -26.79 16.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 73.32 110.892 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 73.44 110.924 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.454 ' N ' ' HE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.843 0.354 . . . . 63.13 110.93 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.3 t -143.4 -36.86 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 73.12 111.14 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.96 -11.67 81.28 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.757 -0.735 . . . . 73.03 112.45 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.454 ' HE1' ' N ' ' A' ' 1' ' ' LYS . 1.7 m-85 -86.16 -42.42 13.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.918 0.39 . . . . 64.23 110.87 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.409 ' O ' ' HB3' ' A' ' 9' ' ' TYR . 24.0 m-85 -69.51 -30.97 68.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 73.35 110.853 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.3 mmtm -55.53 -34.59 64.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.14 -0.482 . . . . 72.34 110.943 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 10.8 ptt180 -108.59 -18.19 13.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 72.13 110.859 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -89.62 -46.16 8.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 54.02 110.899 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.409 ' HB3' ' O ' ' A' ' 5' ' ' PHE . 9.6 t80 -65.15 -42.49 93.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 71.24 110.907 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.97 -29.61 68.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 72.41 110.893 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -78.22 -37.08 46.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.215 -0.448 . . . . 75.4 110.839 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.9 ppp? -77.28 -21.01 54.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.474 . . . . 42.11 110.901 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.2 tpt -85.16 -36.74 20.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 62.21 110.877 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -75.09 -28.02 60.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.226 -0.443 . . . . 74.31 110.91 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -76.95 -32.73 57.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.48 . . . . 74.3 110.915 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -93.06 -10.31 36.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 72.04 111.143 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.5 -10.47 55.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 61.42 110.905 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 120.11 42.3 0.52 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.688 -0.768 . . . . 70.34 112.512 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -47.76 -25.57 1.29 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.777 0.322 . . . . 75.11 110.94 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.461 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -121.33 -11.12 9.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.161 -0.472 . . . . 71.11 111.13 179.967 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.735 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -106.72 164.66 14.39 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.555 0.693 . . . . 73.43 111.098 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.735 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.6 Cg_endo -69.78 -4.72 14.6 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.698 2.265 . . . . 42.52 112.321 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -62.61 -34.74 77.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 73.34 110.899 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -54.57 104.13 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 65.34 110.859 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.7 -6.51 16.0 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.725 -0.75 . . . . 54.11 112.456 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.2 p -90.43 -48.4 7.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.703 0.287 . . . . 71.42 111.105 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -111.05 -6.81 14.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 74.32 110.951 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -47.79 155.54 0.8 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.631 0.729 . . . . 71.32 111.118 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 68.94 1.68 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.67 2.247 . . . . 54.0 112.345 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -92.95 155.32 41.51 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.662 0.744 . . . . 72.02 110.85 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 167.74 23.49 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.69 2.26 . . . . 64.33 112.374 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 -21.52 33.42 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.705 2.27 . . . . 65.11 112.365 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.63 -29.27 68.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 72.2 110.827 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.41 -26.23 51.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.125 -0.489 . . . . 63.21 110.917 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.118 -0.492 . . . . 73.13 110.926 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.459 ' H2 ' ' HE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.787 0.327 . . . . 74.24 110.878 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.9 t -142.99 -36.7 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 75.15 111.119 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.29 -12.57 83.47 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.807 -0.711 . . . . 43.33 112.466 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.459 ' HE1' ' H2 ' ' A' ' 1' ' ' LYS . 1.6 m-85 -85.72 -45.41 11.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.848 0.356 . . . . 74.04 110.865 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.44 ' O ' ' HB3' ' A' ' 9' ' ' TYR . 21.5 m-85 -67.43 -29.36 68.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 71.32 110.884 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -55.98 -35.12 66.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 63.12 110.898 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.4 ptt85 -108.68 -18.31 13.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 73.21 110.891 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -89.25 -46.29 8.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.459 . . . . 70.3 110.914 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.44 ' HB3' ' O ' ' A' ' 5' ' ' PHE . 9.9 t80 -64.84 -42.2 95.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 73.42 110.925 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.08 -33.31 75.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.144 -0.48 . . . . 71.4 110.876 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -74.23 -37.6 63.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.438 . . . . 74.12 110.935 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.34 -24.7 59.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 73.12 110.93 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.23 -37.37 28.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 74.1 110.842 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -74.08 -29.14 61.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 72.15 110.864 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.415 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 6.2 pt-20 -76.81 -30.81 56.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 72.21 110.862 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -94.93 -10.28 31.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 64.21 111.104 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -86.02 -10.05 55.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 73.14 110.892 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 120.04 42.55 0.51 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.728 -0.749 . . . . 52.22 112.448 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.415 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 4.3 tp-100 -47.61 -25.6 1.21 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.782 0.325 . . . . 75.24 110.911 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.463 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -120.95 -11.16 9.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 62.34 111.134 179.932 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.738 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -106.68 165.02 13.66 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.623 0.725 . . . . 64.33 111.041 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.738 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.8 Cg_endo -69.76 -4.22 13.59 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.705 2.27 . . . . 75.44 112.345 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.641 ' O ' HG22 ' A' ' 26' ' ' THR . 3.8 mt-10 -65.17 -31.81 73.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.464 . . . . 72.24 110.863 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -52.58 104.19 0.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 62.31 110.873 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.87 -7.03 13.32 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.747 -0.74 . . . . 74.33 112.551 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.641 HG22 ' O ' ' A' ' 23' ' ' GLU . 7.0 t -90.77 -31.88 16.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.749 0.309 . . . . 73.31 111.121 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -111.9 -12.52 13.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 64.42 110.923 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -47.35 155.84 0.67 Allowed Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.61 0.719 . . . . 71.22 111.177 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 67.74 1.73 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.716 2.277 . . . . 73.32 112.343 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.9 155.29 54.31 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.692 0.758 . . . . 74.44 110.885 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 167.75 23.48 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.693 2.262 . . . . 73.34 112.353 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -19.06 36.48 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.716 2.277 . . . . 63.33 112.363 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.3 t -68.35 -31.74 71.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 74.45 110.81 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -90.2 -26.86 19.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 74.22 110.884 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.3 mttt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.49 . . . . 73.44 110.928 -179.993 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.498 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 1.4 mtmm . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.789 0.328 . . . . 72.0 110.924 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 55.6 t -154.49 -39.44 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 70.22 111.135 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.04 -12.55 75.57 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.704 -0.76 . . . . 43.44 112.438 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.498 ' CE1' ' HA ' ' A' ' 1' ' ' LYS . 1.6 m-85 -84.8 -41.71 15.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.87 0.367 . . . . 72.11 110.884 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.438 ' O ' ' N ' ' A' ' 9' ' ' TYR . 24.3 m-85 -67.39 -33.73 75.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.467 . . . . 71.2 110.846 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.95 -32.71 54.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 75.31 110.905 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.0 ptt180 -109.21 -19.47 13.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.445 . . . . 63.24 110.92 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.433 ' HA ' ' HG2' ' A' ' 11' ' ' GLU . 0.8 OUTLIER -90.0 -45.34 9.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 75.05 110.919 -179.948 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.438 ' N ' ' O ' ' A' ' 5' ' ' PHE . 9.3 t80 -65.83 -40.16 91.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 74.34 110.961 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.2 ptmt -63.87 -40.32 96.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.094 -0.503 . . . . 65.55 110.889 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.433 ' HG2' ' HA ' ' A' ' 8' ' ' GLN . 9.6 pt-20 -77.11 -25.92 52.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 74.03 110.872 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.06 -22.11 33.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 64.43 110.895 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.7 tpt -85.03 -36.66 21.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 70.51 110.905 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -76.33 -26.66 55.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.271 -0.422 . . . . 71.3 110.891 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.443 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 22.9 pt-20 -78.43 -30.59 47.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 62.31 110.89 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -94.88 -11.58 28.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 72.11 111.115 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -87.24 -6.93 58.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.438 . . . . 62.4 110.913 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 117.98 45.58 0.49 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.709 -0.758 . . . . 32.5 112.511 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.443 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 6.1 tt0 -46.91 -24.66 0.63 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.755 0.312 . . . . 74.14 110.874 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.493 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -117.17 -13.29 10.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 34.1 111.128 179.949 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.651 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -108.72 162.48 19.85 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.568 0.699 . . . . 63.44 111.102 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.651 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.3 Cg_endo -69.82 -4.39 13.96 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.657 2.238 . . . . 71.53 112.342 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -56.73 -33.07 66.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.229 -0.441 . . . . 71.24 110.917 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -49.58 103.55 0.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 70.43 110.871 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.438 ' HA2' ' CG2' ' A' ' 28' ' ' THR . . . 116.71 32.95 1.49 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.701 -0.761 . . . . 25.13 112.484 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 93.1 m -92.76 -69.69 0.73 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.759 0.314 . . . . 72.41 111.108 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.43 -2.72 11.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 42.02 110.949 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.438 ' CG2' ' HA2' ' A' ' 25' ' ' GLY . 0.7 OUTLIER -46.98 148.22 1.99 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.573 0.701 . . . . 72.44 111.095 -179.905 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 65.34 1.81 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.662 2.241 . . . . 63.22 112.36 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.3 p -68.63 155.32 93.21 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.679 0.752 . . . . 73.33 110.857 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 167.7 23.77 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.689 2.259 . . . . 74.11 112.304 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 171.08 15.05 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.706 2.271 . . . . 75.33 112.367 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 31.3 p -59.46 -35.28 73.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.237 -0.438 . . . . 74.32 110.843 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -63.5 -26.04 68.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.103 -0.498 . . . . 71.1 110.875 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.7 mtmt . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 72.12 110.934 179.989 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.431 ' N ' ' HE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.829 0.347 . . . . 73.51 110.902 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 41.1 t -142.99 -36.78 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 71.25 111.117 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.31 -12.03 83.81 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.711 -0.757 . . . . 71.32 112.512 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.431 ' HE1' ' N ' ' A' ' 1' ' ' LYS . 1.6 m-85 -86.24 -43.92 12.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.885 0.374 . . . . 71.02 110.888 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.451 ' O ' ' HB3' ' A' ' 9' ' ' TYR . 20.6 m-85 -69.17 -29.17 67.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.1 -0.5 . . . . 63.22 110.862 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.23 -35.77 67.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 71.42 110.862 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -108.4 -17.47 13.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 65.53 110.914 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -90.01 -45.96 8.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 65.03 110.91 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.451 ' HB3' ' O ' ' A' ' 5' ' ' PHE . 9.6 t80 -65.64 -41.73 92.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 74.15 110.915 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.4 ptmt -64.82 -33.8 76.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.127 -0.488 . . . . 72.42 110.85 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.49 -34.15 58.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 75.53 110.904 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.4 ptt? -77.91 -21.49 51.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 74.14 110.895 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.52 -36.94 21.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.431 . . . . 71.34 110.874 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -74.43 -29.05 61.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 70.24 110.901 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.404 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 23.4 pt-20 -76.17 -32.74 59.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 62.34 110.88 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -93.0 -10.3 36.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 60.14 111.115 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.47 -10.46 56.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 73.31 110.917 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 120.07 42.33 0.52 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.759 -0.734 . . . . 35.14 112.488 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.404 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 11.6 tt0 -47.74 -25.61 1.3 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.807 0.337 . . . . 73.32 110.931 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.453 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -121.36 -11.08 9.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.479 . . . . 74.52 111.166 179.97 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.727 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -106.74 164.61 14.5 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.581 0.705 . . . . 41.13 111.092 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.727 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 54.0 Cg_endo -69.68 -4.72 14.53 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.735 2.29 . . . . 74.42 112.343 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -62.55 -34.83 77.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.429 . . . . 73.12 110.903 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -54.49 104.01 0.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.467 . . . . 70.31 110.898 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.68 -6.48 16.07 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.745 -0.741 . . . . 74.21 112.48 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 24.6 m -90.36 -48.45 7.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.747 0.308 . . . . 73.21 111.138 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -111.03 -6.81 14.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 72.33 110.932 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -47.83 155.52 0.81 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.612 0.72 . . . . 75.11 111.11 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 68.91 1.7 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.655 2.236 . . . . 63.44 112.361 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.2 m -55.71 155.35 11.14 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.67 0.748 . . . . 72.31 110.873 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 167.71 23.64 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.725 2.283 . . . . 64.43 112.338 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 177.69 5.32 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.728 2.285 . . . . 62.44 112.337 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.23 -27.36 24.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 71.11 110.851 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -70.85 -26.17 63.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 74.11 110.854 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.3 ttmt . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.195 -0.457 . . . . 74.41 110.893 179.971 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.543 ' HD3' ' H1 ' ' A' ' 1' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.78 0.324 . . . . 64.41 110.912 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.8 t -143.62 -36.84 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.431 . . . . 73.13 111.105 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.65 -11.45 83.03 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.734 -0.746 . . . . 72.44 112.5 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.476 ' HE1' ' H2 ' ' A' ' 1' ' ' LYS . 1.8 m-85 -86.16 -41.12 14.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.929 0.395 . . . . 75.14 110.902 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.414 ' O ' ' HB3' ' A' ' 9' ' ' TYR . 23.4 m-85 -70.8 -33.0 70.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 73.34 110.86 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 42.6 mmtt -56.02 -29.3 60.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.169 -0.469 . . . . 60.15 110.914 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.93 -18.79 12.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.446 . . . . 64.25 110.854 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -92.0 -45.49 8.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 51.42 110.91 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.414 ' HB3' ' O ' ' A' ' 5' ' ' PHE . 9.2 t80 -64.73 -38.6 91.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 72.21 110.913 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.7 mmtt -70.89 -37.37 72.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 72.04 110.905 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.15 -27.98 54.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 51.42 110.868 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -82.99 -19.95 36.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 74.41 110.902 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.73 -36.14 18.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 65.21 110.902 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -76.78 -25.99 53.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.239 -0.437 . . . . 55.43 110.902 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.411 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 1.0 OUTLIER -78.88 -31.87 45.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.105 -0.498 . . . . 71.24 110.901 -179.957 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -93.97 -10.49 33.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 55.42 111.119 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.59 -10.33 56.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 45.54 110.868 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 120.16 42.37 0.51 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.739 -0.744 . . . . 63.14 112.509 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.411 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 10.0 tt0 -47.57 -25.63 1.2 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.766 0.317 . . . . 75.21 110.925 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.463 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -121.23 -11.1 9.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 72.51 111.162 179.932 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.734 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -106.7 164.72 14.28 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.549 0.69 . . . . 53.2 111.129 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.734 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 54.0 Cg_endo -69.74 -4.72 14.59 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.733 2.289 . . . . 72.53 112.337 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -62.89 -34.33 77.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.238 -0.437 . . . . 54.44 110.859 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -54.49 104.11 0.1 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 72.5 110.887 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.62 -5.78 16.59 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.71 -0.757 . . . . 45.11 112.514 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 66.5 p -90.39 -48.58 7.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.76 0.314 . . . . 74.54 111.123 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.04 -6.74 14.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 73.43 110.906 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -47.72 155.52 0.79 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.576 0.703 . . . . 65.34 111.167 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 68.93 1.69 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.664 2.242 . . . . 53.04 112.394 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.94 155.29 43.96 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.67 0.747 . . . . 55.11 110.841 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 167.76 23.47 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.647 2.231 . . . . 70.32 112.359 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -21.68 33.09 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.708 2.272 . . . . 64.11 112.298 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.6 t -73.9 -26.57 60.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.258 -0.428 . . . . 63.13 110.882 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.54 -26.23 20.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 74.01 110.863 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 74.11 110.917 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.504 ' HD3' ' H1 ' ' A' ' 1' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.805 0.336 . . . . 73.55 110.869 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.3 t -143.3 -36.53 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 71.1 111.102 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.01 -12.07 83.58 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.771 -0.728 . . . . 52.14 112.487 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.446 ' HE1' ' N ' ' A' ' 1' ' ' LYS . 1.7 m-85 -85.78 -43.83 13.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.836 0.351 . . . . 72.22 110.868 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -68.4 -31.64 71.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.188 -0.46 . . . . 53.52 110.854 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.93 -31.04 62.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 74.44 110.884 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -110.86 -18.88 13.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.269 -0.423 . . . . 72.02 110.905 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -90.63 -45.68 8.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 74.12 110.91 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -63.66 -42.97 98.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.25 -0.432 . . . . 71.14 110.922 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.9 mmmm -65.51 -40.43 92.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 72.02 110.87 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -75.12 -26.04 58.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 71.12 110.918 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 21.2 mmm -82.96 -21.85 33.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 71.33 110.852 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -85.74 -35.99 20.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 72.12 110.875 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -77.16 -24.99 51.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 73.11 110.866 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.462 ' HA ' ' HB2' ' A' ' 19' ' ' GLN . 0.0 OUTLIER -80.17 -31.07 38.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 74.0 110.915 -179.935 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.23 -9.7 32.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.134 -0.485 . . . . 44.12 111.112 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.19 -11.38 55.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 75.53 110.956 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 119.85 42.68 0.51 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.728 -0.749 . . . . 72.53 112.481 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.462 ' HB2' ' HA ' ' A' ' 15' ' ' GLU . 5.3 tm0? -47.4 -25.36 1.01 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.802 0.334 . . . . 73.53 110.931 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.483 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -119.46 -11.76 10.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.436 . . . . 62.23 111.106 179.985 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.726 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -106.98 165.04 13.56 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.588 0.709 . . . . 71.5 111.101 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.726 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 53.4 Cg_endo -69.83 -3.89 12.97 Favored 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.723 2.282 . . . . 62.44 112.335 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.649 ' O ' HG22 ' A' ' 26' ' ' THR . 0.6 OUTLIER -66.36 -31.19 71.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 72.33 110.87 -179.984 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -51.83 104.34 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 64.53 110.88 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.2 -7.65 12.63 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.785 -0.722 . . . . 60.12 112.495 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.649 HG22 ' O ' ' A' ' 23' ' ' GLU . 6.8 t -91.53 -31.16 16.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.785 0.326 . . . . 74.32 111.172 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -111.81 -2.84 15.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 75.32 110.933 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.6 t -45.88 147.03 1.77 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.578 0.704 . . . . 74.55 111.165 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 65.0 1.77 Allowed 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.685 2.257 . . . . 61.2 112.365 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.48 155.37 20.08 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.681 0.753 . . . . 74.11 110.831 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 167.76 23.57 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.658 2.238 . . . . 73.01 112.341 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -35.83 11.96 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.672 2.248 . . . . 72.52 112.342 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 p -59.5 -28.29 66.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.445 . . . . 74.52 110.821 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.97 -26.45 13.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 64.43 110.863 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.0 tptm . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 63.12 110.868 179.927 . . . . . . . . 0 0 . 1 stop_ save_